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Abstract
Introduction: Many women living with HIV can have safe, healthy and satisfying sexual and reproductive health, but there is still
a long way to go for this to be a reality, especially for the most vulnerable amongst them who face repeated violations of their
rights.
Discussion: The contributions in this Supplement from researchers, clinicians, programme managers, policy makers, and women
living with HIV demands an important appreciation that the field of sexual and reproductive health and human rights for women
living with HIV is complex on many levels, and women living with HIV form a very diverse community.
Conclusions: The manuscripts emphasize that attention must be paid to the following critical dimensions: 1) Placing human
rights and gender equality at the centre of a comprehensive approach to health programming, in particular in relation to
sexuality and sexual health; 2) Ensuring health systems responsiveness to minimizing inequalities in access to health care and
quality of care that often do not meet the needs of women living with HIV; 3) Engaging and empowering women living with
HIV in the development of policies and programmes that affect them; and 4) Strengthening monitoring, evaluation and
accountability procedures to provide good quality data and ensuring remedies for violations of health and human rights of
women living with HIV.
Keywords: HIV; women’s health; sexual health; reproductive health; reproductive rights; gender; equity; human rights.
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Introduction
An integrated approach to health and human rights lies at
the heart of ensuring dignity and well-being of individuals
around the world and is linked to improvements in the up-
take of services and incidence of positive outcomes. Through
the roll out of antiretroviral treatment, advances in over-
coming stigma and discrimination, and development of HIV
prevention interventions, the HIV and AIDS response has
given hope for a healthy life for many around the world.
However, for those who remain the most vulnerable, there is
not nearly enough progress. Women and girls, for instance,
remain especially vulnerable to HIV infection because of
a host of biological, social, cultural and economic reasons,
including women’s entrenched social and economic inequal-
ity within sexual relationships and marriage. HIV is not only
driven by gender inequality, but it also entrenches gender
inequality, leaving women more vulnerable to its impact [1].
Moreover, women and girls at risk of, or living with, HIV
have additional challenges linked to sexual and reproductive
health that includes risk of unintended pregnancy, complica-
tions arising from unsafe abortions and a host of other sexual
and reproductive health morbidities. Violence, whether it be
physical, sexual and/or emotional, or fear of violence can
prevent women from negotiating safer sex and from learning
and/or sharing their HIV status if the results turn out positive.
In addition, women living with HIV are sometimes blamed for
bringing HIV into the family and for being immoral and
breaking sexual norms. Many women living with HIV can
achieve safe and satisfying sex lives, but there is still a long
way to go for this to be a reality for the most vulnerable
amongst them who face repeated violations of their rights.
For this special Supplement, we sought for seminal, peer-
reviewed contributions that discussed varied perspectives
and topics related to sexual and reproductive health and
human rights of women living with HIV. These perspectives
include contributions from researchers, clinicians, programme
managers, policy makers and women living with HIV. The
latter perspective is important in allowing this Supplement to
hear the voices of the women that we aim to support. The
topics in this Supplement are equally varied from HIV preg-
nancy programming and sexual health to safer disclosure of
HIV, mental health and violence, amongst others. This wide
range of topics demands an appreciation of the fact that
the field of sexual and reproductive health and human rights
for women living with HIV is complex on many levels, and
women living with HIV form a very diverse community.
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The potential solutions regarding gender inequalities [2]
and the challenges of ensuring human rights considerations
as present in normative bodies [3], policies and programmes
[4] reflect two cross-cutting issues, gender equality and
human rights, that permeate the whole Supplement and
form the foundation for strengthened services that meet the
needs of women living with HIV.
The papers on sexual health for women living with HIV
were purposively positioned before those on reproductive
health, given that sexual health and the right to a safe and
satisfying sex life [5] is a topic often not addressed by clini-
cians despite its vital importance, at a personal level for
women, especially in an era of over-criminalization of HIV.
Whether in resource-constrained or wealthier settings, women
living with HIV should be offered choices and health inter-
ventions that would allow them to lead healthier lives. This is
true, for instance, of cervical cancer, which is a disease that is
preventable, but for which screening and prevention in low-
income countries [6] remains a challenge. Two other topics
that have developed a significant amount of momentum
globally over the past decade include the development and
delivery of preconception services for women and couples
affected by HIV in resource-constrained settings [7] and the
roll out of Option B for the management of women living
with HIV during the perinatal period [8], which has been a
breakthrough for infant, maternal and women’s treatment of
HIV at the global level, but which needs to be implemented
within a rights-based framework.
The next set of papers are about women’s mental health,
gender-based violence and disclosure  three of the most
core topics of importance to, and experienced by, women
living with HIV, issues that are under-addressed and under-
recognized, but fundamentally affect the experiences of
women living with HIV in their most intimate lives. The first
two papers are critical as they were led by women living with
HIV giving the first-person’s voice to the experience of mental
health and violence, and both arose from the largest global
survey of women living with HIV on sexual and reproductive
health and rights priorities [911]. Building capacity for the
community to be better heard within an academic context
and further strengthening research to address gaps in our
knowledge remain two critical priorities in order to build
evidence-based guidance and recommendations. The sys-
tematic review of disclosure in the context of fear of violence
[12] and the review of the needs of adolescent girls living
with HIV [13] remind us that much remains to be achieved in
the post-2015 era.
Discussion
The past 20 years have seen tremendous progress in the
area of sexual and reproductive health and rights. This is
evidenced by an over 40% decrease in maternal mortality
between 1990 and 2013, and a 58% increase in the use of
modern contraceptive methods. The number of births to
adolescents has also declined worldwide [14].
However, evidence shows the slow and uneven progress in
various areas related to women and health, such as nutrition,
sexual and reproductive health, HIV and other sexually trans-
mitted infections and violence against women. Poor sexual
and reproductive health outcomes represent one-third of
the total global burden of disease for women between the
ages of 15 and 49 years, with unsafe sex a major risk factor
for death and disability among women and girls in low- and
middle-income countries. In addition, worldwide, in 2013,
225 million women were estimated to have an unmet need
for modern contraception.
When we look at the situation of women living with HIV
in relation to sexual and reproductive health, the scenario
remains bleak. In 2013, almost 60% of all new HIV infections
among young people aged 1524 years occurred among girls
and young women. In low-income countries, tuberculosis is
often linked to HIV infection and is among the leading causes
of death of women of reproductive age and those aged
2059 years.
Persistent obstacles in health systems to realizing the
aims of the international declarations and conventions, in-
cluding a lack of gender responsiveness with regard to sex-
disaggregated data and gender analysis, result in health
services that do not take into account the specific needs and
determinants of women’s health. Women, especially those
living with HIV, continue to have inequitable access to good-
quality health care services in many countries. Pockets of low
health system coverage exist globally, and services in many
rural areas and urban slums are often of low quality. Women
living with HIV are confronted with multiple and intersecting
forms of discrimination, which additionally contributes to the
lack of good health services. Poor health service coverage is
exacerbated by HIV status and gender-related barriers to
access to prevention, treatment and care.
The papers in the Supplement aim to ensure that the
sexual and reproductive health and human rights of women
and girls living with HIV are addressed, with due attention
accorded to the following critical dimensions:
1) placing human rights and gender equality at the centre
of a comprehensive approach to health programming,
in particular in relation to sexuality and sexual health;
2) ensuring health systems responsiveness to inequalities
in access to health care and quality of care that often
do not meet the needs of women living with HIV;
3) engaging and empowering women living with HIV in the
development of policies and programmes that affect
them; and
4) strengthening monitoring, evaluation and accountabil-
ity procedures to provide good-quality data and ensur-
ing remedial action against violations of health and
human rights of women living with HIV.
Conclusions: articulating a vision for the future
This Supplement includes contributions from a broad range
of stakeholders on the complexity of issues related to sexual
and reproductive health and human rights of women living
with HIV. To realize this vision, the international development
agenda in this regard should emphasize providing an enabling
environment for women living with HIV to receive services
that are based on principles of human rights and gender
equality. Emphasis should also be placed on investing
in integrated programmes interlinked with the different
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health-enhancing sectors, including, but not limited to, edu-
cation and nutrition.
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Abstract
Introduction: Globally, women constitute 50% of all persons living with HIV. Gender inequalities are a key driver of women’s
vulnerabilities to HIV. This paper looks at how these structural factors shape specific behaviours and outcomes related to the
sexual and reproductive health of women living with HIV.
Discussion: There are several pathways by which gender inequalities shape the sexual and reproductive health and wellbeing
of women living with HIV. First, gender norms that privilege men’s control over women and violence against women inhibit
women’s ability to practice safer sex, make reproductive decisions based on their own fertility preferences and disclose their
HIV status. Second, women’s lack of property and inheritance rights and limited access to formal employment makes them
disproportionately vulnerable to food insecurity and its consequences. This includes compromising their adherence to
antiretroviral therapy and increasing their vulnerability to transactional sex. Third, with respect to stigma and discrimination,
women are more likely to be blamed for bringing HIV into the family, as they are often tested before men. In several settings,
healthcare providers violate the reproductive rights of women living with HIV in relation to family planning and in denying them
care. Lastly, a number of countries have laws that criminalize HIV transmission, which specifically impact women living with HIV
who may be reluctant to disclose because of fears of violence and other negative consequences.
Conclusions: Addressing gender inequalities is central to improving the sexual and reproductive health outcomes andmore broadly
the wellbeing of women living with HIV. Programmes that go beyond a narrow biomedical/clinical approach and address the social
and structural context of women’s lives can also maximize the benefits of HIV prevention, treatment, care and support.
Keywords: gender inequalities; stigma; discrimination; laws; sexual and reproductive health.
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Introduction
Globally, women constitute half of all persons living with HIV.
In sub-Saharan Africa, the region with the highest burden
of HIV, women constitute 57% of persons living with HIV; and
adolescent girls and young women are twice as likely to be
living with HIV as compared to boys and young men. In low-
and middle-income countries, female sex workers are 13.5
times more likely to be living with HIV as compared to the
general population of women in reproductive age groups [1].
Globally, transgender women are 49 times more likely to be
living with HIV as compared to all adults of reproductive age
groups [24].
The sexual and reproductive health needs of women living
with HIV require particular attention because these women
are disproportionately vulnerable to certain reproductive health
problems as compared to HIV-negative women and also in
relation to the prevention of vertical transmission of HIV.
Studies show that, as with women who are HIV negative,
women living with HIV have high rates of unintended preg-
nancy and low rates of contraceptive use including condom
use [59]. In sub-Saharan Africa, women living with HIV are
significantly more likely to die during pregnancy or the post-
partum period as compared to HIV-negative women [10,11].
Globally, women living with HIV are also more likely to have
a higher incidence and progression of cervical neoplasia as
compared to women who are HIV negative [12].
There has been increasing attention given to certain as-
pects of reproductive health of women living with HIV, par-
ticularly in the context of preventing vertical transmission
of HIV. However, much of this focus has largely addressed
the biomedical/clinical and health systems factors [1315].
There has been less attention to a more holistic response that
goes beyond disease prevention and addresses the sexual,
emotional and mental health as well as social and economic
wellbeing of women living with HIV as a legitimate focus of
programming and research in its own right [16,17]. This state
of affairs stands in stark contrast to what women living
with HIV have articulated as their needs and priorities. These
needs include the importance of addressing gender inequal-
ities, violence against women, financial security and social
support, reproductive health beyond pregnancy, and sexuality
in a positive framework [18]. The UNAIDS Gap Report [3]
highlights women living with HIV as one of the 12 priority
populations. The report identifies stigma and discrimination,
gender inequalities, and punitive laws and policies as three
of the top four reasons for their vulnerability.
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Nearly two decades of research and programming have
highlighted that gender inequalities are a key structural
driver of women’s vulnerability to acquiring HIV. The impor-
tance of addressing gender inequalities is well recognized
in key global commitments to ending HIV. Some countries
are beginning to address them as part of their national HIV
and AIDS responses [19,20]. However, concrete actions on a
significant scale and in a sustained manner with concomi-
tant resources are yet to materialize. The pathways by which
gender inequalities shape women’s risk of acquiring HIV
are increasingly being mapped out, particularly as they relate
to the intersections of intimate partner violence and HIV
[2123]. There is a small, but increasing body of evidence on
interventions that work to address gender inequalities as a
structural driver of women’s risk of becoming infected with
HIV, such as those that promote egalitarian gender norms,
empower women and girls economically and in their sexual
and reproductive decision-making, and reduce violence against
women [2327].
While gender inequalities affect HIV-negative women as
well as women living with HIV in many similar ways, the latter
face unique challenges related to stigma and discrimination,
as well as pressures related to their sexual and childbearing
decisions, economic security, mental health and emotional
wellbeing. This paper describes how gender inequalities shape
the sexual and reproductive health and wellbeing of women
living with HIV, specifically via the following pathways: (1)
unequal power relations, harmful gender norms and violence
against women; (2) women’s unequal access to and control over
economic resources; (3) stigma and discrimination; and (4)
punitive laws and gender-discriminatory policies. These path-
ways are examined in terms of four interrelated outcomes: (1)
disclosure of HIV status; (2) ability to have safe and pleas-
urable sex; (3) fulfilment of fertility intentions and enabling
of reproductive choices; and (4) management of treatment. The
concept of wellbeing is included to underscore the importance
of considering mental and emotional health as well as social and
economic factors.
Unequal power relations in sexual and
reproductive decision-making: the role of
harmful gender norms and violence against
women
In many settings, gender norms privilege men’s control over
women or perpetuate unequal power relations. These norms
prevent women from having autonomy in sexual and re-
productive health decisions. Surveys of women of reproduc-
tive age (e.g. demographic and health surveys) show that in
many settings, a large proportion of married women, es-
pecially young women, do not have a final say in their own
healthcare decisions [3,28,29]. Analysis of sexual behaviours
of women and men from surveys shows that in general,
married women find negotiation of safer sex and condom use
much more difficult than do single women [30].
In many societies, women living with HIV, like others,
face tremendous social pressures to bear children. Women
gain status and their worth is proven through their fertility.
Research highlights the importance of partners’ dominance in
decision-making with respect to condom use and desire for
children in shaping the sexual and reproductive decisions of
women living with HIV as well as in the uptake of prevention
of mother-to-child HIV transmission (PMTCT) services [3134].
Hence, women, including those living with HIV, face pressures
to have unprotected sex in order to conceive or are unable to
use contraception because of such social norms [18,3537].
Gender norms related to sexuality confer different ex-
pectations for women and men to have consensual sex [3840].
For women, a central issue is that of freedom from vio-
lence, which is a stark expression of men’s power, control
and entitlement over women. Globally 30% of women have
experienced physical and/or sexual violence by an intimate
partner in their lifetime [41,42]. Data show that intimate
partner violence against women is associated with a 1.5-fold
increase in risk of sexually transmitted infections (STIs) or HIV
in some regions [41]. Data on prevalence of intimate partner
violence among women living with HIV are not easily ob-
tained. However, one systematic review of studies from the
United States of America highlighted a higher proportion of
women living with HIV experiencing partner violence as
compared to women in the general population [43]. A large
body of studies from sub-Saharan Africa show that women’s
fear or experience of violence are a major barrier to HIV
disclosure [44,45]. Studies on HIV disclosure outcomes
among women living with HIV show that rates of negative
outcomes, including violence, range from 3 to 15% and up to
59% in a couple of studies [4648]. Studies also show an
association between partner violence and lower uptake of
PMTCT, continued or increased sexual risk behaviours and
poor adherence to antiretroviral therapy  in part explained
by stress, poor mental health, and a lack of control over
health-promoting behaviours [43,4953].
Unequal access to and control over economic
resources: the role of food insecurity and lack
of property and inheritance rights
An increasing number of studies highlight that, while anti-
retroviral therapy (ART) access has improved, there continue
to be socio-economic barriers to uptake of and adherence to
treatment. Food insecurity has been identified as a key barrier
to ART adherence and quality of life for people living with HIV
by a number of studies [5456]. Women are disproportio-
nately susceptible to food insecurity because of their lack of
access to and control over economic resources in the form
of ownership of land, assets and other property, and their
lower access to formal employment than men. Research from
sub-Saharan Africa and South Asia highlights how women
living with HIV are denied their property and inheritance
rights by relatives when their husbands die due to HIV-related
conditions [5760].
This denial of land and property rights contributes to food
insecurity, which in turn increases sexual risk taking (e.g.
transactional or commercial sex) and limits women’s ability
to leave abusive relationships. For example, a study from
Swaziland and Botswana highlighted that food insecurity
among women was associated with significantly higher odds
of inconsistent condom use with a non-primary partner,
transactional sex and lack of control in sexual relationships,
but that these associations were weaker among men [61].
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Similar findings were shown in a qualitative study on food
insecurity among women living with HIV in Uganda [62].
Studies also highlight women’s economic dependency and
their fear of being abandoned as a barrier to HIV disclosure
[44,45,63,64]. Other adverse consequences of food insecurity
on women living with HIV are in relation to their increased
nutritional and energy requirements during pregnancy and
lactation as well as the increased stress and burden on them
to procure food and clean water for family members, in-
cluding children who may also be living with HIV [6567].
Stigma and discrimination
Stigma and discrimination are among key barriers that
women living with HIV face in achieving their sexual and
reproductive health. While all those who are living with HIV
can face stigma because of judgments made about their
behaviours by families and communities, women are more
likely to be blamed because many societies have different
expectations and standards for women’s sexual conduct than
for men’s [68,69]. Moreover, in sub-Saharan Africa, as women
are more likely to be tested first in the context of PMTCT
programmes, they are also more likely to be blamed for
bringing HIV into the family [44,45,70]. This potential con-
sequence is likely not only to affect women’s willingness to
disclose their HIV status, but also to compromise their safety
due to threats or experience of violence. Some women living
with HIV report rejection of sexual relations by their partners
or inability to find sexual partners because of their HIV status
[18,71]. Women living with HIV may also experience inter-
nalized stigma that includes fear and anxiety that partners
may not find them attractive [70,72,73]. In some settings, HIV
programme staff discourage women living with HIV to have
sex or blame them as being irresponsible if they have unpro-
tected sex, which can affect their sexual, emotional andmental
health and wellbeing [74,75].
For a number of women living with HIV who want children,
there are pressures from institutions such as healthcare to
not bear children [76]. Data from Bangladesh, the Dominican
Republic and Ethiopia show that between a quarter to nearly
half of all women living with HIV were advised by health
workers to not have children [77]. Reports of women living
with HIV being coerced into sterilizations have occurred in
several settings (e.g. Bangladesh, Chile, Dominican Republic,
Honduras, El Salvadaor, Mexico, Nicaragua and Namibia)
[3,78]. Several countries surveyed as part of the stigma index
(i.e. a survey-based tool to assess or measure levels of stigma
experienced by people living with HIV) reported the pro-
portion of women living with HIV who were denied family
planning services in the last 12 months to be at least 10% [4].
These data highlight the contradictory pressures that women
living with HIV face in relation to their fertility intentions and
reproductive choices. The enactment of these contradictory
pressures on women by healthcare institutions violates their
reproductive rights.
Laws that criminalize HIV transmission and
gender-discriminatory HIV policy responses
Laws that criminalize HIV transmission, exposure and non-
disclosure are not only unjust and difficult to enforce, but
make for poor public health practice and outcomes by
disempowering those living with HIV and discouraging them
from testing, accessing treatment programmes or disclosing
their HIV status [79]. Despite this, 61 countries have adopted
laws that criminalize HIV transmission, while prosecutions
for non-disclosure, exposure and transmissions have been
recorded in at least 49 countries [3]. These laws are being
adopted in a context of rapid expansion of HIV testing of preg-
nant women through PMTCT programmes. In West and
Central Africa, laws criminalize women who transmit HIV
to the foetus or child. This puts women in an impossible
quandary, given that many are unable to demand condom use
or disclose their HIV status due to fears of violence or
abandonment by their partners [79]. Data show that punitive
laws and law enforcement practices related to sex work and
injecting drug use also contribute to stigma, violence and
other rights violations against women living with HIV from
key populations [3,79].
HIV policies have often failed to take into account gender
inequalities in ways that further contribute to discrimination
against women. Such policies have also failed to address
the reasons behind men’s lower access to HIV services. For
example, HIV testing and counselling and disclosure has a
distinct gendered pattern and dimension [44,45,80]. In a
number of countries, more women are tested and know their
HIV status compared to men, particularly in the context of
women’s higher frequency of use of maternal and child
health services [81]. Studies from sub-Saharan Africa show
that masculine norms and stigma prevent men from seeking
HIV testing services [82,83]. Men use their partners’ HIV
status as a proxy for their own [45]. At the same time, an
increasing number of countries are putting in place partner
notification policies [45]. Hence, the onus of disclosure is on
women, even as it brings with it the risk of violence and
other negative consequences.
A number of countries with the highest burden of HIV
among women and children have started to implement
lifelong ART (Option B ) for all pregnant and postpartum
women living with HIV and their infants [81]. The public health
rationale and benefits for implementing Option B have been
well established [84]. However, there is less consideration of
the implications of early initiation and lifelong treatment,
regardless of CD4 count, on women that takes into account
the gendered realities of their daily lives [85]. Data from
Malawi, South Africa and Tanzania suggest that, while women
are motivated to initiate and adhere to ART during pregnancy
and post-partum periods in order to prevent HIV transmission
to their child, they are less motivated to continue thereafter
[8688]. Qualitative data from Malawi, Tanzania and Uganda
suggest that women living with HIV appreciate the positive
benefits of Option B, including the ability to prevent trans-
mission to their children and partners, their own improved
health and reduced stigma. However, they raise concerns
about treatment and adherence in relation to the following:
the lack of food security and nutrition that is required to
maintain treatment; the requirement to disclose their HIV
status, especially for those who face or fear partner violence;
lack of information, support and counselling; and the side
effects of treatment [87,89].




Addressing gender inequalities is central to improving the
sexual and reproductive health outcomes and more broadly,
the wellbeing of women living with HIV. Even as HIV preven-
tion, treatment and care services for women living with HIV
are being expanded and bringing many benefits, the context
of gender inequalities is undermining these efforts. Figure 1
summarizes the pathways by which gender inequalities shape
the sexual and reproductive health and wellbeing of women
living with HIV.
This paper highlights the importance of interventions for
women living with HIV to promote egalitarian and non-violent
norms along with equitable decision-making between women
and men. It also highlights the importance of interventions to
address economic inequalities that contribute to food inse-
curity, such as interventions that promote land, property
and inheritance rights of women living with HIV. Stigma
and discrimination, particularly in healthcare settings, needs to
be addressed in order to support the reproductive choices of
women living with HIV. Strong advocacy is needed to repeal
laws that criminalize HIV transmission. Finally, it is not enough
to design HIV policies from a narrow biomedical/clinical and
health systems framework. Instead, policies must take into
account the social and structural context of women’s lives
from the very inception, so that women living with HIV feel less
isolated and are more empowered to make informed choices
and decisions with respect to their health and wellbeing.
The evidence for effective women-centred approaches is
limited. One such example is a study to improve the sexual
and reproductive health of Canadian women living with HIV.
As part of this study, a framework was developed to identify
the elements of a women-centred model of care that ad-
dresses their physical health needs (i.e. from a clinical and
biomedical perspective) as well as their social, emotional,
mental, spiritual and cultural needs more broadly. The frame-
work considers gender along with other intersecting social
inequalities. It highlights the needs of women living with HIV
for safety, respect, acceptance, self-determination, access to
social and other supportive services, tailored and culturally
sensitive information, and peer support, among others [90].
While this model is being empirically tested in one setting, it
needs to be further applied in low- andmiddle-income country
settings. Amore holistic social science research agenda is needed
to provide women-centred services to women living with HIV
and promote their sexual and reproductive health and well-
being  one that is grounded in social justice and human rights.
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Abstract
Introduction: The right to sexual and reproductive health (SRH) is an essential part of the right to health and is dependent upon
substantive equality, including freedom from multiple and intersecting forms of discrimination that result in exclusion in both
law and practice. Nonetheless, general and specific SRH needs of women living with HIV are often not adequately addressed.
For example, services that women living with HIV need may not be available or may have multiple barriers, in particular stigma
and discrimination. This study was conducted to review United Nations Human Rights Council, Treaty Monitoring Bodies and
Special Rapporteur reports and regional and national mechanisms regarding SRH issues of women living with HIV. The objective
is to assess areas of progress, as well as gaps, in relation to health and human rights considerations in the work of these
normative bodies on health and human rights.
Methods: The review was done using keywords of international, regional and national jurisprudence on findings covering
the 2000 to 2014 period for documents in English; searches for the Inter-American Commission on Human Rights and national
judgments were also conducted in Spanish. Jurisprudence of UN Treaty Monitoring Bodies, regional mechanisms and national
bodies was considered in this regard.
Results and discussion: In total, 236 findings were identified using the search strategy, and of these 129 were selected for review
based on the inclusion criteria. The results highlight that while jurisprudence from international, regional and national bodies
reflects consideration of some health and human rights issues related to women living with HIV and SRH, the approach of these
bodies has been largely ad hoc and lacks a systematic integration of human rights concerns of women living with HIV in relation
to SRH. Most findings relate to non-discrimination, accessibility, informed decision-making and accountability. There are critical
gaps on normative standards regarding the human rights of women living with HIV in relation to SRH.
Conclusions: A systematic approach to health and human rights considerations related to women living with HIV and SRH by
international, regional and national bodies is needed to advance the agenda and ensure that policies and programmes related
to SRH systematically take into account the health and human rights of women living with HIV.
Keywords: sexual and reproductive health; HIV; women living with HIV; human rights.
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Introduction
Protection of the sexual and reproductive health (SRH) and
human rights of women living with HIV/AIDS is fundamental
to their dignity, health and wellbeing [1]. However, HIV con-
tinues to be a leading cause of death among women of
reproductive age worldwide. To address this situation, the
global HIV response must fully recognize the significant role
that gender inequality and violation of human rights plays in
increasing women and girls’ vulnerability to HIV [2].
Everyone has the equal rights concerning their SRH.
However, women living with HIV/AIDS require special protec-
tion in this regard. HIV infection accelerates the natural history
of some reproductive illnesses and increases the severity of
others [1]. Moreover, infection with HIV has serious effects on
the sexual health and wellbeing of women [1]. Studies demon-
strate that women and girls living with HIV have less access to
prevention, treatment, care and support [3]. There is a growing
realization that protection and promotion of SRH and rights,
including through improved and sustained investment in women
and girls living with HIV, can help countries move towards
universal access to HIV prevention, treatment, care and sup-
port services [4].
For decades, organizations and groups of women living
with HIV, such as the Salamander Trust, the Athena Network,
Khosla R et al. Journal of the International AIDS Society 2015, 18(Suppl 5):20280
http://www.jiasociety.org/index.php/jias/article/view/20280 | http://dx.doi.org/10.7448/IAS.18.6.20280
10
the Global Network for and by People Living with HIV and the
International Community of Women Living with HIV/AIDS,
have been at the forefront of development of research and
normative standards in relation to the SRH and human rights
of women living with HIV. The work of these organizations
has not only helped in the galvanization of support for the
development of normative standards in this regard, but also
in the improvement of prevention of treatment and care for
women living with HIV [5].
The right to SRH is an essential part of the right to health
and is dependent upon substantive equality, including free-
dom from multiple and intersecting forms of discrimina-
tion that exacerbate exclusion in both law and practice [6].
Multiple reports highlight the fact that general and specific
SRH needs of women living with HIV are often not adequately
addressed [79]. For example, the SRH services that women
living with HIV needmay not be available or these womenmay
face multiple barriers, in particular stigma and discrimina-
tion, in accessing existing services (see Supplementary Table 1)
[8,1013].
This study was conducted to review findings of interna-
tional, regional and national bodies regarding SRH issues of
women living with HIV. This study was conducted with the
objective to assess key areas of progress and possible gaps in
relation to normative development of human right standards
by United Nations, regional and national human rights bodies
regarding the SRH of women living with HIV.
Method
The starting point for this study is the UN Population Fund
(UNFPA) and the World Health Organization (WHO) guide-
lines, Sexual and reproductive health of women living with
HIV/AIDS (2006) [1]. The recommendations on care, treatment
and support for women living with HIV/AIDS and their
children were used to define the search strategy for this study.
The study reviewed relevant findings of the UN Human
Rights Council, Treaty Monitoring Bodies and Special Rappor-
teurs (these included reports, concluding observations and
general comments) in relation to normative developments
regarding the human rights of women living with HIV in the
context of SRH. The review was done for findings covering
2000 to 2014 for documents in English; searches were also
conducted in Spanish for the Inter-American Commission on
Human Rights (IACHR/CIDH) including the site of the Organi-
zation of American States (OAS) and national judgments. The
period of 2000 to 2014 was selected with the view that this
is period in which the UN Committee on Economic, Social and
Cultural Rights General Comment No. 14 on the right to health
laid down the framework on health and human rights [14].
The review process was divided into three stages.
First, an international normative review was undertaken.
This step included reviews of findings of the Human Rights
Council, Treaty Monitoring Bodies and Special Rapporteur
reports. Four databases were therefore used: the OHCHR
Universal Human Rights Index; bayefsky.com; the University of
Minnesota Human Rights Library; and the Universal Periodic
Review (UPR). The list of search terms and databases used for
the purposes of this review are included in Supplementary
Annex 1. Findings include results from documents of the
Committee against Torture; Committee on the Elimination of
Discrimination against Women; Committee on the Rights of
the Child; Committee on Economic, Social and Cultural Rights;
Committee on Civil and Political Rights; Special Rapporteur
on Health; Special Rapporteur on Mental and Physical Health;
Special Rapporteur on Violence against Women; and UPR
Working Group.
Second, a regional normative review was undertaken. This
included reviews of findings from resolutions and decisions
of regional human rights bodies. Sites from the IACHR/CIDH,
including the site of the OAS; the African Commission of
Human and Peoples’ rights (including the site of the African
Union); and the European Commission of Human Rights
(including the site of the Council of Europe) were reviewed.
The list of search terms and databases used for this review
are included in Supplementary Annex 2.
Third, a national normative review was undertaken. This
step included reviews of data extracted from national
judgments. Different databases were consulted, including
LexisNexis, the Treatment Action Campaign database, the
South African Legal Information Institute database, the Center
of Reproductive Health database, the Global Health and Rights
database and national databases with official publications
of judgments. References to judgments were also found in the
United Nations Development Programme (UNDP) Compendium
of Judgments for Judicial Dialogue on HIV, Human Rights and
the Law in East and Southern Africa of October 2013, the UNDP
Compendium of Judgments for Judicial Dialogue on HIV, Human
Rights and the Law in Asia and the Pacific of June 2013 and the
UNAIDS Judging the Epidemic: A Judicial Handbook on HIV,
Human Rights and the Law of May 2013. Subsequently,
references were used to locate the original decisions, and
data were directly extracted from official publications. Where
the judgments could not be found, the data extraction table
(Supplementary Table 1) indicates this.
In terms of the inclusion criteria, a decision was made to
include not only findings where human rights bodies had
explicitly made observations on the SRH of women living with
HIV, but also those that were implicitly dealing with these
issues even if not specifically addressing the nine agreed-
upon human rights dimensions found in the WHO’s Ensuring
Human Rights in the Provision of Contraceptive Information
and Services (2014):
1) Equality and non-discrimination (alternate terms:
reduce discrimination, reduce criminalization, combat
negative social and cultural attitudes, stigma, prejudice,
[domestic] violence, gender inequality)
2) Participation (alternate terms: involvement, advocacy,
influence)
3) Privacy and confidentiality
4) Informed decision-making (alternate terms: [direct] con-
sent, choice, coerced, forced, informed, comprehensible)
5) Availability (alternate terms: make available, provide,
exist)
6) Accessibility (alternate terms: access, receive, affordable,
eligible)
7) Acceptability (alternate terms: conscientious objection,
medical ethics, human rights sensitivity)
Khosla R et al. Journal of the International AIDS Society 2015, 18(Suppl 5):20280
http://www.jiasociety.org/index.php/jias/article/view/20280 | http://dx.doi.org/10.7448/IAS.18.6.20280
11
8) Quality of services (alternate terms: proper medical
care, adequacy)
9) Accountability (alternate terms: liability, responsi-
bility, calling upon state parties, enforcement, legal
measures) [15].
Findings that dealt with issues related to HIV and SRH
without a specific focus on issues related to women living
with HIV were excluded. Similarly, findings that looked at SRH
issues of women without a specific focus on women living
with HIV were also excluded. Further, in order to capture the
widest array of relevant observations to be found in the
normative work, search terms also included stigma, respect
and disrespect, as well as choice.
Data on determinants of health were included to a limited
extent.
Results and discussion
The principles that are most discussed by international,
regional and national bodies or courts, in the context of SRH
of women living with HIV, are non-discrimination (see Box 1),
accessibility, informed decision-making and accountability
(see Supplementary Table 1 for survey findings; see also
Figure 1).
Box 1: Key definitions
(1) The principle of non-discrimination obliges states to
guarantee that human rights are exercised without
discrimination of any kind based on, inter alia,
colour, sex, language, religion, political or other
opinion, national or social origin, property, birth or
other status, such as disability, age, marital and
family status, sexual orientation and gender identity,
health status, place of residence and economic and
social situation.
(2) The principle of accessibility implies that health
facilities, goods and services have to be accessible
to everyone without discrimination.
(3) The principle of informed decision-making implies
giving each person the choice and opportunity to
make autonomous reproductive choices. The princi-
ple of autonomy, expressed through free, full and
informed decision-making, is a central theme in
medical ethics and is embodied in human rights law.
(4) The principle of accountability implies that generally
states’ legal, policy and programmatic frameworks and
practices should be in line with international, regional
and national human rights standards. The establish-
ment of effective accountability mechanisms is in-
trinsic to ensuring that the choices of individuals are
respected, protected and fulfilled. Effective account-
ability requires individuals to be aware of their
entitlements with regard to SRH and of the mechan-
isms available to them.
A total of 236 findings were identified based on the search
strategy. Based on the inclusion criteria, 129 findings were
selected, the full text was reviewed and data were extracted.
The results of the review were classified according to the
nine human rights principles and arranged on the basis
of them being most cited, less cited or rarely cited. The
authors manually reviewed the findings to ascertain how
these principles had been dealt with and the frequency with
which these principles were referred to in the human rights
normative developments related to women living with HIV
and SRH. For the purposes of this classification, principles
cited 10 times were classified as most cited, principles
cited B10 times as less cited and principles cited B5 times
as rarely cited. In addition, principles that did not feature
under the nine developed by the WHO but were frequently
cited by the UN and/or regional and national human rights
bodies were also noted.
Most-cited human rights principles in relation to women
living with HIV and SRH
The principle of non-discrimination
The review of international, regional and national jurispru-
dence of normative standards found that the most-cited
human rights principle in relation to the SRH of women living
with HIV is the need to combat discrimination and violence
against women living with HIV. The findings from various
human rights bodies refer to the need to eliminate discrimi-
nation against women, girls and adolescents living with HIV
through challenging gender inequality, stereotypes, stigma,
prejudice and violence. According to the findings, discrimina-
tion toward women living with HIV occurs primarily within
families, communities and healthcare facilities.
Furthermore, violence is highlighted in the findings of
human rights bodies as a central concern with regard to the
SRH of women living with HIV. The findings highlight the
need to eliminate violence by addressing gaps in legislation
and policy. Violence or fear of violence is identified as a prime
barrier to HIV testing and disclosure of a women’s seropositive
status. Different types of violence (psychological and physical)
are mentioned, including sexual violence, prejudicial tradi-
tional or customary practices, coercion or abuse, early and
forced marriage, fear of conflict with partners, forced vaginal
examinations, mandatory testing and involuntary sterilization.
The findings emphasize that women living with HIV are more
likely to experience violence than men living with HIV [16].
In this context, it is important to highlight the findings on the
need to empower women, support their economic indepen-
dence and protect their fundamental rights and freedoms,
including their SRH rights.
Human rights bodies also cite stigma and prejudice as
leading obstacles to the enjoyment of SRH by women living
with HIV. They impede the access of women living with HIV to
justice and severely limit or deny the enjoyment of these
women’s SRH.
The findings of human rights bodies further identify gender
inequalities and stereotypes as a major issue. The vulnerabi-
lity of women and girls living with HIV/AIDS is a major human
rights challenge because of the effect of inequality between
the sexes. Mothers are held solely responsible for infecting
their children. Women are held responsible for HIV transmis-
sion by the very person who infected them, and HIV-positive
men sometimes believe that they have the right to maintain
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the pleasure of unprotected sex [17]. The findings also
highlight the relationship between violence and gender
stereotypes. The findings emphasize the need to combat
discrimination and violence by addressing gaps in legislation
and policy, putting programmes into place and implementing
initiatives [18].
The principle of accessibility
Accessibility of information and services related to SRH
remains a challenge for women living with HIV. The findings
of human rights bodies indicate issues of discrimination
in accessibility by women living with HIV to SRH information
and services, in particular in family planning, pregnancy and
childcare. Most findings are related to treatment of women
in their reproductive years and some to female children;
however, some categories of women, such as women without
children and older women, are hardly taken into account.
Nevertheless, one particular reference stresses the need for
equitable access to SRH care throughout the lives of women
living with HIV [19] and is one of the few examples whereby
human rights bodies have made explicit reference to the
importance of access to treatment throughout women’s lives.
Findings of human rights bodies also point to the physical
inaccessibility of most rural and marginalized women living
with HIV to healthcare services, which leads to delays and
difficulties in the utilization of adequate information and
services. Furthermore, findings highlight that migrant women
living with HIV also face social, language, legal and financial
barriers and are exposed to the risk of inaccessibility to
services when submitted to deportation [20,21].
Economically accessible information and SRH services, such
as HIV testing, counselling, contraceptives and antiretro-
viral (ARV) treatment, are often supported, according to the
findings of human rights bodies. However, as with the physical
accessibility of services, all these references primarily focus
on pregnant women’s economic accessibility to services.
The principle of informed decision-making
Women living with HIV are often sterilized without their
knowledge or consent, and there is a need for education
about the effects of sterilization and the alternatives available
[22]. In addition, pregnant women living with HIV are often
advised or pressured to terminate their pregnancies [8]. The
review of findings of human rights bodies highlights the need
for these women to be informed about ARV medication
during pregnancy and delivery and after birth. Findings also
highlight that many women are submitted to mandatory
HIV testing and therefore emphasize the need for free and
informed consent with regard to all medical procedures [23].
Within this context, a large number of findings relate to the
lack of information on prevention of mother-to-child trans-
mission (PMTCT) of HIV.
The principle of accountability
Findings of human rights bodies refer to the need to encourage
a policy, legal and social environment that promotes human
rights for women living with HIV, ensuring the full recognition
of their SRH and rights. Findings point towards the need to
address existing gaps in HIV-related legislation and policy and
further highlight the need to effectively use parliamentary
processes. National mechanisms such as commissions, courts,
legislation and coordinated strategiesmust be strengthened to
protect, enforce and monitor the human rights of women
living with HIV. Implementation and enforcement of protec-
tion in law for women living with HIV remains a challenge. The
issue of criminalization of HIV transmission to others and, in
the case of pregnant women, to the foetus is also emphasized
in several human rights bodies’ findings [24,25].
Furthermore, the findings of human rights bodies points
towards evidence that women living with HIV face multiple
forms of discrimination with regard to access to justice.
Findings highlight the need to put reinsertion programmes
into place for women living with HIV who are victims of
discrimination.
Less-cited human rights principles in relation to
women living with HIV and SRH
The results from the review of findings from human rights
bodies reflect a primary focus on issues related to non-
discrimination, accessibility, informed decision-making and
accountability in international, regional and national juris-
prudence related to women living with HIV and SRH. Some
additional references are also found for other key health and
human rights considerations, in particular availability and
privacy and confidentiality.
Figure 1. Review findings.




Within the principle of availability, the human rights bodies’
findings primarily focus on PMTCT [2628]. A lot of references
are made to the availability of sufficient quantity of goods and
services and programmes [29]. The availability of goods
focuses primarily on ARV treatment for PMTCT. The findings
also refer to the availability of sufficient and regular paediatric
ARV treatment and the availability of ARVs in prisons and
public hospitals. The availability of services is also primarily
dealt with in the context of PMTCT. Within this context,
the findings underline the need for prevention of unintended
pregnancies and for appropriate antenatal, delivery and post-
partum care, including counselling on infant feeding options.
Furthermore, the findings underline the importance of the
integration of HIV/AIDS services in SRH care and vice versa.
Most findings relate to the importance of integrating HIV/
AIDS issues in SRH programmes [25,30,31].
Privacy and confidentiality
Findings of human rights bodies on confidentiality and
privacy primarily deal with the disclosure of women’s HIV
status. There is a lack of confidentiality in health facilities,
schools, prisons and courts. Test results are made available to
husbands, friends, families and the community at large.
Least-cited human rights principles in relation to women
living with HIV and SRH
The principles of acceptability, quality and participation are
least dealt with in international, regional and national human
rights jurisprudence related to women living with HIV and
SRH. Whereas hardly any references are found regarding
principles related to acceptability and quality, there are some
references related to participation. Participation is primarily
emphasized with respect to women living with HIV, as well as
civil society at large, which must be encouraged to participate
in the development and implementation of national policies
and actions. Religious communities are encouraged to include
provisions on premarital HIV counselling and testing in their
by-laws.
Newly cited principles: determinants of health
The analysis of jurisprudence also points to some references to
the experience of discrimination faced by women living with
HIV in access to housing, education, employment, healthcare
and justice [32]. These principles are in addition to the nine
health and human rights principles of WHO and are noted
here for their relevance to the issue of women living with HIV
and SRH.
Gaps and challenges
These findings clearly illustrate that while international, regional
and national bodies have been considering issues related to
health and human rights of women living with HIV and SRH,
various health and human rights considerations are often not
systematically addressed.
The study identified some key limitations in the way
that UN human rights mechanisms have dealt with issues
related to women living with HIV and SRH. These include the
following issues.
Ambiguity around the subject of women living with HIV
An overwhelming number of references to mother-to-child
transmission or vertical transmission of the virus were found
in the review, and although the prevalence of HIV among
women is said to be ‘‘particularly concerning’’ in its own
right, the focus was on its potential to transmit the disease
through child rearing. In addition, many items promoting SRH
for women living with HIV rely on vague terms. For example,
some documents provide that states should ‘‘eliminate
discrimination against women and persons living with HIV.’’
This statement leaves its subject unclear. Should member
states not discriminate against women and persons with
HIV (separate categories)? Or rather, should the statement
be understood as non-discrimination against ‘‘women and/or
persons living with HIV?’’ This ambiguity in the way the
issues have been dealt with obscures meaning and impact of
the findings. One cannot assume that lists of disadvantaged
social categories incorporate persons at the intersection.
Ambiguity around the subject of sexual and
reproductive health
Often, references to the ‘‘prevention and future control
of HIV’’ and ‘‘human rights guarantees’’ for women living
with HIV are mixed with specific human rights related to
women living with HIV and SRH. Despite the fact that SRH is a
human right, not all persons agree on the extent to which
the former falls under the purview of the latter. These
issues have therefore been handled with an overall lack of
specificity.
This review points out that despite rhetorical attention,
there is little jurisprudence and systematic integration of
human rights related to women living with HIV in the context
of SRH. As this review of the jurisprudence shows, there are
clear gaps and areas of concern that have not yet been
sufficiently addressed.
A number of critical human rights issues have not been
well addressed, for example the economic independence and
financial security of women living with HIV and its influence
on their ability to exercise their sexual and reproductive
rights [8]. The Global Commission on HIV and the Law noted
that when women lack the protection of laws that recognize
equal rights to property, they are more likely to be rendered
economically dependent on, and susceptible to, control by
their spouses in all domains, including their sexual lives [8].
Furthermore, while issues such as criminalization of SRH
services are often dealt with by international, regional and
national human rights bodies [33], a systematic analysis is
often missing of issues related to misinformation, intimida-
tion tactics and barriers faced by women living with HIV in
access to SRH information and services [22]. Within the
human rights jurisprudence, there are also persistent gaps in
relation to dealing with specific SRH issues, such as unwanted
pregnancy, cervical cancer screening and management for
women living with HIV and safe abortion services [9]. The
review also points towards gaps in relation to normative
standards pertaining to fertility issues of women living with
HIV generally, specifically in relation to the desire to have
children [34], use of SRH services and advice from providers
[35]. Overall issues related to training and preparedness of
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healthcare providers to provide services to women living
with HIV are often inadequately dealt with in human rights
jurisprudence. Evidence points towards the critical impor-
tance of these interventions [36].
Conclusions
The last 20 years have seen improvements in SRH and human
rights in many countries. This advance has been supported
by awareness raised by women’s health advocates, increas-
ingly by youth groups, and also by organizations of health
professionals [37]. In the HIV/AIDS area, the involvement
of organizations of people living with HIV/AIDS is crucial to
improve prevention and care. The advocacy done by women
living with HIV has helped both in the normative develop-
ment of standards related to women living with HIV and
in the improvement of treatment and care at the country
level [38]. However, after victories during the 1990s, whereby
women’s rights groups made strides by combatting opposi-
tion from social and political conservatives, recent years have
seen the backsliding of gains made [37].
The right to SRH is an essential part of the right to
health and is rooted in numerous international human rights
instruments. Despite the development in international stan-
dards and jurisprudence, the full enjoyment of the right to SRH
remains a distant goal for millions of people throughout the
world. This analysis of key human rights principles shows
that issues related to the human rights of women living with
HIV regarding SRH have not been comprehensively dealt with
by the UN or other human rights mechanisms. This leaves
critical gaps in normative developments in this area, which
often result in ad hoc integration of these issues into health
policies and programming.
At the national level, governments have not dealt with
many human rights principles and outcomes as part of
their legal and policy response to the human rights of women
living with HIV. For example, discrimination, stigma and
prejudice against women living with HIV occur primarily
within families, communities and healthcare facilities; how-
ever, these issues are not appropriately dealt with at the
national level. National legislation rarely deals with issues
related to availability, privacy and confidentiality, acceptabil-
ity, quality of services and meaningful participation by the
community of women living with HIV. Resulting policies lack
human rights guarantees for women living with HIV. There
is therefore a clear need for strengthening global, regional
and national standard setting for this underserved population.
Within the findings of different human rights bodies at
the global, regional and national levels, it was found that
the language used for articulation of recommendations and
standards is often pejorative and stereotypical and does not
take into account the health and human rights of women living
with HIV.
Further work is also needed to strengthen normative
standards at the country level and enhance accountability
for the violations of human rights of women living with HIV.
Clear normative guidance is needed at the global, regional
and national levels to address the SRH and human rights
needs of women living with HIV. This work should build on the
work of organizations and groups of women living with HIV.
Furthermore, regular monitoring of implementation of the
recommendations by the UN Human Rights Council through
its UPR Working Group and Special Procedure mechanism can
help enhance accountability for the human rights of women
living with HIV.
A promising vision has been created by the growing youth
movement for SRH and rights and the potential for open-
ing up larger alliances around sexual and bodily rights with
HIV/AIDS activists, sex workers, people living with HIV and
AIDS and human rights organizations [38]. Together these
alliances can lead to a meaningful change in the lives of this
vulnerable group [39].
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Abstract
Introduction: Even as the number of women living with HIV around the globe continues to grow, realization of their sexual and
reproductive health and human rights remains compromised. The objective of this study was to review the current state of
knowledge on the sexual and reproductive health and human rights of women living with HIV to assess evidence and gaps.
Methods: Relevant databases were searched for peer-reviewed and grey literature. Search terms included a combination of
MeSH terms and keywords representing women, HIV/AIDS, ART, human rights, sexual and reproductive health.We included both
qualitative and quantitative literature published in English, French, or Spanish between July 2011 and December 2014.
Results and discussion: The search yielded 2228 peer-reviewed articles, of which 40 met the inclusion criteria in the final review.
The grey literature search yielded 2186 documents of which seven met the inclusion criteria in the final review. Of the articles
and documents reviewed, not a single peer-reviewed article described the explicit implementation of rights in programming, and
only two documents from the grey literature did so. With one possible exception, no articles or documents were found which
addressed rights comprehensively, or addressed the majority of relevant rights (i.e. equality; non-discrimination; participation;
privacy and confidentiality; informed decision making; availability, accessibility, acceptability and quality (3AQ) of services
individually or in their totality; and accountability). Additional findings indicate that the language of rights is used most often to
describe the apparent neglect or violation of human rights and what does exist only addresses a few rights in the context of a
few areas within sexual and reproductive health.
Conclusions: Findings from this review suggest the need to better integrate rights into interventions, particularly with attention to
provider training, service delivery, raising awareness and capacity building among the community of women living with HIV.
Further research is urgently needed to support the sexual and reproductive health and rights of women living with HIV, to identify
what works and to inform future programming and policies to improve care, treatment and support for women living with HIV.
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Introduction
Realization of the sexual and reproductive health (SRH) of
women living with HIV remains a key challenge, in part due to a
lack of integration of human rights in health programming and
policies affecting them, and often because of the outright
neglect and violation of their human rights in many aspects of
their lives. Reproductive health can be understood as a state
of complete physical, mental and social well-being, and not
merely the absence of disease or infirmity, in all matters
relating to the reproductive system and to its functions and
processes. Sexual health is concerned with the enhancement
of life and personal relations, and not merely with counselling
and care related to reproduction and sexually transmitted
diseases.
Universal access to quality SRH information and services is
essential to achieving the highest attainable standard for
health, including SRH, and requires respecting, protecting and
fulfilling the human rights of all individuals, including women
living with HIV. In 2006, the World Health Organization (WHO)
released the Guideline on Sexual and Reproductive Health of
Women Living with HIV/AIDS: Guidelines on Care, Treatment
and Support for Women Living with HIV/AIDS and Their
Children [1]. In 2014, WHO advanced a framework which
focused attention on specific human rights in the provision of
contraceptive information and services [2]. Given the need to
consider relevant rights with explicit attention to women living
with HIV, along with changes in both the bio-medical and
political aspects of the HIV response, a key step in support of
advancing this process is a review of the literature to identify
the existing evidence and gaps in interventions to address/
promote human rights in the broader context of SRH
programmes and policies for women living with HIV.
This literature review builds on a study by MacCarthy et al.
[3] that examined the pregnancy-related needs, rights and
decisions of women living with HIV and reported several
issues: contraceptive options for pregnancy prevention for
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women living with HIV are insufficient  condoms are not
always available or acceptable, and other options are limited
by affordability, availability or efficacy; coerced sterilizations
of women living with HIV is widely reported; information
gaps persist in relation to effectiveness, safety and best
practices regarding assisted reproductive technologies; atten-
tion to neonatal outcomes generally outweighs attention to
the health of women before, during and after pregnancy;
access to safe abortion and post-abortion care services are
often curtailed; there is inadequate attention to HIV-positive
sex workers, injecting drug users and adolescents; and the
many challenges women living with HIV encounter in their
interactions with SRH services contribute to their pregnancy
decisions. Authors suggested it was critical that women living
with HIV be more involved in the design and implementation
of research, policies and programmes related to their
pregnancy-related needs and rights. Authors noted several
human rights issues in their analysis, including the avail-
ability, accessibility, affordability, acceptability and quality of
services, participation, as well as the neglect of human rights
more generally as requiring attention for the fulfilment of the
SRH and rights of women living with HIV [3]. A review of
United Nations and regional human rights norms and
standards relevant to the SRH and human rights of women
living with HIV are found elsewhere in this volume [4]. The
objective of the present study is to review the current state
of knowledge on the SRH and human rights of women living
with HIV in order to assess evidence and gaps, and suggest
areas requiring further study and action.
Methods
With a focus on current knowledge, we conducted a targeted
search of peer-reviewed and grey literature published in
English, French or Spanish between July 1, 2011, and
December 31, 2014.This review,which brings explicit attention
to many aspects of the SRH and rights of women living with
HIV, builds on the findings and conclusions of the literature
review by MacCarthy et al. [3] summarizing the literature
through June 2011 with an explicit focus on the pregnancy
intentions of women living with HIV [3]. This review looks at
the literature since that time and casts a wider net to include
the topics included in theWHO guideline (2006) such as sexual
health; family planning; antenatal, intrapartum, postpartum
and newborn care; eliminating unsafe abortion; sexually
transmitted infections (STIs), reproductive tract infections
(RTIs) and cervical cancer, as well as violence and ageing.
Databases including PubMed, Web of Science, Social Science
Research Network (SSRN), Global Health, Public Affairs
Information Service (PAIS) and International Bibliography of
Social Sciences were searched for peer-reviewed literature
using a combination of MeSH terms and keywords represent-
ingwomen, HIV/AIDS, ART, human rights and the above named
areas within SRH. Databases including ProQuest Dissertations
and Theses, New York Academy of Medicine Grey Literature
Report, WHO Global Health Library, Scopus, Popline and PAIS
were searched for grey literature using combinations of the
keywords above. With respect to human rights, the decision
was made to cast a wide net in order to include not only
articles and documents where researchers had explicitly
determined that human rights were part of their actions,
but also those that were implicitly dealing with human rights
using the nine agreed upon human rights dimensions found
in the WHO Framework for Ensuring Human Rights in the
Provision of Contraceptive Information and Services as the
basis of this work [2] (i.e. equality; non-discrimination;
participation; privacy and confidentiality; informed decision
making; availability, accessibility, acceptability and quality
(3AQ) of services individually or in their totality; and account-
ability) [2]. Thus, in order to capture the widest array of
rights concepts to be found in the literature, search terms
included also equity, stigma, respect and disrespect, as well as
reproductive choice [2] (more details on the exact search
strategy can be found in the appendix).
The peer-reviewed search results were imported into End-
Note organized by SRH topic. By contrast, due to limitations in
the search capacity of the grey databases, grey literature
search results were imported into EndNote in relation to SRH
more broadly. An initial review of each abstract or summary
was completed followed by a full-text review of all articles and
documents appearing tomeet the inclusion criteria. Articles or
documents were included in the review if they had as their
primary focus the SRH and rights of women living with HIV or
women receiving ART, including (but not limited to) SRH
education and promotion, family planning, pregnancy, child-
birth, eliminating unsafe abortion, STIs, violence and ageing.
Finally, in order to broaden the pool of articles and documents
reviewed, it was agreed that they need not focus only on
women to be included, but that the extent to which attention
was given to women in each specific case would be noted.
Upon full-text review, any articles or documents which were
then determined not to meet the inclusion criteria were
removed.
Through this process, a final group of articles and docu-
ments meeting the inclusion criteria was identified. Of note, as
there is a plethora of articles and documents that address
stigma, but do not take discrimination or any other human
rights standard into account in doing so, stigma-related articles
and documents were included only if they explicitly made
linkages to discrimination or other human rights. Relevant data
(i.e. author(s), year, title, article/document type, abstract,
population focus, geographic focus, human rights dimension(s)
and SRH topic(s)) from all articles and documents identified for
inclusion were abstracted and entered into an Excel table.
Finally, a qualitative content analysis was conducted of the
final pool of articles and documents to determine how exactly
human rights had been addressed in each, including the types
and frequency of mention of human rights and the context in
which theywere raised (i.e. human rights-based programming,
human rights violations, etc.). Based on analysis and discussion
of individual articles and documents within each of the SRH
topics, broader themes that emerged within the topic were
identified and are summarized in each topical sub-section of
the results.
Results and discussion
Results of the search
The search of peer-reviewed literature yielded 2228 unique
articles. All abstracts were reviewed and 42 were selected for
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full-text review, 40 of which met the inclusion criteria in the
final review (Figure 1). Of the 40 publications, 32 represented
original empirical studies (80% of findings) including 5
quantitative research studies, 14 qualitative research studies,
6mixedmethods studies and 7 policy analyses, while 8 (20% of
findings) publications were either literature reviews, concep-
tual pieces, or viewpoints. Twenty-seven (68%) of these publi-
cations focused or drew on data from low- and middle-income
countries (LMIC), while eight (20%) were global in scope.
Thirty-nine (98%) of them were written in English, one in
Spanish (2%) and none in French.
The search for grey literature yielded 2186 documents of
which seven met the inclusion criteria in the final review. Of
the seven documents, three were programme reports (43%),
one was a programming guide (14%) and three were general
documents related to the subject (43%). Three (43%) of these
documents focused or drew on data from LMIC while four
(57%) were global in scope. All seven (100%) of them were
written in English.
Consistent with the topics included in the WHO guideline
(2006), and the additional emphasis on violence and ageing,
retrieved citations were organized by SRH topics pertinent to
women living with HIVand women receiving ART. Upon review
of the literature, it became evident the distinction between
women living with HIV and those receiving ART was no
longer pronounced in the literature. Results were therefore
combined. In addition, the search brought to light some arti-
cles and documents which could not be easily placed within
the identified topical areas but were relevant to the task at
hand.These were ultimately placed in two new groupings: one
on integrated models of care and the other on structural,
societal and contextual factors impacting the SRH and rights of
women living with HIV.
Table 1 indicates the final number of articles and documents
that met the inclusion criteria according to the primary topic
they addressed from the total citations retrieved.
As the primary focus of this review was to determine how
human rights concerns are addressed in the literature, an
effort was made also to group articles so as to highlight which
rights principles are most often addressed and with respect to
which SRH topics. Table 2 presents all the peer-reviewed
articles included in our review organized by author(s), year of
publication, title, and the human right(s) and/or right(s)-
related issue(s) addressed in each (i.e.(general) human rights,
‘‘human rights principles,’’ human rights violations, reproduc-
tive rights, reproductive and sexual rights, right to health,
women’s rights and rights-based approach). Table 3 presents
all the grey documents in our review organized similarly by
author(s), year of publication, title, and the human right(s)






































47 full-text articles and documents





Figure 1. Results of the search strategy (peer-reviewed and grey).
*Of the 42 full-text peer-reviewed articles assessed for inclusion, one was removed based on full-text review and one was removed due to
inaccessibility of the full-text article.
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Findings are presented in the following sections mirroring
the organization of the WHO guideline (2006), followed by
the additional topics of violence; ageing; integrated models
of care; and structural, societal and contextual factors. Within
each category, findings are separated by those which
emerged from the peer-reviewed literature, and those which
emerged from the grey literature.
Promoting sexual health
Of the 1469 citations that were retrieved from the peer-
reviewed literature search in relation to promoting the sexual
health of women living with HIV (as consistent with the WHO
guideline this included SRH education, availability of informa-
tion, access to family planning counselling, etc.), only three
met the criteria for inclusion in this review. All three addressed
disclosure of HIV status in one way or another. Taken together,
several themes emerge: 1) there is a dearth of peer-reviewed
literature on the promotion of sexual health for women living
with HIV which includes attention to their rights, and what
does exist is entirely within the context of disclosure;
2) research is needed as to how best to support women living
with HIV in HIV disclosure not only in the immediate but
throughout their sexual lives; and 3) discrimination by health
providers based on HIV status for women who remain sexually
active remains a persistent problem [57].
The search of the grey literature yielded a report describing
a programme in India, SANGRAM Plus, which states that it
deliberately implements rights-based principles in their ap-
proaches to enable collective transformation to help margin-
alized populations, including female sex workers living with
HIV, to support one another, including increasing awareness of
free health services available to people living with HIV and
mechanisms to address violations. A second report from the
grey literature presents findings from a global survey on SRH
and human rights of women living with HIV. It represents the
values and preferences of women living with HIV in a manner
intended to be analogous to the form of building a safe house
with foundations, walls, and a roof. Among the findings, it
identifies challenges faced in a fulfilling and pleasurable sex
life associated with fears of the consequences of disclosure,
and difficulties with condom availability and negotiation.
Taken together, these findings echo the need to support
women living with HIV throughout their sexual lives and
the findings also provide examples of a rights-based approach
to programming to promote sexual health among this
population [8,9].
Providing high-quality services for family planning
Of the 149 citations that were retrieved from the peer-
reviewed literature search in relation to family planning
services for women living with HIV (as consistent with the
WHO guideline this included family planning counselling,
contraception and dual protection, sterilization, counselling
for pregnancy planning, conception, etc.), 12 met the criteria
for inclusion in this review. Taken together, the following key
themes emerge: 1) the increased accessibility and availability
of ART has profoundly impacted the ability of women living
with HIV to realize their reproductive desires and rights
although barriers still remain; 2) a wide range of experiences
with healthcare providers has been reported and there is a
demonstrated need to provide further clinical and rights-
based training to providers to ensure women living with HIV
Table 1. Number of articles and documents that met inclusion criteria by primary SRH topical area
Topics
Peer-reviewed articles: women living with
HIV and/or women receiving ART (combined)
Grey documents: women living with HIV
and/or women receiving ART (combined)
Promoting sexual health 3 1
Providing high-quality services for family
planning
12 1
Improving antenatal, intrapartum, postpartum
and newborn care
6 1
Eliminating unsafe abortion 5 0
Combating sexually transmitted infections,
reproductive tract infections and cervical
cancer
1 0
Reducing violence 1 2
Promoting healthy ageing 0 1
Integrated models of care 4 1
Structural, societal and contextual factors




Total (peer-reviewed or grey) 47
aSalamander Trust [8] is counted only once in the ‘‘promoting healthy ageing’’ category in the above table even as the document equally focused
on other categories (i.e. promoting sexual health, providing high-quality services for family planning; and reducing violence) but is referred to in
the text within each of those categories.
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Table 2. Human rights aspects addressed by peer-reviewed articles included in the review
Author(s) Year Title Human right(s) and/or rights-related issue(s) addressed
C. Barroso & S. Sippel 2011 Sexual and reproductive health and rights: integration as a holistic and rights-
based response to HIV/AIDS
Discrimination; equality; human rights violations; reproductive
and sexual rights; rights-based approach; quality; women’s
rights
C. Beyrer, S. Baral, D. Kerrigan, N. El-Bassel,
L.-G. Bekker and D. D. Celentano
2011 Expanding the space: inclusion of most-at-risk populations in HIV prevention,
treatment, and care services
Accessibility; criminalization; discrimination; human rights
principles; participation
C. H. Logie, L. James, W. Tharao and
M. R. Loutfy
2011 HIV, gender, race, sexual orientation, and sex work: a qualitative study of
intersectional stigma experienced by HIV-positive women in Ontario, Canada
Accessibility; discrimination
H. MacGregor and E. Mills 2011 Framing rights and responsibilities: accounts of women with a history of AIDS
activism
Accessibility; gender inequality; privacy and confidentiality;
reproductive and sexual rights; right to health
E. Mykhalovskiy 2011 The problem of ‘‘significant risk’’: exploring the public health impact of
criminalizing HIV non-disclosure
Criminalization; privacy and confidentiality
P. Orner, M. d. Bruyn and D. Cooper 2011 ‘‘It hurts, but I don’t have a choice, I’m not working and I’m sick’’: decisions
and experiences regarding abortion of women living with HIV in Cape Town,
South Africa
Discrimination; laws/policies; 3AQ
P. J. Orner, M. de Bruyn, R. M. Barbosa, H. Boonstra,
J. Gatsi-Mallet and D. D. Cooper
2011 Access to safe abortion: building choices for women living with HIV and AIDS Accessibility; laws/policies; reproductive and sexual rights
G. Anderson, G. Caswell, O. Edwards, A. Hsieh,
B. Hull, C. Mallouris, . . . C. Nöstlinger
2012 Community voices: barriers and opportunities for programmes to successfully
prevent vertical transmission of HIV identified through consultations among
people living with HIV
Accessibility; human rights violations; participation; privacy
and confidentiality; quality; reproductive and sexual rights
R. M. Barbosa, A. A. Pinho, N. S. Santos and
W. V. Villela
2012 Exploring the relationship between induced abortion and HIV infection in
Brazil
Accessibility; laws/policies; quality; reproductive and sexual
rights
M. de Bruyn 2012 HIV, unwanted pregnancy and abortion  where is the human rights
approach?
Accessibility; discrimination; human rights; laws/policies;
reproductive rights; women’s rights
O. Erhabor, C.I. Akani, & C.E. Eyindah 2012 Reproductive health options among HIV-infected persons in the low-income
Niger Delta of Nigeria
Discrimination; laws/policies; reproductive and sexual rights;
3AQ
Z. Essack and A. Strode 2012 I feel like half a woman all the time: the impacts of coerced and forced
sterilisations on HIV-positive women in South Africa
Discrimination; human rights violations; informed consent;
reproductive and sexual rights
S. Fried, B. Harrison, K. Starcevich, C. Whitaker and
T. O’Konek
2012 Integrating interventions on maternal mortality and morbidity and HIV: a
human rights-based framework and approach
Accountability; discrimination; gender inequality; human
rights violations; participation; right to health; 3AQ
E. Ghanotakis, D. Peacock and R. Wilcher 2012 The importance of addressing gender inequality in efforts to end vertical
transmission of HIV
Accessibility; gender inequality
A. Gibbs, E. T. Crone, S. Willan and J. Mannell 2012 The inclusion of women, girls and gender equality in National Strategic Plans
for HIV and AIDS in southern and eastern Africa
Accessibility; accountability; gender inequality; laws/policies;
reproductive and sexual rights
A. Gibbs, M. Mushinga, E. T. Crone, S. Willan and
J. Mannell
2012 How do national strategic plans for HIV and AIDS in southern and eastern
Africa address gender-based violence? A women’s rights perspective







































































































Table 2 (Continued )
Author(s) Year Title Human right(s) and/or rights-related issue(s) addressed
C. H. Logie, L. James, W. Tharao and
M. R. Loutfy
2012 We don’t exist: a qualitative study of marginalization experienced by HIV-
positive lesbian, bisexual, queer and transgender women in Toronto, Canada
Accessibility; discrimination; participation; quality
S. MacCarthy, J. J. K. Rasanathan, L. Ferguson and S.
Gruskin
2012 The pregnancy decisions of HIV-positive women: the state of knowledge and
way forward
Participation; reproductive and sexual rights; 3AQ
L. J. Messersmith, K. Semrau, T.L. Anh,
N.N. Trang, D.M. Hoa, K. Eifler, & L. Sabin
2012 Women living with HIV in Vietnam: desire for children, use of sexual and
reproductive health services, and advice from providers
Accessibility; discrimination; human rights violations;
reproductive and sexual rights
G. Paz-Bailey, V. I. Fernandez, S. Morales Miranda,
J. O. Jacobson, S. Mendoza, M. A. Paredes, D. C.
Danaval, D. Mabey and E. Monterroso
2012 Unsafe sexual behaviours among HIV-positive men and women in Honduras:
the role of discrimination, condom access, and gender
Accessibility; discrimination; gender inequality
M. M. Schaan, M. Taylor, J. Puvimanasinghe, L.
Busang, K. Keapoletswe and R. Marlink
2012 Sexual and reproductive health needs of HIV-positive women in Botswana  a
study of health care worker’s views
Discrimination; 3AQ
J. A. Smit, K. Church, C. Milford, A. D. Harrison and
M. E. Beksinska
2012 Key informant perspectives on policy- and service-level challenges and
opportunities for delivering integrated sexual and reproductive health and
HIV care in South Africa
Accessibility; laws/policies
A. Strode, S. Mthembu and Z. Essack 2012 She made up a choice for me: 22 HIV-positive women’s experiences of
involuntary sterilization in two South African provinces
Discrimination; informed consent; reproductive and sexual
rights
C. J. Badul and A. Strode 2013 LM and Others v Government of the Republic of Namibia: the first sub-
Saharan African case dealing with coerced sterilisations of HIV-positive
women  Quo vadis?
Discrimination; human rights violations; informed consent
S. Bott and C. M. Obermeyer 2013 The social and gender context of HIV disclosure in sub-Saharan Africa: a
review of policies and practices
Criminalization; human rights; laws/policies; privacy and
confidentiality
B. Chimphamba Gombachika, E. Chirwa,
A. Malata, J. Sundby and H. Fjeld
2013 Reproductive decisions of couples living with HIV in Malawi: what can we
learn for future policy and research studies?
Accessibility; availability; laws/policies
K. Church, A. Wringe, P. Fakudze, J. Kikuvi,
D. Simelane and S. H. Mayhew
2013 Are integrated HIV services less stigmatizing than stand-alone models of care?
A comparative case study from Swaziland
Discrimination; 3AQ
G. G. Eamer and G. E. Randall 2013 Barriers to implementing WHO’s exclusive breastfeeding policy for women
living with HIV in sub-Saharan Africa: an exploration of ideas, interests and
institutions
Accessibility; availability; laws/policies; participation
T. Kendall 2013 Falling short of universal access to reproductive health: unintended pregnancy
and contraceptive use among Mexican women with HIV
Accessibility; discrimination; reproductive rights
E. J. King, S. Maman, J. M. Bowling,
K. E. Moracco and V. Dudina
2013 The influence of stigma and discrimination on female sex workers’ access to
HIV services in St. Petersburg, Russia
Accessibility; discrimination; quality
A. K. Laar 2013 Reproductive rights and options available to women infected with HIV in









































































































Table 2 (Continued )
Author(s) Year Title Human right(s) and/or rights-related issue(s) addressed
M. Loutfy, U. Sonnenberg-Schwan,
S. Margolese, & L. Sherr
2013 A review of reproductive health research, guidelines and related gaps for
women living with HIV
Accessibility; discrimination; reproductive rights
M. Malta and C. Beyrer 2013 The HIV epidemic and human rights violations in Brazil Discrimination; laws/policies; rights-based approach
K. Clouse, S. Schwartz, A. Van Rie, J. Bassett,
N. Yende and A. Pettifor
2014 What they wanted was to give birth; nothing else: barriers to retention in
option B plus HIV care among postpartum women in South Africa
Accessibility; discrimination; laws/policies
S. MacCarthy, J. J. K. Rasanathan, A. Crawford-
Roberts, I. Dourado and S. Gruskin
2014 Contemplating abortion: HIV-positive women’s decision to terminate
pregnancy
Laws/policies; reproductive and sexual rights; 3AQ
P. Madhivanan, K. Krupp, V. Kulkarni,
S. Kulkarni, N. Vaidya,
R. Shaheen, . . . C. Fisher
2014 HIV testing among pregnant women living with HIV in India: are private
healthcare providers routinely violating women’s human rights?
Discrimination; human rights violations; informed consent;
privacy and confidentiality; rights-based approach; right to
health; quality
S. Malavé, J. Ramakrishna, E. Heylen, S. Bharat and
M. L. Ekstrand
2014 Differences in testing, stigma, and perceived consequences of stigmatization
among heterosexual men and women living with HIV in Bengaluru, India
Gender inequality
E. Marsicano, R. Dray-Spira, F. Lert, C. Aubriere, B.
Spire and C. Hamelin
2014 Multiple discriminations experienced by people living with HIV in France:
results from the ANRS-Vespa2 study
Discrimination
S. A. Spangler, M. Onono, E. A. Bukusi,
C. R. Cohen, & J. M. Turan
2014 HIV-positive status disclosure and use of essential PMTCT and maternal health
services in rural Kenya
Women’s rights
M. G. van Dijk, K. S. Wilson, M. Silva,
X. Contreras, H. D. Fukuda and S. G. Garcia
2014 Health care experiences of HIV-infected women with fertility desires in
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can realize their reproductive desires and rights; 3) forced
sterilizations continue to violate the rights of women living
with HIV and must be addressed everywhere it occurs as a
matter of urgency; and 4) recent court judgments are
beginning to show promise in upholding the reproductive
rights of women living with HIV although key barriers still
remain [1021].
The search of the grey literature found one report
documenting cases of forced sterilization of women living
with HIV in Chile, the Dominican Republic, Mexico, Namibia,
South Africa and Venezuela [22]. The report on findings from
a global survey on SRH and human rights of women living
with HIV referenced earlier identifies a lack of quality care in
family planning services for women living with HIV and calls
for compassionate, holistic, unconditional care and support
for informed choice [9]. Findings from these reports echo the
demonstrated need to provide further rights-based training
to providers to ensure women living with HIV can realize their
reproductive desires and rights.
Improving antenatal, intrapartum, postpartum and
newborn care
Of the 233 citations that were retrieved from the peer-
reviewed literature search in relation to antenatal, intrapar-
tum, postpartum and newborn care (as consistent with the
WHO guideline this included counselling during pregnancy,
childbirth and the postpartum period; preventing HIV infec-
tion among infants; and skilled care during pregnancy,
childbirth, and postpartum period), only six met the criteria
for inclusion in this review. Taken together, the following
themes emerge: while ART and related efforts have signifi-
cantly reduced transmission of HIV from mothers to infants,
1) there remains inadequate attention to the challenges with
disclosure and the attitudes of providers in the context of
pregnancy, childbirth and postpartum care; and 2) despite
some attention to human rights in prevention of mother-to-
child transmission (PMTCT) programmes, more research is
needed as to the potentially positive impacts of human
rights-based approaches in PMTCT as well as other antenatal,
intrapartum, postpartum and newborn care programmes
[3,2327].
The search of the grey literature yielded one report
by Amnesty International in relation to antenatal care in
South Africa which identified cases of discrimination and
abuses by healthcare workers (including breaches of privacy
and confidentiality) faced by women living with HIV. The
findings in this report once again affirm that there remains
inadequate attention to the discrimination faced by women
living with HIV particularly in the context of pregnancy and
childbirth [28].
Eliminating unsafe abortion
While only three citations were retrieved from the peer-
reviewed literature search in relation to abortion (as
consistent with the WHO guideline this included abortion
counselling, surgical and medical methods of abortion, post-
abortion care and family planning), after full-text review of all
articles meeting the inclusion criteria for review, five were
Table 3. Human rights aspects addressed by grey documents included in the review
Author(s) Year Title
Human right(s) and/or rights-related issue(s)
addressed
Jain, S., Greene, M.,
Douglas, Z., Betron, M.,
& Fritz, K.
2011 Addressing HIV and gender from the ground up.
Maanisha Community Focused Initiative to Control
HIV: a program to build the capacity of civil society
organizations in Kenya
Laws/policies; participation; women’s rights
Khan, A. 2011 Gender-based violence and HIV: a program guide for
integrating gender-based violence prevention and
response in PEPFAR programs
Accessibility; discrimination; gender inequality; human
rights; human rights violations; informed consent;
participation; privacy and confidentiality; quality;
women’s rights
Kundu, N. K. 2011 SANGRAM’s Collectives. Engaging communities in
India to demand their rights
Discrimination; gender inequality; human rights;
participation; rights-based approach
Open Society Institute 2011 Against her will: forced and coerced sterilization of
women worldwide
Accessibility; accountability; discrimination; human
rights violations; informed consent
Orza, L. 2011 Community innovation: achieving sexual and
reproductive health and rights for women and girls
through the HIV response
Accessibility; discrimination; gender inequality; human
rights; laws/policies; participation; reproductive and
sexual rights; rights-based approach; women’s rights
Amnesty International 2014 Struggle for maternal health: barriers to antenatal
care in South Africa
Discrimination; human rights violations; informed
consent; privacy and confidentiality; right to health;
3AQ
Salamander Trust 2014 Building a safe house on firm ground: key findings
from a global values and preferences survey
regarding the sexual and reproductive health and
human rights of women living with HIV
Discrimination; gender inequality; human rights;
human rights principles; human rights violations;
laws/policies; participation; reproductive and sexual
rights; 3AQ
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ultimately found to be relevant to abortion. Taken together,
the following key themes emerge: 1) restrictive abortion laws
fundamentally infringe upon the reproductive rights of
women living with HIV often resulting in the need to seek
unsafe abortion; and 2) even in settings where abortion law
is relatively liberal, there is a need for attention to other
reasons that may result in women living with HIV needing to
seek unsafe abortion including stigma and discrimination,
socio-economic status and health service implementation
factors [2933].
The report on findings from a global survey on SRH and
human rights of women living with HIV referenced earlier
identifies a lack of informed consent in reproductive decision
making. Findings suggest that more consistency is needed
among global, regional and national policy and programming
documents to ensure women living with HIV have access to
safe abortion services and are able to exercise their
reproductive rights [9].
Combating STIs, RTIs and cervical cancer
Of the 252 citations that were found from the peer-reviewed
literature search in relation to STIs, RTIs and cervical cancer
(as consistent with the WHO guideline this included STIs and
RTIs, screening for STIs, comprehensive case management,
cervical cancer screening and treatment, etc.), only one
article ultimately met the criteria for inclusion in the review.
This study suggested the need to pay attention to rights in
relation to reducing STI prevalence, improving service
delivery and helping to establish an enabling legal and policy
environment. No article made an explicit linkage between
denial or promotion of rights and research findings. Overall,
the limited literature on human rights and STIs, RTIs and
cervical cancer affecting women living with HIV suggests the
need for additional research with explicit attention to these
linkages [34].
The search of the grey literature did not retrieve any
documents specifically on this topic, echoing the need for
additional research and documentation with explicit atten-
tion to these linkages.
Reducing violence
Of the 53 citations that were retrieved from the peer-
reviewed literature search in relation to violence among
women living with HIV (as consistent with the WHO guideline
this included sexual violence, physical assault and psycholo-
gical violence), only one article had a primary focus on
violence. This suggests an urgent need for research which
considers the linkages between human rights; the various
forms of violence, including gender-based violence, intimate
partner violence, and structural forms of violence; and how
these act as key barriers to HIV prevention, access, treatment
and health outcomes for women living with HIV [35].
The search of the grey literature yielded a report of an
initiative in Kenya which emphasizes the importance of
community participation in addressing the links between
HIV and gender-based violence [36]. In addition, the global
survey report on SRH and human rights of women living with
HIV referenced earlier identified the human rights dimen-
sions of the violence experienced in homes, communities and
institutions (including health services) and calls for safety in
all of these settings [9]. Finally, the grey literature search
yielded a guide for programme managers on integrating
human rights into gender-based violence and HIV services
[37]. While limited, these documents can offer insights into
the need for and rights-based approaches to reduce violence
among women living with HIV although more evidence is
clearly needed in this area.
Promoting healthy ageing
Of the 73 citations that were found from the peer-reviewed
literature search in relation to ageing among women liv-
ing with HIV, none gave attention to its human rights
dimensions.
The search of the grey literature only retrieved the findings
from the global survey on SRH and human rights of women
living with HIV referenced earlier [9]. Respondents reported
sizeable gaps in clinical care, practice, policy and research for
women and girls outside the reproductive years and/or not
wanting to have children and made a request for health
services to adopt a holistic, women-centred con(tra)ception
to old-age approach to sexual and reproductive healthcare,
with a comprehensive package of age and stage-appropriate
(i.e. infancy, adolescence, adulthood) services. This echoes
the need for additional attention to human rights in relation
to ageing for women living with HIV.
Integrated models of care
Of the 40 articles included in this review from the peer-
reviewed literature search, four emphasized integrated
models of care as relevant to the SRH and rights of women
living with HIV  three discussed integrated SRH and HIV
services while another specifically discussed the potential
synergies of integrating maternal health and HIV services.
While some studies found clear consensus among decision
makers on the need for more integrated systems of SRH and
HIV care and the effectiveness integrated care can provide, a
study from Swaziland suggested patients may experience
increased felt-stigma in integrated settings. Taken together,
the literature in this area suggests the following themes: 1)
while integrated models of care likely provide opportunities
to reduce discrimination and stigma for women living with
HIV and improve accessibility and quality of care, results are
not uniformly positive; and 2) rights-based approaches to
SRH and HIV remain to be better defined but can elucidate
both shared determinants and solutions in improving service
delivery for and health outcomes of women living with HIV
[3841].
The search of the grey literature yielded one report
addressing integrated models of care as relevant to the
sexual and reproductive health and rights (SRHR) of women
living with HIV. The report documents case studies of
successful approaches at the intersection of SRHR and HIV
innovated and/or led by women living with HIV with the
intention of strengthening in practice the integration of
services. Among the case studies are examples of projects
integrating SRH and HIV services in the city of Memphis
within the United States, programmes in Russia and Malawi
reducing violence against women living with HIV, and home-
based care for women and girls living with HIV in Kenya [42].
The report echoes that integrated models of care may
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improve accessibility and quality of care for women living
with HIV although more research is needed.
Structural, societal and contextual factors impacting SRH
and rights
Of the 40 articles included in our review of the peer-reviewed
literature, eight can be considered to have raised larger
structural, societal and contextual factors impacting the SRH
and rights of women living with HIV. Taken together, the
literature in this area suggests the following themes: 1)
gender inequality remains a key barrier to be addressed to
improve the SRH of women living with HIV, with potential
impacts also on all aspects of HIV prevention, access and
treatment; and 2) discrimination against women living with
HIV, and particularly women from key populations (in
particular sex workers, injecting drug users and transgender
women), continues to be pervasive and influence health
behaviours, care-seeking, adherence to treatment and health
outcomes [4350].
Findings from all of the grey literature reviewed provide
support and depth consistent with the conclusions above
[8,9,22,28,36,37,42].
Conclusions
Human rights increasingly form part of the language and
approach of international organizations, governments, non-
governmental organizations and civil society groups con-
cerned with the SRH of women living with HIV. Most, if not
all, States have committed themselves to promote and
protect relevant human rights by ratifying international
and/or regional human rights instruments, and making
political commitments [51]. Beyond rhetorical commitments,
the on-the-ground implications of a commitment to human
rights for the lives and health of women living with HIV
remain unclear. Even when efforts are made by States to
improve the SRH of women living with HIV in line with their
human rights commitments, legal, policy, structural and
systems barriers continue to exist both inside and outside
the health sector. Further, even as efforts are increasingly
being made by a number of different actors to bring human
rights into relevant SRH programming, documentation is
inadequate and inconsistent. While there are tremendous
strides taking place at the normative level and very important
work happening on the ground, within the literature there
are few well-documented examples of bringing human rights
into the work undertaken to support the SRH of women
living with HIV.
In this review, we found the amount of peer-reviewed
literature to directly address human rights and the SRH of
women living with HIV to be far more limited than expected
in terms of quantity, and what does exist only addresses a
few rights in the context of a few areas within SRH. Once the
inclusion criteria were applied, the search yielded few
articles. Even within the literature that met the criteria for
inclusion, the language of rights is used most often to
describe their apparent neglect or violation rather than their
promotion or inclusion in programming or services. Several
articles do point to the need to better integrate rights into
interventions, particularly as it concerns provider training,
raising client awareness and service delivery. From issues
related to privacy and confidentiality to forced sterilization,
awareness and integration of human rights in provider
training is of critical importance. Increased education and
information incorporating human rights is necessary for
women living with HIV to claim their rights and make
informed decisions regarding their healthcare. Finally, addi-
tional efforts must be made to test, validate and write up the
inclusion of rights in comprehensive, quality care and service
delivery models geared towards women living with HIV.
Similarly, the available and accessible grey literature in this
search that directly addresses the application of human rights
to address the SRH of women living with HIV is also limited.
While a handful of examples were found, the grey literature
search did not identify significant existing evidence on
interventions to address/promote human rights in the context
of SRH programmes and policies for women living with HIV.
Rather, the grey literature offers significant examples of
violations of rights and a few case studies of successful
interventions. These give context and substance by providing
information that demonstrates the SRH rights and needs of
women living with HIV are real issues to be addressed.
While rights may be explicitly addressed in policies
relevant to the lives of women living with HIV, there was
not a single peer-reviewed article found through this review
that described the conscious and explicit implementation of
rights concepts in programming to address the SRH of
women living with HIV. With the possible exception of one
article by Fried et al. [40], none were found which addressed
rights comprehensively, or addressed the majority of rights
considered central to a rights-based approach, with only a
handful addressing particular rights within a SRH topic.
Several articles were included because it was determined
that they met the criteria for implicit use of rights,
particularly in relation to different aspects of the 3AQ, but
it remains unclear if researchers had consciously brought
rights concepts into these interventions, if they would as a
consequence have been shaped differently and ultimately
would have been more effective in health and rights terms.
While it can be argued that articles and documents excluded
from our review might also have raised rights implicitly to
some degree, in particular the literature found on stigma,
these lacked a sufficiently explicit link to human rights.
In sum, there appears to be a significant disconnect
between those who are implementing rights-based interven-
tions and those who are publishing in the peer-reviewed and
grey literature. What can be found in the literature is limited,
insufficiently funded and ultimately inadequate to represent
the evidence base in this area. While it is possible that there
may be wonderful examples of implementation of rights-
based approaches to SRH of women living with HIV happening
on the ground, this is not reflected in the literature, be it peer-
reviewed or grey. There is an urgent need for more research in
this area and to conduct rigorous interviews with institutions
and organizations implementing rights-based interventions
geared to supporting the SRH and rights of women living with
HIV, including in-depth interviews with key informants work-
ing with women living with HIV (e.g. International Community
of Women Living with HIV/AIDS (ICW), Global Coalition on
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Women and AIDS (GCWA), Athena, among others). Along with
more research, attention to the normative work happening
both globally and within regions and countries is warranted.
Most importantly, the voices and experiences of women living
with HIV must ultimately frame the discussion and inform
evidence-based guidelines to improve the treatment, care and
support of women living with HIV.
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Abstract
Introduction: Women represent nearly one-quarter of the 71,300 people living with HIV in Canada. Within a context
of widespread HIV-related stigma and discrimination and on-going risks to HIV disclosure, little is known about the influence
of growing social, legal and public health surveillance of HIV on sexual activity and satisfaction of women living with HIV
(WLWH).
Methods: We analyzed baseline cross-sectional survey data for WLWH (]16 years, self-identifying as women) enrolled in the
Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS), a multisite, longitudinal, community-based
research study in British Columbia (BC), Ontario (ON) and Quebec (QC). Sexual inactivity was defined as no consensual sex (oral
or penetrative) in the prior six months, excluding recently postpartum women (56 months). Satisfaction was assessed using an
item from the Sexual Satisfaction Scale for Women. Multivariable logistic regression analysis examined independent correlates of
sexual inactivity.
Results: Of 1213 participants (26% BC, 50% ON, 24% QC), median age was 43 years (IQR: 35, 50). 23% identified as Aboriginal,
28% as African, Caribbean and Black, 41% as White and 8% as other ethnicities. Heterosexual orientation was reported by 87%
of participants and LGBTQ by 13%. In total, 82% were currently taking antiretroviral therapy (ART), and 77% reported an
undetectable viral load (VLB40 copies/mL). Overall, 49% were sexually inactive and 64% reported being satisfied with their
current sex lives, including 49% of sexually inactive and 79% of sexually active women (pB0.001). Sexually inactive women had
significantly higher odds of being older (AOR1.06 per year increase; 95% CI1.051.08), not being in a marital or committed
relationship (AOR4.34; 95% CI3.135.88), having an annual household income below $20,000 CAD (AOR: 1.44; 95%
CI1.081.92), and reporting high (vs. low) HIV-related stigma (AOR1.81; 95% CI1.093.03). No independent association
was found with ART use or undetectable VL.
Conclusions: Approximately half of WLWH in this study reported being sexually inactive. Associations with sexual dissatisfaction
and high HIV-related stigma suggest that WLWH face challenges navigating healthy and satisfying sexual lives, despite good HIV
treatment outcomes. As half of sexually inactive women reported being satisfied with their sex lives, additional research is
required to determine whether WLWH are deliberately choosing abstinence as a means of resisting surveillance and disclosure
expectations associated with sexual activity. Findings underscore a need for interventions to de-stigmatize HIV, support safe
disclosure and re-appropriate the sexual rights of WLWH.
Keywords: HIV; women; Canada; sexual and reproductive health; sexual abstinence; sexual satisfaction; community-based
research; antiretroviral therapy; CHIWOS.
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Introduction
Globally, women account for over half of all adults living with
HIV [1]. In Canada, approximately one-quarter of the 71,300
people living with HIV (PLWH) are women, nearly double the
proportion observed in 1999 (12%) [2]. With early and
sustained use of antiretroviral therapy (ART), women living
with HIV (WLWH) are living longer and healthier lives [35]
with improved sexual and reproductive options accompanying
lowered risks of sexual and perinatal HIV transmission
[68]. This altered landscape of HIV risk has re-ignited global
discourse regarding the need for a rights-based approach to
sexual health [912]. Sexual health research and programming
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targeting WLWH, however, are largely focused on risk be-
haviours (such as condom use) rather than broader sex-
positive considerations of sexual intimacy, well-being and
satisfaction [13,14]. Moreover, prevailing concern about
individual-level behaviours ignores the broader clinical, legal
and social factors that regulate the sexual lives and rights of
WLWH [15,16].
The criminalization of HIV non-disclosure [17] and ‘‘Treat-
ment as Prevention’’ (TasP) [18] are two legal and public health
strategies aimed at preventing HIV transmission that have
emerged in many global settings, including Canada [11,19
21]. While both initiatives place sexual activity of PLWH and
‘‘Positive Prevention’’ (HIV prevention strategies directed at
PLWH) at the centre of their efforts, they are theoretically
opposing and deviate from the ‘‘shared responsibility’’
messaging for HIV prevention endorsed by the Global Network
of People Living with HIV (GNP), the Canadian AIDS Society
and other international agencies [22,23]. Growing evidence
demonstrates that early and sustained use of ART for greater
than six months with viral suppression generates a very low
risk of HIV transmission during condomless sex between HIV
sero-discordant sexual partners, with recent studies reporting
a transmission risk approaching zero [2426]. These findings
have supported the implementation of TasP initiatives in a
number of global jurisdictions [20,27,28], where PLWH are
monitored along a care cascade from HIV diagnosis to linkage
and retention in care, and initiation and adherence to ART to
achieve sustained viral suppression [29,30].
Despite the evidence and growing optimism about what it
means to live with HIV, in terms of improved quality of life,
clinical health and lowered transmission risks, Canada has
among the most aggressive judicial approaches to prevent
perceived sexual exposure to HIV through the criminalization
of HIV non-disclosure [19,21]. In October 2012, the Supreme
Court of Canada ruled that PLWH are legally required to
disclose their HIV status to sexual partners prior to sexual
activity that poses a ‘‘realistic possibility’’ of HIV transmission
[17,31]. The Supreme Court defined realistic possibility as any
sexual activity without the use of a condom and without a low
HIV plasma viral load (defined by the court as VLB1500
copies/mL). PLWH who fail to meet both criteria and do not
disclose their HIV status to sexual partners risk a criminal
charge of aggravated sexual assault. If convicted, this charge
results in jail time with a maximum sentence of life imprison-
ment and mandatory listing on a national Sexual Offender
Registry. The inconsistency between legal definitions of the
‘‘realistic possibility’’ of HIV transmission and contemporary
scientific assessments of HIV transmission risk and prognosis
detract from rights-based approaches to improving the sexual
health of WLWH and propagate misconceptions about the
sexual and reproductive realities of living with HIV.
For many WLWH around the world, such public health and
legal HIV prevention strategies have introduced increased
surveillance (including monitoring VL, HIV disclosure and
condom use) and present attendant consequences to their
sexual lives. Importantly, expectations of HIV status disclosure
exist within a context of widespread HIV-related fear, violence,
and stigma and discrimination, which when combined with
gender and relationship power inequities, disproportionately
compromise WLWH’s navigation of intimate relationships
[3235]. Together, these social factors mute conversations about
sexuality and HIV, deny risks that WLWH face with forced
disclosure and/or condom use, compromise opportunities for
safe disclosure and sexual relationships for WLWH and reduce
the willingness and agency of WLWH to seek out critical health
services [36]. In Canada and elsewhere, increasing use of ART
has not substantially alleviated the presence or impact of
stigma and discrimination [37] despite attempts to normalize
HIV through initiatives under the TasP umbrella [38,39].
In response to growing social, legal and public health
surveillance, WLWH may adopt various strategies to protect
and navigate their sexual lives, including the avoidance of
sexual and romantic partnerships. Indeed, previous research
has suggested that WLWH may forgo sexual activity to avoid
expectations and risks of HIV disclosure to sexual partners
[3234]. To understand drivers of sexual activity decision-
making amongWLWH in Canada, wemeasured the prevalence
of sexual inactivity and sexual satisfaction among a cohort
of WLWH and assessed demographic, HIV clinical and socio-
structural correlates of sexual inactivity.
Methods
Study setting
In Canada, approximately 16,600 women were living with HIV
in 2011 [40], of whom 81% lived in one of the three provinces:
British Columbia (BC), Ontario or Quebec.
Study design
Baseline cross-sectional data were analyzed for WLWH
enrolled in the Canadian HIV Women’s Sexual and Reproduc-
tive Health Cohort Study (CHIWOS; www.chiwos.ca), a large,
multisite, longitudinal, community-based research (CBR) pro-
ject conducted by, with and for WLWH in BC, Ontario and
Quebec (full cohort: n1427). The primary objective of
CHIWOS is to assess the prevalence, barriers and facilitators
to use of women-centred HIV care, and the impact of such
patterns of use on health outcomes. CHIWOS is grounded in
Critical Feminist theory [41] and CBR principles, and guided by
a Social Determinants of Women’s Health framework [42,43]
(described in detail elsewhere [44]). Consistent with CBR
methodology, WLWH and allied clinicians, researchers, com-
munity partners, social and public health service delivery
personnel, and policy-makers were involved in all stages of this
research.
Study population and recruitment
This analysis includes participants enrolled in CHIWOS be-
tween 27 August 2013 and 13 March 2015.WLWH aged ]16
years from one of the three enrolling study provinces were
eligible to participate. CHIWOS is inclusive to self-identified
trans and cis gendered women, two-spirited women, gender
queer and women of other gender identities. Given the
importance of including young women’s voices in the study,
an exemption was sought and approved such that parental/
guardian consent for women aged 1618 years was not
required.
WLWH were recruited for participation through peer word-
of-mouth, HIVclinics in large and small communities across the
three provinces, AIDS Service Organizations (ASOs), non-HIV
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community-based organizations (e.g. immigration and refugee
services, women’s shelters, harm reduction and sex worker
support services), the networks of our national Steering
Committee and three provincial Community Advisory Boards,
and online methods (e.g. Listservs for WLWH, and our study
website (www.chiwos.ca), Facebook page (www.facebook.
com/CHIWOS) and Twitter feed (www.twitter.com/CHIWOS
research).
Consistent with data showing an over-representation of
Aboriginal and African, Caribbean and Black (ACB) women
among WLWH in Canada, targeted efforts were made to
recruit Aboriginal and ACB participants. These efforts included
hiring a diverse national team of 38 WLWH as Peer Research
Associates (PRAs), including 6 Aboriginal and 14 ACB PRAs, and
the creation of a CHIWOS Aboriginal Advisory Board whose
members assisted and advised on community outreach and
recruitment.
Overall, 1355 women were enrolled in CHIWOS at time of
analysis. For this analysis, 142 (10%) women were excluded,
including 84 who requested to skip the Sexual Health section
of the survey, 7 who reported a live birth at or less than six
months prior to interview, 40 who reported never having had
consensual sex, and 13 who were missing data on recent
consensual sex (the primary outcome), yielding an analytic
sample of 1213 WLWH. Given our objective to measure
intentional sexual activity, women who experienced non-
consensual sex in the six months prior to interview without
report of consensual sexual activity, were not considered
sexually active.
Data collection
All participants completed a structured, online questionnaire
(supported by FluidSurveysTM software) at baseline (study
enrolment), administered by PRAs (WLWH hired as members
of the study team). PRAs underwent extensive training in
research ethics, CBR, consenting, administering question-
naires, social positioning, self-care and support for parti-
cipants [45]. Questionnaires were conducted in English or
French and administered in-person in a confidential setting at
collaborating HIV clinics, ASOs or community organizations, or
in women’s homes. For some participants in rural or remote
areas, questionnaires were administered via phone or Skype.
Median survey completion time was 89 minutes [IQR: 71, 115]
and participants received a $50 honorarium for their partici-
pation, regardless of whether all questions or sections of the
questionnaire were completed.
Measures
A national team of experts in women’s health and HIV con-
tributed to the development of the CHIWOS questionnaire,
which was designed to maximize psychometric validity and
reliability [46] and collected information on socio-demographics,
HIV medical history and clinical care, experiences of violence
and stigma and discrimination, and sexual, reproductive,
women’s and emotional health outcomes. Given the sensi-
tive nature of questions about sexual health and violence,
participants were given the option of completing these survey
sections with the PRA, independently, or skipping the sections
entirely.
Primary outcomes: sexual inactivity and sexual satisfaction
The primary outcome was recent sexual inactivity (vs. sexual
activity) defined as no (vs. any) consensual sex (oral or
penetrative) in the six months prior to interview.
Among all women, regardless of recent sexual activity or
inactivity, sexual satisfaction was assessed using a five-point
Likert scale item from the Sexual Satisfaction Scale for Women
(SSS-W) [47]: ‘‘Overall, how satisfactory or unsatisfactory is
your present sex life.’’ Responses were dichotomized into
satisfactory (‘‘Completely/Very/Reasonably satisfactory’’) vs.
unsatisfactory (‘‘Not very/Not at all satisfactory’’).
Covariates
Covariates of sexual inactivity included socio-demographic
characteristics (i.e. age, education, gender identity, sexual
orientation, ethnicity, annual household income, relationship
status, and number of children); self-reported clinical HIV
history and outcomes, including years living with HIV, receipt
of HIV medical care in past year (yes vs. no), receipt of ART in
past year (yes vs. no), most recent VL (undetectable (B40
copies/mL) vs. detectable ]40 copies/mL, shown to have a
high positive predictive value [48]), most recent CD4 cell count
(B200 cells/mm3vs. 200500 cells/mm3vs.500 cells/mm3),
as well as having ever discussed the impact of VL on risk of HIV
transmission with a healthcare provider (yes vs. no) and
perceptions of how ART changes personal risk of transmitting
HIV (lowers the risk of transmission vs increases the risk of
transmission or makes little difference); the SF-12 physical and
mental health-related quality of life summary scores (scored
on a 0100 scale, where a higher score indicates better health)
[49,50]; depression (measured using the 10-item Center for
Epidemiologic Studies Depression Scale (CES-D 10), scored on
a 030 scale, with higher scores indicating greater depression
symptomology and a cutoff score of ]10 considered indi-
cative of ‘‘probable depression’’) [51,52]; and HIV-related
stigma measured using the 10-item HIV Stigma Scale (HSS)
[53,54]. Scores for the HSS range from 0 to 100, with higher
scores indicating higher stigma. Scores greater or equal to the
scale median were considered ‘‘high HIV-related stigma’’ vs.
‘‘low HIV-related stigma.’’
Among sexually active women, we describe types of sexual
partnerships and knowledge about HIV status. In the survey,
‘‘Regular Sexual Partners’’ were defined to include, but not
limited to, ‘‘spouses, common law partners, long term
relationships, friends with benefits, or partners seen on and
off for some time.’’ ‘‘Casual Sexual Partners’’ were defined to
include, but not limited to, ‘‘serious sexual relationships that
have recently begun, new sexual relationships that exist but
you’re not sure about, chance sexual encounters, or one night
stands.’’
Data analysis
Descriptive statistics (median Interquartile Range [IQR]) for
continuous variables and n (%) for categorical variables) were
used to characterize baseline distributions of study variables.
Baseline differences between sexually inactive and sexually
active women were compared using Wilcoxon rank sum test
for continuous variables and Pearson x2 or Fisher’s exact test
for categorical variables.
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We fit a multivariable logistic regression explanatory
model to the data to examine covariates of sexual inactivity.
After testing normality assumptions and collinearity, vari-
ables with a significant association with sexual inactivity
in bivariate analyses (at pB0.20) were considered for the full
model to obtain the relative contribution of each covariate.
Model selection was achieved by minimizing the Akaike
Information Criterion while maintaining Type III p-values for
covariates below 0.20 [55]. All statistical tests were two-
sided and were considered statistically significant at a0.05.
Data were analyzed using SAS version 9.3 (SAS Institute, Inc.,
Cary, NC).
Ethical statement
All participants provided written, voluntary informed consent
(or oral consent with a study team member present as a
witness for surveys conducted by phone or Skype) at
enrolment in the survey phase of the CHIWOS study. Ethical
approval for all study procedures was provided by the
Research Ethics Boards of Simon Fraser University, University
of British Columbia/Providence Health, Women’s College
Hospital and McGill University Health Centre.
Results
Baseline characteristics
Of 1213 participants, 26% were from BC, 50% from Ontario
and 24% from Quebec. Median age was 43 years [IQR: 35, 50],
95% identified as cis gender women and 5% identified as trans
women, two-spirited or gender queer. Eighty-seven percent
were heterosexual and 13% identified as LGBTQ (Lesbian, Gay,
Bi-Sexual, Two-spirited, or Queer). Nearly one-quarter (23%)
identified as Aboriginal, 28% ACB, 41% White and 8%
other ethnicities. Sixty-three percent had an annual household
income B$20,000 CAD, and 34% were married, common law
or in a relationship.
Median years living with HIV was 10.8 [IQR: 5.9, 16.8], 94%
reported receiving HIV medical care in the past year and 82%
were currently taking ART. By self-report, 77% had undetect-
able VL and 50% had CD4 cell count 500 cells/mm3 at most
recent visit. Sixty-nine percent of participants reported
discussing the impact of VL on HIV transmission risk with
their healthcare provider, and overall, 81% perceived that use
of antiretrovirals lowers HIV transmission risk. Median SF-12
physical and mental health summary scores were 48 [IQR: 33,
56] and 42 [IQR: 31, 52], respectively. Median HIV stigma score
was 60 [IQR: 50, 73] with 48% classified as experiencing high
(vs. low) HIV-related stigma. Median depression symptom
severity score (based on CES-D) was 9 [IQR: 4, 15], with 49%
meeting the criteria for probable depression (Table 1).
Sexual inactivity, sexual satisfaction and summary of sexual
partnerships
Forty-nine percent (49%) of participants reported being
sexually inactive in the six months prior to baseline interview.
Sixty-four percent (64%) of women reported being satisfied
with their current sex lives, including 49% of sexually inactive
women and 79% of sexually active women (pB0.001).
Of sexually active WLWH (n618), 81% had one and 6%
had two or more regular sexual partners in the previous six
months. Of those with at least one regular sexual partner
(n543), 27% reported that their primary sexual partner was
HIV-positive, 64% reported that the partner was HIV-negative
and for 9% the partner’s HIV status was unknown. Ninety-
one percent (91%) reported that their current or most
recent regular partner knew the participant’s HIV status at
their last sexual encounter. One-fifth (21%) of all sexually
active participants reported having a casual sexual partner in
the previous six months.
Correlates of sexual inactivity
In unadjusted analyses, sexual inactivity was associated (at
pB0.20) with older age, gender identity, sexual orientation,
household income B$20,000 per year, not being in a martial
or committed relationship, longer time living with HIV, current
ART use, poorer physical health, high HIV-related stigma
scores, probable depression, sexual dissatisfaction and having
discussed the role of VL on HIV transmission risk with a
healthcare provider (Table 2).
In the logistic regression model, sexually inactive women
had significantly higher adjusted odds of being older
(AOR1.06 per year increase in age; 95% CI1.051.08),
not being in a marital or committed relationship (AOR4.34;
95% CI3.135.88), having an annual household income
below $20,000 CAD (AOR1.44; 95% CI: 1.081.92), and
reporting high (vs. low) HIV-related stigma (AOR1.81; 95%
CI1.103.03). No independent association was found with
current ART use, undetectable plasma HIV VL or CD4500
cells/mL. However, sexually inactive women were significantly
more likely to report not having discussed the role of VL on
decreasing HIV transmission risk with a healthcare provider
(AOR1.57; 95% CI: 1.162.11; Table 2).
Discussion
This is the first multisite cohort study to evaluate sexual
inactivity among WLWH in Canada in the modern era of TasP
and HIV criminalization. Nearly half of WLWH in this Canadian
cohort reported being sexually inactive and over two-thirds
report being satisfied with their sexual lives. Other studies
have similarly shown that sexual inactivity is common among
PLWH, particularly women. The Women’s Interagency HIV
Study (WIHS), an on-going cohort study of WLWH in
the United States (US), found that 35% of WLWH reported
no vaginal, oral or anal sex over a six-month time period
compared with 23% of HIV-negative women [56]. Other US
research has found that WLWH are significantly more likely to
be sexually inactive (34%) compared with HIV-positive gay and
bisexual men (28%) [57]. Similar results were seen in a study
by Bogart et al. [58], where a higher proportion ofWLWH (18%)
were deliberately abstinent compared to gay and bisexual
men with HIV (11%). The prevalence of sexual inactivity (49%)
in our study was notably higher than estimates from other
HIV cohorts. Some of this difference may be explained by the
older median age of WLWH enrolled in CHIWOS compared
with other referenced cohorts and the evidence that sexual
activity and satisfaction decline with increasing age [59,60];
and shown in Table 1. Some difference may also be explained
by our distinction between and exclusion of non-consensual
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n (%) or median
[IQR] p-value
Median age [IQR] (years) 43 [35, 50] 1213 40 [33, 46] 46 [38, 54] B0.001
Age category (years)
16 to B30 114 (9.4) 1213 83 (13) 31 (5.2) B0.001
30 to B40 366 (30) 218 (35) 148 (25)
40 to B50 392 (32) 215 (35) 177 (30)
50 341 (28) 102 (17) 239 (40)
Province
British Columbia (BC) 317 (26) 1213 172 (28) 145 (24) 0.009
Ontario 607 (50) 283 (46) 324 (55)
Quebec 289 (24) 163 (26) 126 (21)
Gender identitya
cis gender woman 1157 (95) 1213 581 (94) 576 (97) 0.02
Trans woman, two-spirited, gender queer, or
other gender
56 (5) 37 (6) 19 (3)
Sexual orientationb
Heterosexual 1050 (87) 1209 525 (85) 525 (88) 0.121
LGBTQ 159 (13) 90 (15) 69 (12)
Ethnicity
Aboriginal 277 (23) 1213 142 (23) 135 (23) 0.391
African, Caribbean and Black Canadian (ACB) 338 (28) 164 (27) 174 (29)
White 502 (41) 268 (43) 234 (39)
Other ethnicities 96 (8) 44 (7.1) 52 (8.7)
Education
BHigh school 180 (15) 1207 93 (15) 87 (15) 0.798
]High school 1027 (85) 520 (85) 507 (85)
Annual household income (CAD)
]$20,000 419 (35) 1213 242 (39) 177 (30) B0.001
B$20,000 759 (63) 353 (57) 406 (68)
Don’t know/prefer not to answer 35 (3) 23 (3.7) 12 (2.0)
Relationship status
Single/separated/divorced/widowed 802 (66) 1207 306 (50) 496 (84) B0.001
Married/common law/in a relationship 405 (34) 307 (50) 98 (17)
Number of children
0 372 (32) 1162 175 (30) 197 (34) 0.204
13 630 (54) 332 (57) 298 (52)
4 160 (14) 78 (13) 82 (14)
Median time living with HIV [IQR] (years) 10.8 [5.9, 16.8] 1180 10.1 [5.6, 15.8] 11.7 [6.2, 17.6] 0.004
Received HIV medical care in the past year
Yes 1139 (94) 1212 574 (93) 565 (95) 0.102
No 73 (6.0) 44 (7.1) 29 (4.9)
Currently taking ART
Yes 999 (82) 1213 500 (81) 499 (84) 0.176
No 214 (18) 118 (19) 96 (16)
Current plasma viral load (self-reported)
Detectable (]40 copies/mL) 173 (14) 1213 91 (15) 82 (14) 0.869
Undetectable (B40 copies/mL) 939 (77) 477 (77) 462 (78)
Don’t know/never received results 101 (8.3) 50 (8.1) 51 (8.6)
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sex in our definition of sexual activity. However, the remaining
difference may be explained by a high reported prevalence
of HIV stigma and the context of surveillance for WLWH in
the Canadian setting [61]. Our estimates of sexual inactivity
are also significantly higher than those reported in the general
population (1014%) [62], echoing previous research that
an HIVdiagnosis impacts the sexual health of women [63] even
several years after the initial diagnosis [64].
The association between sexual inactivity and high HIV-
related stigma and sexual dissatisfaction but not ART use or
viral suppression suggests that WLWH face challenges
navigating healthy, satisfying and safe sexual lives, despite
good treatment outcomes. This suggests that good treatment
outcomes alone do not lead to higher likelihood of sexual
activity or eliminate prevailing socio-structural barriers to
sexual health for WLWH.
HIV-related stigma and discrimination are critical barriers
to cultivating loving, intimate relationships, facilitating HIV
status disclosure and engaging with healthcare for WLWH
[65,66]. The increasingly strict use of the criminal law for HIV
non-disclosure against PLWH in Canada presents an addi-
tional form of stigmatization [67] and additional challenges
for WLWH initiating sexual relationships and navigating HIV
disclosure to sexual partners. This judicial approach shifts the
responsibility for condom use and the burden of proof onto
PLWH, introducing the potential for false accusations of HIV
non-disclosure by sexual partners and concerns of secondary
disclosure within the wider community [68,69]. Observations











n (%) or median
[IQR] p-value
Current CD4 cell count (self-reported)
B200 cells/mm3 66 (5.5) 1211 34 (5.5) 32 (5.4) 0.597
200500 cells/mm3 329 (27) 166 (27) 163 (28)
500 cells/mm3 606 (50) 302 (49) 304 (51)
Don’t know/never received results 210 (17) 116 (19) 94 (16)
Discussed VL on HIV transmission risk with
healthcare provider
Yes 826 (69) 1201 461 (75) 365 (62) B0.001
No 375 (31) 151 (25) 224 (38)
Perception of how ART changes HIV transmission
risk
Lowers risk of transmission 979 (81) 1213 509 (82) 470 (79) 0.214
Increases risk of transmission or makes little
difference
130 (11) 57 (9.2) 73 (12)
Don’t know 104 (8.6) 52 (8.4) 52 (8.7)
Median health-related quality of life score [IQR]
Physical health summary score 48 [33, 56] 1206 50 [36, 56] 46 [32, 55] 0.004
Mental health summary score 42 [31, 52] 1206 42 [31, 52] 43 [32, 53] 0.537
HIV stigma scale
High HIV-related stigma 575 (48) 1200 280 (46) 295 (50) 0.155
Low HIV-related stigma 625 (52) 330 (54) 295 (50)
Satisfaction with present sex life
Completely, very or reasonably satisfied 777 (64) 1213 488 (79) 289 (49) B0.001
Not very or not at all satisfied 347 (29) 115 (19) 232 (39)
Prefer not to answer 89 (7.3) 15 (2.4) 74 (12)
Probable depression (CESD-10)
No (scoreB10) 600 (51) 1173 330 (55) 270 (47) 0.007
Yes (score ]10) 573 (49) 270 (45) 303 (53)
Notes: aGender identity was self-reported as cis or trans gender woman, two-spirited, gender queer or an ‘other’ gender identity. Given small
numbers, we grouped participants self-identifying as trans gender, two-spirited, gender queer or ‘other’ gender for this analysis. Of the 56
women included in this grouped category, 48 (86%) identified as transgender women.
bLGBTQ includes participants who identify as Lesbian, Gay, Bi-sexual, Two-spirited or Queer; CADCanadian dollars; ARTantiretroviral
therapy; VLviral load.
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that the sexuality of PLWH is being policed [70] and reports
of discriminating medical surveillance in the reproductive
healthcare setting [61] raise concerns that the sexual rights
of WLWH are being unjustly compromised in the current legal
climate. While we are unable to directly assess the effect of
criminalization of HIV non-disclosure on sexual activity within
this study, qualitative studies in Canada have found that fear,
anxiety and uncertainty related to the current legal obligation
to disclose HIV serostatus to sexual partners have resulted in
some PLWH abstaining from sexual activity altogether [70].
Forgoing sexual activity removes expectations and risks of
HIV disclosure to sexual partners, difficulties negotiating
condom use and risks of sexual HIV transmission. For some
WLWH, sexual abstinence may also be a response to fear and
threats of rejection by sexual partners, secondary disclosure,
relationship dissolution, violence and social isolation follow-
ing disclosure of HIV status [32,58,71,72].
Despite the high prevalence of sexual inactivity in our
cohort, a large proportion of women overall report being
satisfied with their current sex lives (64%). While satisfaction
differs by sexual activity, it is higher overall than expected
based on previous research [60]. Among sexually inactive
women, half report being satisfied with their present sex
lives, suggesting that sexual abstinence may be deliberate or
intentional, not simply circumstantial. However, sexually
inactive women report higher HIV-related stigma. This
suggests that HIV-related stigma plays an important role in
sexual decision-making, expression and lives of WLWH.
Furthermore, WLWH experiencing high HIV-related stigma
may be actively choosing sexual inactivity as a strategy to
avoid having to navigate disclosure and risk stigma and
discrimination in initiating sexual partnerships, and for many
women this is a satisfactory approach to their sexual lives.
Interventions are required to reframe the approach to
sexual health among WLWH. A component of this reframing
is a movement towards models that advocate for Positive
Health, Dignity and Prevention frameworks [23,73], which
place the person living with HIV at the centre of their health,
Table 2. Unadjusted and adjusted odds ratios for correlates of sexual inactivity in the previous six months among women living
with HIV enrolled in CHIWOS
Sexually inactive vs. Sexually active over the last six months
Characteristics Unadjusted OR (95% CI) Adjusted OR (95% CI)




Annual household income (CAD)
]$20,000 1.0 1.0
B$20,000 1.57 (1.242.0) 1.44 (1.081.92)
Relationship status
Married/common law/in a relationship 1.0 1.0




Discussed VL on HIV transmission risk with healthcare provider
Yes 1.0 1.0
No 1.87 (1.462.4) 1.57 (1.162.11)
HIV-related stigma
Low HIV-related stigma 1.0 1.0
High HIV-related stigma 1.18 (0.941.47) 1.81 (1.093.03)
Probable depression (CESD-10)
No (score B10) 1.0
Yes (score ]10) 1.37 (1.091.73)
Physical Health Summary score 0.99 (0.980.99)
Satisfaction with present sex life
Completely, very, or reasonably satisfied 1.0
Not very or Not at all satisfied 3.41 (2.614.45)
Prefer not to answer 8.33 (4.6914.8)
Note: Model adjusted for Province of residence; LGBTQ includes participants who identify as Lesbian, Gay, Bi-sexual, Two-spirited or Queer;
CADCanadian dollars; ARTantiretroviral therapy; VLviral load.
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care and well-being, well beyond a role in ‘‘positive
prevention’’ of on-going transmission of HIV. For example,
the Au-delà du VIH: être femme Plurielle [Beyond HIV:
valuing the many aspects of women’s lives] program in
Quebec is grounded in an empowerment approach to sexual
health for WLWH, and supports the capacity of WLWH to
respond to their sexual needs and mobilize available
resources to gain control over their sexual lives. This, and
other similar interventions, recognize WLWH as sexual beings
with sexual rights and aim to overcome beliefs and taboos of
female sexuality and desire [74].
Limitations to this study are acknowledged. First, cross-
sectional analyses preclude determination of causality be-
tween correlates and sexual inactivity, and reverse causality
is possible (e.g. sexual inactivity leading to depression).
Second, there is risk of reporting bias whereby women may
underreport sexual activity because of prevailing stigma and
discrimination against sexually active WLWH. However,
surveys were administered by PRAs, a diverse group of
WLWH with identities and life experiences in common with
participants, which may have decreased the extent of social
desirability bias in reports about sexual activity (with B10%
of participants completing the sexual health section inde-
pendently). Third, we are unable to report whether sexual
inactivity represents deliberate or intentional abstinence for
sex or a lack of opportunity for sex; however, this difference
will be explored in the CHIWOS 18-month follow-up ques-
tionnaire. Finally, several important psychosocial aspects of
sexual inactivity, including sensation seeking, desire and
motivation, as well as knowledge and perceived effect of
criminalization of HIV non-disclosure on sexual activity, were
not directly assessed in this study, and are likely to be
important explanatory pathways to understanding sexual
inactivity among WLWH. These pathways will also be
assessed in the follow-up questionnaire.
Conclusions
A satisfying sexual life is a critical component of health and
well-being for all people, including WLWH. The observed high
rate of sexual inactivity coupled with associations with HIV-
related stigma and sexual dissatisfaction underscores a need to
revisit the narrative about sexual activity among WLWH. This
narrative has focused heavily on HIV risk reduction approaches
and now increasingly on the public health importance of viral
suppression and the legal test for HIVnon-disclosure, butmuch
less has been said about healthy sexuality. A transitioning of
the approach to healthy sexuality among WLWH requires that
we finally erase the current view of WLWH as ‘‘vectors, vessels
and victims’’ of HIV [75], rather as empowered individuals
with agency and deserving of intimate relationships. These
findings underscore an urgent need for public health and
socio-structural interventions to de-stigmatize HIV, support
safe disclosure and re-appropriate the sexual rights of WLWH.
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Abstract
Introduction: HIV and cervical cancer are intersecting epidemics that disproportionately affect one of the most vulnerable
populations in the world: women in low- and middle-income countries (LMICs). Historically, the disparity in cervical cancer risk
for women in LMICs has been due to the lack of organized screening and prevention programmes. In recent years, this risk has
been augmented by the severity of the HIV epidemic in LMICs. HIV-positive women are at increased risk for developing cervical
precancer and cancer, and while the introduction of antiretroviral therapy has dramatically improved life expectancies among
HIV-positive women it has not been shown to improve cancer-related outcomes. Therefore, an increasing number of HIV-positive
women are living in LMICs with limited or no access to cervical cancer screening programmes. In this commentary, we describe
the gaps in cervical cancer prevention, the state of evidence for integrating cervical cancer prevention into HIV programmes and
future directions for programme implementation and research.
Discussion: Despite the biologic, behavioural and demographic overlap between HIV and cervical cancer, cervical cancer
prevention has for the most part been left out of sexual and reproductive health (SRH) services for HIV-positive women. Lower
cost primary and secondary prevention strategies for cervical cancer are becoming more widely available in LMICs, with
increasing evidence for their efficacy and cost-effectiveness. Going forward, cervical cancer prevention must be considered a
part of the essential package of SRH services for HIV-positive women. Effective cervical cancer prevention programmes will
require a coordinated response from international policymakers and funders, national governments and community leaders.
Leveraging the improvements in healthcare infrastructure created by the response to the global HIV epidemic through
integration of services may be an effective way to make an impact to prevent cervical cancer among HIV-positive women, but
more work remains to determine optimal approaches.
Conclusions: Cervical cancer prevention is an essential part of comprehensive HIV care. In order to ensure maximal impact
and cost-effectiveness, implementation strategies for screening programmes must be adapted and rigorously evaluated through
a framework that includes equal participation with policymakers, programme planners and key stakeholders in the target
communities.
Keywords: cervical cancer prevention; HIV; integration; low- and middle-income countries.
Received 7 May 2015; Revised 29 August 2015; Accepted 22 September 2015; Published 1 December 2015
Copyright: – 2015 Huchko MJ et al; licensee International AIDS Society. This is an Open Access article distributed under the terms of the Creative Commons
Attribution 3.0 Unported (CC BY 3.0) License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
Introduction
The combined threat that cervical cancer and HIV present
to women’s quality of life, reproductive capacity and overall
mortality highlights a glaring inequality in global women’s
health. The enormous international disparity in the incidence
of and survival from cervical cancer has historically aligned
most closely with country income [1]. Nearly 85% of cases
and 87% of deaths occur in less developed regions, where
several factors conspire to make cervical cancer a leading
cause of cancer and cancer-related mortality [2]. Inadequate
healthcare and public health infrastructure, competing health
priorities and persistent poverty prevent large-scale cervical
cancer prevention programmes from gaining traction, resulting
in only a small minority of the population being screened
[3]. Rates of cervical cancer in less developed countries
are similar to those seen in the United States prior to the
introduction of widespread screening [4].
In the last 20 years, the increased burden of cervical cancer
has been intensified by the contribution of HIV to cervical
precancer and cancer. Global maps showing country-specific
HIV prevalence match the global maps of cervical cancer
incidence and mortality. For example, the incidence of cervical
cancer is 42.7 per 100,000 women in Eastern Africa, a high
HIV-prevalence region with low screening coverage, compared
to 30.6/100,000 in Middle Africa (moderate HIV prevalence,
low screening) and 6.6/100,000 in Northern Africa (low HIV
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prevalence, moderate screening coverage) [5]. The high rate
of HIV infection in many low- and middle-income countries
(LMICs) has potentiated the already increased risk for cervical
cancer for women living in these countries. The decrease in
cellular immunity caused by HIV increases the risk for new
and persistent human papillomavirus (HPV) infections  the
primary cause of cervical cancers and precancerous cervical
lesions  and contributes to an accelerated incidence and
progression of cervical neoplasia [6,7].
Increased availability of HIV care and treatment, com-
bined with greater coverage of antiretroviral therapy (ART)
in recent years, has been lifesaving for entire populations
of HIV-positive women. In contrast to other AIDS-related
malignancies, which show improvement with ART, the positive
effect of ART on cervical cancer outcomes is not clear [811].
Conversely, researchers have shown that the risk of anal
cancer, another HPV-related malignancy, actually increases
after ART use, making it plausible that the biologic risk for
cervical cancer may increase [12]. Regardless of the direct
biologic effect of ART on cervical cancer risk, in the many
LMICs that have addressed their high HIV prevalence through
improved HIV testing and access to treatment, there is a
significant increase in the number of HIV-positive women
living longer with excess cervical cancer risk [13]. This makes
the implementation of effective screening programmes an
urgent public health priority, especially for the HIV-positive
women who are most vulnerable to the disease.
There is a precedent of successful partnerships between
international donors and local governments to strengthen
healthcare infrastructure and build local capacity in ways
that helped to stem the HIV epidemic. Many government
health systems have successfully leveraged these gains in the
healthcare system and numbers of trained healthcare work-
ers to address other healthcare needs such as tuberculosis,
malaria, family planning, maternal health and other non-
communicable diseases (NCDs) [1416]. As evidence for the
efficacy and cost-effectiveness of integrating these other
health services increases, there has been an increase in
donor funding and policy commitment to support integra-
tion. However, cervical cancer is routinely excluded from
the definition of sexual and reproductive health (SRH)
services, which often focus on family planning, prevention
of maternal-to-child transmission (PMTCT) of HIV and
sexually transmitted infection (STI) prevention [1720].While
the World Health Organization (WHO) 2006 Guidelines on
Sexual and Reproductive Health for Women Living with HIV
do include cervical cancer screening as a topic area, inclusion
of cervical cancer prevention as part of essential services for
HIV-positive women is not a focus of that document. Rather,
the section on cervical cancer concludes with recommenda-
tions for HIV-positive women to have the same access
to cervical cancer screening as HIV-negative women [21].
As research into integration of reproductive health and HIV
services evolved, more recent documents that focus on
provision of comprehensive care for people living with HIV in
LMICs include recommendations on how to integrate family
planning, STI prevention and PMTCT, while cervical cancer
is not mentioned [22,23]. The global health community is
failing women in a crucial way: it has neglected prevention,
screening and treatment for cervical cancer among the highest
risk population, HIV-positive women in LMICs. In this com-
mentary, we describe the current policy and evidence around
strategies for implementing cervical cancer into HIV care and
recommend future research and policy directions to ensure
that cervical cancer prevention is included as part of essential
SRH services for HIV-positive women.
Discussion
There are several reasons for the exclusion of cervical cancer
as part of comprehensive care for women living with HIV.
Primarily, the majority of the world’s HIV-positive women
live in countries where there is no access to cervical cancer
prevention for anyone, regardless of their serostatus. One
of the effects of this lack of screening infrastructure is an
absence of cancer registries in most LMICs. Without accurate
estimates of the number of cases each year and the impact of
HIV on the incidence and prevalence of cervical cancer, it
is impossible to set targets and track progress in addressing
this issue. Another reason for the exclusion of cervical cancer
from SRH services offered to HIV-positive women is that,
despite being caused by an infectious agent, it is often con-
ceptualized as an NCD, rather than a component of SRH.
Instead of receiving increased attention by having a home in
two different content areas, this dual identity has actually led
to less focus and attention for cervical cancer prevention,
which is often seen as not fully belonging in either category.
As the immediate and pressing needs of the HIV epidemic
have begun to abate, there is an opportunity to use the
lessons from both NCD and SRH management to address
cervical cancer prevention in a way that best fits the unique
characteristics of the disease.
Cervical cancer prevention fits into an NCD paradigm of
integrating preventative care into existing clinics through
periodic, evidence-based screening, with treatment of early
or preclinical disease. Importantly, though, because of the
counselling, outreach, screening techniques and fertility
implications for treatment of invasive disease, cervical cancer
prevention has a natural place in SRH services. Providers who
are more comfortable talking to women about their repro-
ductive health and family planning, and who can ably counsel
women and perform pelvic exams, may be better suited to
perform cervical cancer screening [24]. A successful cervical
cancer prevention programme should include elements from
NCD prevention strategies (disease awareness, coupled with
periodic, universal screening and access to risk-reduction
interventions) when providing services under the paradigm
of reproductive health.
Another key reason for the exclusion of cervical cancer
from primary healthcare in LMICs, and more recently from
comprehensive HIV care, was the lack of feasible and
affordable prevention strategies. We now have a wide range
of low-cost and effective primary and secondary prevention
options that can be operationalized in LMICs, making dramatic
global reductions in cervical cancer incidence a realistic goal
within a generation. HPV vaccination is the most successful
and cost-effective strategy for cervical cancer prevention,
especially in high HIV-prevalence areas [2527]. The WHO has
prequalified two HPV vaccines that could dramatically reduce
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cervical cancer deaths in LMICs if vaccination coverage can be
scaled up [28]. GAVI, the Global Vaccine Alliance, is supporting
initiatives to provide vaccines in selected LMICs, and pilot
delivery programmes are ongoing [29]. The vaccination of
adolescent girls also provides an opportunity to provide them
with other reproductive health services and health education
(including family planning and menstrual hygiene); it would
provide primary prevention of HPV and cervical cancer prior
to sexual exposure to HIV. Ensuring that adolescent girls have
the opportunity to receive a vaccine that protects them from
the morbidity and mortality related to cervical cancer should
be a key global health priority.
Conventional screening methods, using Pap smears and
biopsies, require infrastructure and clinical expertise and are
hard to scale up in LMICs. However simpler, cheaper screening
techniques, such as visual inspection with acetic acid (VIA)
and HPV DNA testing, hold great promise and are under-
going widespread evaluation [30,31]. The WHO Global Action
Plan on NCDs describes screening with VIA as a ‘‘best buy,’’
meaning that it is both highly cost effective (i.e. it costs less
than the per capita gross domestic product to avert one
disability adjusted life-year) and it is feasible to implement
in settings with constrained health systems [32]. There
are promising results from large trials, suggesting that VIA
can reduce cervical cancer incidence by 25 to 30% [33],
with similar performance characteristics among HIV-positive
women compared to HIV-negative women [34]. Although
screening with HPV is more expensive than with VIA, a study
by Goldie et al. [35] in five LMICs found that HPV screening
is very cost-effective, and a single test at age 35 years reduces
lifetime cancer risk by 25 to 36%. This finding has been
supported in models of HPV screening among HIV-positive
women [36]. Ongoing and completed studies are looking
at novel strategies to maximize uptake of HPV screening,
including self-collection and community health campaign
models, in low-resource/high HIV-prevalence settings [37,38].
The WHO has recognized and summarized the evidence
for low-cost cervical cancer prevention strategies in their
2013 Comprehensive Cervical Cancer Prevention and Control
Manual [39], which includes recommendations for screening
strategies for HIV-positive women.
One strategy for ensuring that HIV-positive women access
cervical cancer screening and prevention is through service
integration. Integrating care for HIV, sexual health, reproduc-
tive health and maternal health has been shown to improve
uptake of services, reduce HIV-related stigma and improve
the quality of care received by women [40,41]. Although
there are many definitions of integration, the model that is
most feasible for cervical cancer and HIV care is integration of
cervical cancer services into existing HIV-care programmes,
given the lack of standalone cervical cancer prevention clinics
and periodicity of screening. There is growing evidence for
the feasibility of integrating cervical cancer prevention into
HIV services using low-cost screening strategies coupled with
treatment for precancerous lesions [4245]. Furthermore,
integrating cervical cancer prevention services into HIVprimary-
care facilities, rather than referring women to a separate
family planning or reproductive health facility, provides an
opportunity to include and educate male partners, which may
be particularly important in areas where men have control
over healthcare decisions [46,47].
However, integration may not be feasible or successful in
all settings. While integration holds the promise of leveraging
stronger health systems to improve access to and uptake
of secondary services in higher risk populations through a
decrease in the visit burden and loss to follow-up, several
studies in sub-Saharan Africa have shown significant weak-
nesses in models of various health services integrated into
HIV care. These include limited interest among the general
population in receiving care through integrated models [41],
concerns about disclosure and resultant stigma in general
outpatient settings [40], lack of clear policies, unacceptable
clinical load on the staff, longer wait times and concerns
about quality of care [48].
While the promise of integration has not been borne out in
every setting, this does not mean that it should be discarded
for the next big idea in service delivery. One randomized study
of integrated HIV and antenatal services showed high rates
of attrition in both arms, suggesting that there are structural
barriers to uptake that lie outside of the care model [49]. This
finding, along with the difficulties experienced in different
settings, speaks to the need for community-driven, context-
specific adaptation of the evidence-proven interventions for
cervical cancer prevention, specifically VIA, HPV testing and
‘‘see and treat’’ strategies. While the efficacy and effective-
ness of these low-cost strategies have been clearly shown in
large, well-conducted trials, there are few implementation
studies done in partnership with target communities to adapt
and iteratively evaluate the effectiveness of the resulting
intervention and implementation strategy. Implementation
and dissemination science, or ‘‘the scientific study of methods
to promote the systematic uptake of research findings and
other evidence-based practices into routine practice, and
hence, to improve the quality and effectiveness of health
services and care,’’ provides tools to bridge the gap between
scientific evidence and public health practices and policy.
In addition to the standard clinical effectiveness outcomes,
implementation studies evaluate a combination of quan-
titative, qualitative and process measures to evaluate the
feasibility and sustainability of the implementation, essen-
tially exploring and explaining the individual, interpersonal,
community and policy-level factors necessary for the success
of evidence-based interventions. The above-cited studies of
self-collected HPV in Uganda and Kenya are examples of using
implementation science research to address the gap between
evidence-based cervical cancer prevention, policy and uptake.
Conclusions
HIV and cervical cancer are intersecting epidemics that dispro-
portionately affect one of the most vulnerable populations in
the world: women in LMICs. Despite the biologic, behavioural
and demographic overlap, cervical cancer prevention has
for the most part been left out of SRH services for HIV-positive
women. Similar to the coordinated and multilateral response
to the HIV epidemic, an effective programme for cervical
cancer prevention among HIV-positive women needs inter-
national, national and community leadership for a broad-
based and sustainable response. International guidelines
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for HIV care in LMICs must include a mandate to provide
cervical cancer prevention as part of comprehensive SRH care.
Funding agencies and local governments must then consider
this a key component of HIV care and provide the funding,
training, support supervision and accountability necessary to
ensure maximal coverage of services. Implementation studies
done in partnership with local governments, key stakeholders
and programmes providing HIV care will facilitate cervical
cancer prevention strategies that are not only included as
part of the essential package of services, but are provided
in a context-specific way. Cervical cancer prevention has the
potential to be effective, sustainable and cost-effective. A
crucial part of the implementation strategy will be developing
a monitoring and evaluation programme to measure the
coverage and quality of cervical cancer prevention services
provided as part of comprehensive SRH services for HIV-
positive women.
The climate is right for a coordinated response to the dual
threat posed by HIV and cervical cancer in LMICs: low-cost
strategies, improved health infrastructure and engagement
in the healthcare system by a high-risk population. The ability
to impact this long-standing global health disparity is well
within our reach.
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Abstract
Introduction: HIV-affected women and couples often desire children and many accept HIV risk in order to attempt pregnancy and
satisfy goals for a family. Risk reduction strategies to mitigate sexual and perinatal HIV transmission include biomedical and
behavioural approaches. Current efforts to integrate HIV and reproductive health services offer prime opportunities to incorporate
strategies for HIV risk reduction during pregnancy attempts. Key client and provider values about services to optimize pregnancy in
the context of HIV risk provide insights for the design and implementation of large-scale ‘‘safer conception’’ programmes.
Discussion: Through our collective experience and discussions at a multi-disciplinary international World Health Organization
convened workshop to initiate the development of guidelines and an algorithm of care to support the delivery of services for
HIV-affected women and couples attempting pregnancy, we identified four values that are key to the implementation of these
programmes: (1) understanding fertility care and an ability to identify potential fertility problems; (2) providing equity of access
to resources enabling informed decision-making about reproductive choices; (3) creating enabling environments that reduce
stigma associated with HIV and infertility; and (4) creating enabling environments that encourage disclosure of HIV status and
fertility status to partners. Based on these values, recommendations for programmes serving HIV-affected women and couples
attempting pregnancy include the following: incorporation of comprehensive reproductive health counselling; training to
support the transfer and exchange of knowledge between providers and clients; care environments that reduce the stigma of
childbearing among HIV-affected women and couples; support for safe and voluntary disclosure of HIV and fertility status; and
increased efforts to engage men in reproductive decision-making at times that align with women’s desires.
Conclusions: Programmes, policies and guidelines that integrate HIV treatment and prevention, sexual and reproductive health
and fertility care services in a manner responsive to user values and preferences offer opportunities to maximize demand for and
use of these services. For HIV-affected women and couples attempting pregnancy, the provision of comprehensive services using
available tools  and the development of new tools that are adaptable to many settings and follow consensus recommendations 
is a public health imperative. The impetus now is to design and deliver value-driven inclusive programming to achieve the greatest
coverage and impact to reduce HIV transmission during pregnancy attempts.
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Introduction
Attempting pregnancy to achieve goals for family size is a
basic reproductive right for all individuals, including HIV-
affected women and couples, whether they be HIV-infected
women with partners of known and unknown HIV status,
HIV-serodiscordant couples, or HIV-uninfected women with a
high risk for HIV acquisition [1]. HIV-affected women and
couples face a dilemma when attempting pregnancy, a period
associated with heightened risk of HIV transmission. Many
accept increased HIV risk in order to satisfy their fertility
goals [2]. Pregnancy rates among HIV-affected women and
couples have been documented at 10 to 15% per year,
including substantial proportions with partners of unknown
or HIV-serodiscordant status and important proportions that
are unintended [3]. Antiretroviral use by women is associated
with improved health and hopefulness for the future, con-
tributing to desires to havemore childrenwhile seeking care to
minimize HIV risk during pregnancy attempts [49].Thus, there
is a great clinical need and a public health imperative to
provide services for HIV-affected women and couples desiring
pregnancy to maximize the potential for a healthy pregnancy
while minimizing sexual and perinatal HIV transmission risks.
Biomedical and behavioural strategies are available to support
pregnancy attainment while minimizing HIV risk (i.e. ‘‘safer
conception’’ strategies) and international guidelines to optimize
pregnancy and HIV outcomes are under development [10].
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For HIV-affected women and couples with normal fertility,
evidence-based strategies include antiretroviral therapy use
by the HIV-infected partner, the use of pre-exposure prophy-
laxis (PrEP) by the HIV-uninfected partner, limiting condomless
sex to periods of peak fertility, treatment of sexually trans-
mitted infections, voluntary medical male circumcision and
manual insemination (for serodiscordant couples with an
HIV-uninfected male partner) [1115]. Fertility care services,
including fertility screening and management, offer additional
options when fertility may be compromised. The availability
of multiple strategies offers choice and the possibility of
combining strategies to maximize harm reduction.
The integration of HIV and reproductive health care services
provides a natural opportunity to incorporate pregnancy
planning and fertility management for HIV-affected women
and couples attempting pregnancy [1618]. Models that
include comprehensive reproductive, sexual, maternal and
child health services  and can accommodate individuals
at any stage in their reproductive life  have the potential to
ensure more equitable service provision and reduce missed
opportunities to prevent HIV transmission, unintended preg-
nancy and poor pregnancy outcomes [19]. Within this in-
tegration, opportunities also arise to create programmes
that encourage the engagement of men as supporters of HIV-
infected women in reproductive health decision-making and
as partners in health optimization prior to and during pregnancy.
Thus, recommendations for the design and delivery of services
for HIV-affected women and couples attempting pregnancy
can be contextualized within the premise of integrated systems,
generating programmes thatminimize burden, are cost-effective
and place HIV prevention and reproductive health care within a
holistic and rights-based framework.
This commentary, developed through collaboration by HIV
prevention and fertility care experts, discusses key values of
HIV-affected women and couples seeking services to reduce
HIV risk during pregnancy attempts as well as those of
healthcare providers encountering opportunities to initiate
discussion about fertility goals and provide pre-pregnancy
care. A greater understanding of these values is essential for
maximizing the impact of safer conception programmes and
services. HIV-affected women and couples can also meet their
family goals through adoption, donor gamete or surrogacy,
but values related to these methods are beyond the scope of
this discussion.
Discussion
In December 2014, the WHO convened a meeting to initiate
the development of guidelines and an algorithm of care to
support the delivery of services for HIV-affected women and
couples attempting pregnancy. During discussions, the authors
identified four key values to incorporate into the development
of programmes for HIV-affected women and couples. The
attendees were experts in HIV prevention and treatment as
well as reproductive medicine whose experiences and knowl-
edge about each other’s fields was initially limited. Through
structured debate among the attendees, four key values
emerged as being central to programmatic recommendations:
(1) understanding fertility care and the ability to identify
potential fertility problems; (2) providing equity of access
to resources enabling informed decision-making about re-
productive choices; (3) creating enabling environments that
reduce stigma associated with HIV and infertility; and (4)
creating enabling environments that encourage disclosure of
HIV status and fertility status to partners.
Understanding fertility care and the ability to identify
potential fertility problems
Fertility awareness or confidence in the ability to become
pregnant is often questioned by individuals before pregnancy
occurs. HIV-affected women and couples may unknowingly
have fertility problems and would value provider counselling
on how to evaluate fertility, diagnose infertility and, if needed,
receive fertility services before attempting pregnancy in order
to minimize condomless sex and thus the potential for HIV
transmission. The prevalence of involuntary childlessness due
to infertility has been estimated at one in every four couples
in developing countries [20]. Thus, providers working with
HIV-affected women and couples with fertility aspirations
value information that allows: 1) a recommendation to pre-
sumed fertile couples to engage in condomless sex timed to
peak fertility during the menstrual cycle, or 2) access to basic
fertility evaluation and affordable referral options should
infertility be suspected (Figure 1).
Simple screening questionnaires that assess reproductive
and lifestyle factors have been developed for individuals to
self-assess their fertility potential and to facilitate provider-
initiated discussions of reproductive desires and likelihood
of normal fecundity [8]. Providers can conduct a basic fertility
evaluation to understand history of past pregnancy losses,
terminations and complications; menstrual cycle abnormal-
ities for the woman; a semen analysis for the man; and as-
sessment of individual and couples’ lifestyle, environmental
exposures, STIs and sexual dysfunction that may alter fertility
fitness [21]. These provider competencies must be comple-
mented by offering opportunities for HIV-affected women and
their partners to ask questions and become knowledge-
able about their reproductive potential. Basic fertility inter-
ventions, such as vaginal insemination, could be offered in
addition to an option of natural conception under the premise
of viral suppression with antiretrovirals and/or the use of
PrEP. However, if a desired pregnancy has not occurred within
12 months of regular condomless sex without contraception 
or after six months when HIV risk is high  then HIV-affected
women and couples are likely to be at significant risk of ex-
tended HIV exposure with a reduced chance of pregnancy, and
affordable advanced diagnostic techniques and care services
should be offered.
An infertility diagnosis can be devastating, especially for
HIV-affected women and couples who are already struggling
with HIV-related stigma. Providers, in anticipation of this addi-
tional distress from fertility problems, must be armed with
appropriate knowledge, tools and counselling skills to pro-
vide basic fertility care, support and referral to infertility
services for advanced diagnosis and management as well as
HIV prevention options. To respect the reproductive rights
of HIV-affected women and couples to achieve fertility goals,
HIV and fertility service providers need to collaborate to en-
sure comprehensive, coordinated care.
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Providing equity of access to resources enabling informed
decision-making about reproductive choices
HIV-affected women and couples value autonomy and the
ability to make informed decisions about attempting preg-
nancy in the face of HIV risk and/or undiagnosed fertility
problems. Current evidence suggests that women and men
have low awareness of HIV risk reduction strategies they can
use during pregnancy attempts, despite highly expressed
interest in learning about them [2]. Knowledge about accessi-
bility is an important corollary, because PrEP, fertility screening
and basic and advanced assisted reproductive interventions
are not universally available in resource-limited settings. In
addition, women at risk of acquiring HIV who are considering
PrEP require complete and balanced safety data about use
during pregnancy, including recent data showing that PrEP
does not significantly affect the risk of adverse maternal and
infant outcomes [22].
Providers require the skills and confidence to provide
comprehensive and non-judgmental guidance about suitable
HIV risk reduction and fertility care options. Reproductive
health and HIV providers must incorporate a broader explora-
tion of reproductive goals into their established counselling on
contraceptive uptake, antiretroviral use to prevent perinatal
HIV transmission and consistent condom use. Despite general
provider empathy with the social and cultural importance of
HIV-infected women having children, knowledge and training on
how to support women with this goal remains limited [2325].
Additionally, many providers struggle with the tension be-
tween acknowledging the reproductive rights of HIV-affected
women and couples and the clinical responsibility to pro-
tect partners and future children from HIV transmission and
other pregnancy-related consequences [26]. The traditional
emphasis of counselling on consistent condom use must
shift, acknowledging the tremendous benefit of antiretrovirals
(as treatment and PrEP) as HIV prevention strategies that
enable safer condomless sex and support couples to attain
their pregnancy goals.
Prevailing social and structural barriers may impact HIV-
affected women and couples’ ability to utilize HIV and repro-
ductive health services. For example, optimizing pre-pregnancy
maternal health is important for pregnancy planning but may
be a lower priority for women, particularly in socio-cultural
and normative gendered contexts where pressures and expec-
tations to bear children are high [27]. Where women have
limited autonomy over reproductive decision-making, the de-
lays involved in testing and treating pre-existing conditions or
Service delivery guidance
Understanding fertility care and an
ability to identify potential fertility
problems
Providing equity of access to resources
enabling informed decision - making
about reproductive choices
Creating environments that reduce
stigma associated with HIV and
infertility
Creating environments that encourage
disclosure of HIV and fertility status to
partners
Comprehensive reproductive health counselling
incorporates discussion of fertility goals, including simple
fertility screening and care
Providers have access to basic fertility evaluation and
affordable referral options
Counselling engages women and couples in discussion
of safer conception strategies with personalized options
that align with reproductive goals
Risk reduction algorithms recognize societal expectations
for pregnancy, as well as stigma around HIV and infertility
Community engagement activities are incorporated to 
normalize pregnancy in HIV affected women and couples
and antiretrovirals as routine HIV care
Couple-based disclosure is supported






Figure 1. Key values and service delivery guidance for programmes to reduce HIV risk during pregnancy attempts (i.e. safer conception services).
The identified key values of HIV-affected women and couples were drawn from client and provider values and preferences and provide guidance
for the integration of services to reduce HIV risk during pregnancy attempts. For example, the key value of understanding fertility care and having
the ability to identify potential fertility problems is incorporated into guidance that comprehensive reproductive health counselling should
incorporate discussion of fertility goals, including simple fertility screening and care. The identification of additional values and service delivery
guidance would be warranted through further collaborative discussions.
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infections before pregnancy attempts occur may create difficul-
ties for women. Counselling which directly acknowledges and
addresses these delays provides opportunities to encourage
pre-pregnancy planning and limit disengagement from care.
For some women, pregnancy is not a goal. Ensuring their
autonomy to decide against pregnancy is also a reproductive
right and, therefore, sexual and reproductive health pro-
grammes must also support HIV-affected women and couples
to make this choice with provision of, or linkage to, compre-
hensive contraceptive services [1].
Creating enabling environments that reduce stigma
associated with HIV and infertility
HIV-related stigma emerges as a major challenge to HIV-
affected women and couples seeking services to minimize HIV
risk during pregnancy attempts [28,29]. To combat social
stigma, programmes need to normalize pregnancy and child-
bearing desires and the use of HIV risk reduction strategies
during pregnancy attempts [26]. In addition to HIV-related
stigma, HIV-affected women and couples with suspected or
diagnosed infertility may suffer psychosocial distress related
to childbearing expectations, especially in societies where
childbearing remains a strong expectation. This distress may
be magnified in a setting where fertility is not routinely as-
sessed and fertility care services that could resolve an infer-
tility problem, and could reduce the stigma, may not be well
established or supported [30].
Long-standing community impressions that HIV is asso-
ciated with shorter life expectancy and potentially discounts
a parent from long-term child-rearing may contribute to
stigma associated with pregnancy and childbearing among
HIV-affected women and couples. For HIV-infected women
attempting pregnancy, antiretroviral therapy is a powerful
option to reduce HIV transmission risk, with tremendous
clinical benefits for the woman and prevention benefits for
partners and the future child [13,31]. However, HIV-infected
individuals have long reported barriers to the initiation of
antiretrovirals, citing personal and community perceptions
that antiretroviral therapy use signals sickness and immi-
nent death [32]. For HIV-affected women and couples, early
provider-initiated discussions of fertility goals offer a prime
opportunity to normalize antiretroviral initiation within the con-
text of optimizing health prior to pregnancy and maximizing
the likelihood of pregnancy [33].
Despite well-established directives on the rights of HIV-
affected women and couples to attempt pregnancy, providers
have voiced concerns about managing clinical and relation-
ship complexities presented by HIV-serodiscordant couples
wishing to become pregnant [26]. Thus, providers would value
opportunities to develop skills to counsel non-disclosed HIV-
affected women and couples without inadvertently disclosing
HIV or subfertility status and triggering a cascade of poor out-
comes, including patient/client distrust, couple discord and
intimate partner violence [26]. Of utmost importance is that
providers are able to counsel about fertility and HIV, with high
sensitivity to social and cultural ideas about pregnancy among
HIV-affected women and couples and perceptions of infertility.
Creating enabling environments that encourage disclosure
of HIV and fertility status to partners
For HIV-affected women and couples, disclosing HIV status can
be one of the strongest links to health optimization, yet the act
of disclosure is often met with trepidation and delays are
common due to threats of violence, relationship dissolution
and rejection [34]. Similarly, disclosure of infertility by HIV-
affected women and couples can reduce HIV exposure during
pregnancy attempts that are unlikely to succeed, but infertil-
ity disclosure may also result in these types of consequences.
Environments supportive of reproductive decision-making
must aim to foster the attainment of reproductive autonomy
and support individual decision-making regarding the disclo-
sure of HIV and/or infertility status to partners and providers.
When disclosure is withheld, however, an environment with
supportive providers continues working to maximize pre-
pregnancy health and address HIV risk reduction.
For HIV-infected women with HIV-uninfected male part-
ners, HIV status disclosure to a male partner potentially
increases his personal HIV risk perception, his motivation to
employ risk reduction methods and his engagement in repro-
ductive decision-making [35]. When a heterosexual couple is
mutually disclosed, male partners can take a more active role
supporting reproductive decision-making including planning
to delay pregnancy or seek fertility care to attempt pregnancy
[26]. Models to increase male engagement and emphasize
comfortable spaces for men, as well as women, have been
successfully demonstrated in resource-constrained settings
and can be adapted for programmes tailored to HIV risk
reduction when pregnancy is attempted [36].
Conclusions
We have identified and described four key values: under-
standing fertility care and an ability to identify potential
fertility problems, providing equity of access to resources
enabling informed decision-making about reproductive choices,
creating enabling environments that reduce stigma associated
with HIV and infertility and creating enabling environments
that encourage disclosure of HIV status and fertility status to
partners. These key values should remain central to guide-
lines, policies and programmes being developed to optimize
pregnancy outcomes and reduce HIV risk among HIV-affected
women and couples during pregnancy attempts. At this unique
time in HIV prevention, when the power of antiretrovirals,
including PrEP, and fertility interventions to eliminate HIV risk
has been well established, HIV-affected women and couples
no longer need to accept elevated HIV risk during pregnancy
attempts nor forgo their desires for pregnancy. The imminent
task for low-resource, high HIV-burdened settings is to develop
acceptable and feasible services that are affordable and cost-
effective to meet these needs.
Initially in the HIV epidemic, HIV-affected women and couples
were discouraged from attempting pregnancy [37,38]. The
field has certainly progressed, as HIV is nowa chronic condition
in most societies, and there are great opportunities to help
HIV-affected women and couples satisfy their fertility goals
with minimal HIV risk while strengthening integrated health
systems and fostering collaborations between fertility and
HIV care providers. HIV-affected women and couples seeking
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services must encounter confident, informed providers who
are equipped to initiate and engage in discussion about fertil-
ity desires, fertility care and HIV risk. Service integration pro-
vides opportunities for providers from the two disciplines to
share experiences and best practices. HIV care providers, for
example, can incorporate fertility screening into HIV care,
recognize the importance of delaying pregnancy attempts
when fertility may be compromised, provide access to fertil-
ity care options and provide counsel that recognizes socio-
cultural childbearing expectations. In parallel, fertility care
providers can adapt their practice to the context of HIV in-
fection and recognize opportunities to reduce HIV risk, counsel
about HIV prevention strategies and promote HIV testing and
access to care.
Efforts to integrate services to improve outcomes among
HIV-affected women and couples attempting pregnancy need
to utilize evidence-based tools and approaches consistent
with a sexual and reproductive health rightsbased context [1].
This includes tools to expand provider knowledge and con-
fidence when providing HIV prevention and fertility services
for HIV-affected women and couples, campaigns to increase
demand among HIV-affected women and couples for these
services and appropriate systems to capture uptake and
access to services. Research utilizing implementation science
methods to capture usability and feasibility data is needed to
evaluate various delivery models and determine the most
cost-effective approaches. In addition, international clinical
guidelines based on consensus recommendations from HIV
prevention and fertility care researchers, providers, advocates
and HIV-affected women and couples are urgently needed to
spur the development of scalable programmes to reduce HIV
risk during attempts to become pregnant.
In this commentary, we have described four key values to
prioritize when integrating pre-pregnancy care and counselling
services into HIV prevention and reproductive health services
for HIV-affected women and couples. We identified many
additional values including empowerment, religious beliefs
and mental health services, but limited our descriptions here
to the four that have dominated our discussions. Importantly,
each HIV-affected individual seeking services presents a dif-
ferent HIV risk profile  whether in a seroconcordant partner-
ship with risk of perinatal transmission or superinfection,
HIV-uninfected with a partner of unknown status and the risk
of sexual and perinatal transmission, unknown subfertility
that necessitates prolonged pregnancy attempts or assisted
reproductive care, or myriad other scenarios. Individuals pri-
oritize values differently; programmes must consider each of
these scenarios to ensure that their services accommodate all.
Programmes responsive to client values and preferences
are inherently better positioned tomeet client needs, fostering
greater demand and uptake. Opportunities to incorporate
pregnancy planning and fertility management exist through
ongoing efforts to integrate HIV prevention and sexual and
reproductive health programmes and the resulting pro-
grammes should be poised to fully respond to sexual and
reproductive health needs. Minimizing HIV risk during preg-
nancy attempts for HIV-affected women and couples is a
public health imperative. Tools to accomplish safer conception
are available  and new tools developed alongside global
consensus guidelines will add to this compendium. The
impetus now is to develop value-driven, inclusive, scalable
programmes to deliver interventions to minimize HIV trans-
mission risk during pregnancy attempts with maximal cover-
age and impact.
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Abstract
Introduction: In 2011, the Global Plan towards the Elimination of New HIV Infections among Children by 2015 and Keeping
Their Mothers Alive was launched to scale up efforts to comprehensively end vertical HIV transmission and support mothers living
with HIV in remaining healthy. Amidst excitement around using treatment as prevention, Malawi’s Ministry of Health conceived
Option B, a strategy used to prevent vertical transmission by initiating all pregnant and breastfeeding women living with HIV on
lifelong antiretroviral therapy, irrespective of CD4 count. In 2013, for programmatic and operational reasons, the WHO officially
recommended Option B to countries with generalized epidemics, limited access to CD4 testing, limited partner testing, long
breastfeeding duration or high fertility rates.
Discussion: While acknowledging the opportunity to increase treatment access globally and its potential, this commentary
reviews the concerns of women living with HIV about human rights, community-based support and other barriers to service
uptake and retention in the Option B context. Option B intensifies many of the pre-existing challenges of HIV prevention and
treatment programmes. As women seek comprehensive services to prevent vertical transmission, they can experience various
human rights violations, including lack of informed consent, involuntary or coercive HIV testing, limited treatment options,
termination of pregnancy or coerced sterilization and pressure to start treatment. Yet, peer and community support strategies
can promote treatment readiness, uptake, adherence and lifelong retention in care; reduce stigma and discrimination;
and mitigate potential violence stemming from HIV disclosure. Ensuring available and accessible quality care, offering food
support and improving linkages to care could increase service uptake and retention. With the heightened focus on interventions
to reach pregnant and breastfeeding women living with HIV, a parallel increase in vigilance to secure their health and rights is
critical.
Conclusion: The authors conclude that real progress towards reducing vertical transmission and achieving viral load suppression
can only be made by upholding the human rights of women living with HIV, investing in community-based responses, and
ensuring universal access to quality healthcare. Only then will the opportunity of accessing lifelong treatment result in improving
the health, dignity and lives of women living with HIV, their children and families.
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Introduction
Option B could be good, but we still lack
information.  Woman living with HIV, Uganda [1]
In 2011, the Global Plan towards the Elimination of New HIV
Infections among Children by 2015 and Keeping Their Mothers
Alive (Global Plan) was launched to scale up efforts to com-
prehensively end vertical HIV transmission and support mothers
living with HIV in remaining healthy [2]. This undertaking re-
emphasized the necessity of the four-pillared approach, also
known as prevention-of-mother-to-child-transmission [3,4],
(The term comprehensive prevention of vertical transmission
is used where possible in this commentary in line with
developing usage among the community of people living
with HIV. For a fuller discussion on terminology, see Refs.
[3,4]), which aims to 1) prevent HIV acquisition among women
of reproductive age; 2) provide appropriate care to meet the
family planning needs of women living with HIV; 3) support
pregnant women living with HIV to prevent vertical transmis-
sion; and 4) provide care, treatment and support to women
living with HIV, their children and families [5].
Concurrently, excitement around treatment as prevention
was mounting [68]. Against this backdrop in 2011, Malawi’s
Ministry of Health conceived and began implementing a new
strategy to prevent vertical transmission that provides life-
long antiretroviral therapy (ART) to all pregnant and breast-
feeding women living with HIV, irrespective of their CD4
count. Expanding on an existingWHO recommendation to HIV
programme managers called Option B, which offers triple
combination antiretrovirals (ARVs) as prophylaxis only during
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pregnancy and breastfeeding, Malawi’s approach was dubbed
Option B. Malawi’s primary rationale was the lack of access
to CD4 cell count equipment and systems for successful
referral to ART services for women who need treatment for
their own health, the risk of viral rebound after ARV cessation
and inconsistent breastfeeding cessation patterns, together
causing increased HIV acquisition risk to a sexual partner or
child [9,10].
In 2013, the WHO officially recommended Option B,
for programmatic and operational reasons, particularly in
countries with generalized epidemics, high fertility rates or
long breastfeeding duration [11]. These were ‘‘conditional re-
commendations’’ based on ‘‘low-quality evidence’’ [11].WHO
additionally reasoned that Option B offered simplified im-
plementation with a standardized drug regimen (the same
as for non-pregnant individuals) and was cost-effective [11].
In November 2014, world leaders launched the Fast-Track
Strategy to End the AIDS Epidemic by 2030, in which Option
B plays a leading role [12]. To date, 19 of 22 Global Plan
countries have committed to Option B, though most are in
the early or scale-up phases of implementation [13].
Communities of people living with HIV [1,1416] and
clinicians [1719] have held mixed and evolving perceptions
of Option B since its inception. Women living with HIV
understand the opportunity Option B presents to increase
treatment access globally and its potential (e.g. improved
mothers’ and babies’ health, reduced stigma, opportunities to
breastfeed). However, few articles discuss the need to uphold
human rights, invest in community-based support and address
barriers to service uptake and retention as being essential
in order to comprehensively end vertical transmission. This
commentary reviews these concerns raised by women living
with HIV regarding Option B implementation and calls for
funding to support its examination through women’s lived
experiences.
Discussion
As global momentum and pressure on countries to meet
Global Plan targets have increased, so has the pressure on
pregnant and breastfeeding women to be tested for HIV and
initiate early and lifelong treatment. Option B intensifies
many of the pre-existing challenges of HIV prevention and
treatment programmes. With the heightened focus on inter-
ventions to reach pregnant and breastfeeding women, a
parallel increase in vigilance to secure their health and rights is
critical.
Upholding human rights
Before I start on B, I should be informed of all
options and all of the advantages . . . so that I make
informed decisions based on the benefits that are
there.  Woman living with HIV, Uganda [1]
A primary concern regarding Option B implementation is
whether women’s human rights are upheld and what the
consequences are for rights violations. A rights-based
approach to end vertical transmission requires, at a minimum,
that services be consistent with international human rights
obligations [2027]. Accordingly, women living with HIV have
an autonomous right to make fully informed and voluntary
decisions about whether to have an HIV test, learn the result,
start or opt out of treatment, receive support for whichever
decision they make and determine their sexual and reproduc-
tive lives free from stigma and discrimination [2832]. During
a 2012 consultation held in Malawi and Uganda, women liv-
ing with HIV expressed concern about whether women are
offered sufficient information about why and how to start
lifelong treatment, time to reflect and the opportunity to
choose [1].
A South Africa programme is pilot testing a ‘‘rapid ART
initiation approach’’ as part of Option B [33]. In this
method, women are enrolled in ART within the same week of
their first antenatal care visit [33,34]. The programme boasts
a 97.0% ART initiation rate, with 90.8% initiating within the
same day that treatment eligibility is determined [33].
However, given insufficient time to process the news, along
with the information asymmetry and power disparity between
client and provider [35], women in Malawi have reported
feeling pressured to accept lifelong treatment without being
fully informed of possible side effects, understanding the com-
mitment and having linkage to care and support for adherence
[1]. Such rapid initiation of lifelong treatment requires analysis
as to whether the process meets international human rights
standards for informed consent.
Across the four pillars, women can experience a spectrum
of coercive practices, including lack of informed consent,
involuntary or coercive HIV testing [36,37], limited contra-
ception [38] or treatment options, termination of pregnancy
or coerced sterilization [3944] and pressure to accept parti-
cular contraceptives or start treatment [37,45]. These prac-
tices lead to disempowerment around testing and treatment
choices, which can discourage women from seeking care and
are counterproductive to meeting public health goals [30].
Indeed, early loss to follow-up has been a challenge for
many countries implementing Option B. For instance, in
Malawi, compared to individuals who started ART for their
own health, women who started ART while pregnant were
five times less likely to return to the clinics after the initial visit
(when they initiated ART) [46]. On average, 17 and 22% of all
pregnant women starting ART under Option B dropped out
of care in the first six months and year of therapy, respectively
[46].Women who started ART while breastfeeding were twice
as likely to miss their first follow-up visit [46].
Additionally, non-discriminatory care, free from HIV-related
stigma, is also vital to comprehensively prevent vertical trans-
mission. Unlike previous prophylactic protocols, women must
feel comfortable and supported to begin treatment ‘‘earlier’’
and remain in lifelong care. Yet, women reported receiving
discriminatory care, where service providers do not treat them
with dignity (e.g. yelling derogatory statements) and violate
other human rights (e.g. disclosing serostatus, failing to pro-
vide correct or full information) [47]. Such discriminatory care
provided by clinic staff to clients during labour and delivery
and when they collected ARVs preceded the rollout of Option
B in Malawi and remains a primary concern for women
living with HIV [48].
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Additionally, women are concerned that Option B may
exacerbate inequities around treatment access by men and
non-pregnant women [1,49]. Some women in Malawi and
Uganda feared the potential increase in domestic violence if
one partner discovers her serostatus and/or starts treatment
before the other and is accused of ‘‘bringing the virus home’’
[1]. Yet, policies that have attempted to engage partners (e.g.
Uganda’s requirement for pregnant women to bring their
partners to antenatal visits) have also produced unintended
consequences. As one Ugandan woman shared, ‘‘Women
have chose[n] to hire boda boda (motorcycle taxi drivers)
to go with them to access the services’’ [1]. Consequently,
countries implementing Option B must consider how to
prevent negative consequences of ART prioritization and
design partner engagement policies that do not put women
at greater risk.
Improving the circumstances around offering lifelong ART,
by focusing on quality rather than quantity, is needed to sup-
port women to make informed decisions regarding timely
treatment initiation and to remain in lifelong care [50]. In
particular, programmes seeking to end vertical transmission
should 1) involve women living with HIV in programme design
and implementation; 2) train healthcare workers to pro-
vide non-discriminatory care, provide sufficient information
and obtain informed consent without coercion; and 3) pro-
vide mechanisms for women to raise and address concerns
about human rights violations (e.g. patient representatives,
healthcare facility ombudsman or complaints mechanism).
Finally, funding networks of women living with HIV, to provide
needed information, rights education and other support,
provides an additional opportunity to ensure that human
rights are respected, protected and fulfilled.
Investing in community-based support
There should be education for everybody that states
clearly when people should start treatment so
people are prepared. The doctors and those of
us in support groups know a little but we need to
disseminate the information.  Woman living with
HIV, Malawi [1]
Community-based support is critical to Option B imple-
mentation. Communities play an important role in facilitating
treatment readiness, support and retention in care. After
years of being told to wait before starting ART, women need
education and awareness of the benefits of earlier treatment
initiation for their own health and how to manage lifelong
treatment and side effects.
Personal readiness to start treatment is complex and moti-
vated by many personal and social factors [51,52]. Women
living with HIV from Malawi and Uganda have warned that
starting patients on treatment before they feel ready would
not be conducive to adherence, retention or good health [1].
In Tanzania, women acknowledged the eventual need for
treatment for their own health, but shared that they may lose
motivation to remain in treatment after the risk of transmis-
sion to the child has passed, due to fear of the medications’
side effects and not feeling ready to remain on lifelong
treatment [53]. Additionally, studies have suggested that more
women who start ART for their own health remain in care
than those who start for other reasons [54,55]. Yet, as with
treatment programmes that existed before Option B, stigma
and discrimination at home and in the community, divorce
and physical violence have caused many women to decline
treatment or hide their medications to prevent unintended
disclosure [56,57].
Peer and community support strategies can promote
treatment uptake, adherence and lifelong retention in care
[1,46,5864]. Peer-to-peer strategies can further help to
reduce stigma and discrimination and mitigate potential vio-
lence stemming from disclosure of HIV status [1]. High quality
education and support groups meeting at the hospital or in
the villages have been found to facilitate access and retention
in care [48]. Community-based follow-up, such as home visits
with womeninfant pairs as in Zambia [65], has also improved
antenatal care attendance. Women from Malawi and Uganda
highlighted the need for clear information and education in
communities, peer-to-peer counselling and community-led
retention and adherence models to improve literacy, pre-
paredness [51] and agency in order to enable women to assert
their rights [1].
Overcoming barriers to service uptake and retention
If I am coming from some place and you are referring
me 40 kilometers, you find that the mother does
not have that transport and this will hurt adherence.
 Woman living with HIV, Uganda [1]
Women who commence lifelong ART, especially those with
young children, shoulder new burdens arising from long-term
routine clinic appointments. With Option B, women experi-
ence temporal, financial (i.e. transportation costs, missing
work), relational (e.g. permission from partner), emotional
and physical (e.g. side effects) costs for the remainder of their
lives. These costs affect women’s ability to seek HIV care and
adhere to treatment regimens [1] and have caused some
women in Malawi to stop ART [66].
When women have been able to attend appointments,
dysfunctional clinic and health systems  including health-
care worker shortages, long wait times and distances to
clinics  disincentivize them from seeking care [67]. Studies
in Tanzania and Malawi highlighted that maintenance of
regular supplies of HIV-related test kits and medications are
important in ensuring that all women in need of vertical
transmission prevention services are reached [35,67,68].
Women living with HIV affirmed that ensuring available and
easily accessible quality care, particularly by having follow-
up and ARV distribution points closer to communities, could
increase service uptake [1]. Access to food and food support
(e.g. supplements for their infants, money from support
groups) are also important facilitators to care [48]. A study
of 141 health facilities in Malawi found that the number of
women per HIV testing and counseling (HTC) counsellor, HIV-
related test kit availability and the ‘‘model of care’’ affected
treatment uptake; district location, patient volume and the
model of care affected retention in care [69]. Improving
linkages between antenatal and ARV services is important
[7073], but further research with women living with HIV is
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crucial to determining which models of care will most suc-
cessfully support treatment initiation and lifelong ART [69].
Conclusions
Option B has expanded treatment access for many pregnant
and breastfeeding women living with HIV. However, real pro-
gress towards reducing vertical transmission and achieving
viral load suppression can only be made by upholding the
human rights of women living with HIV, investing in commu-
nity-based responses and ensuring universal access to quality
healthcare. Only then will the opportunity of accessing lifelong
treatment result in improving the health, dignity and lives
of women living with HIV, their children and families.
To meet Global Plan targets, governments and pro-
grammes seeking to end vertical transmission must do the
following:
Uphold human rights by ensuring that service providers
1) always provide women sufficient information and time
to make informed decisions regarding treatment for their
health and the health of the child, 2) do not coerce women
into accepting lifelong treatment should another option
be desired, 3) respect confidentiality and 4) provide non-
discriminatory care.
Invest in community-based responses to improve linkages
to services, treatment literacy, preparedness and agency
to enable women to receive quality services and adhere to
treatment. This investment includes financial support to
deliver community-based services, which are the backbone
of healthcare systems, support groups, peer supporters and
mentor mothers living with HIV, and linkages to networks
and organizations of women living with HIV.
Overcome barriers to service uptake and retention by
ensuring access to quality healthcare and providing decen-
tralized services to address common challenges (e.g. distance
to clinics, transport costs and long waiting times). This
includes ensuring adequate supplies of ARVs, other medica-
tions and diagnostic tools as well as integration with other
programmes (e.g. maternal and child health, nutrition, mental
health) in ways that deliver the best care for women living
with HIV and their families.
The experience and meaningful involvement of women
living with HIV regarding design, implementation, monitoring
and evaluation of Option B are crucial to comprehensively
prevent vertical transmission. Teresia Njoki Otieno, speaking
as ICW Global Chair at the launch of the Fast-Track strategy,
reaffirmed, ‘‘We should end this epidemic, but we can only
do this if we put women living with HIV at the centre’’.
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Abstract
Introduction: Women living with HIV experience a disproportionate burden of mental health issues. To date, global guidelines
contain insufficient guidance on mental health support, particularly regarding perinatal care. The aim of this article is to describe
the extent and impact of mental health issues as experienced by women living with HIV on their sexual and reproductive health
and human rights (SRH&HR).
Methods: A global, mixed-methods, user-led and designed survey on SRH&HR of women living with HIV was conducted using
snowball sampling, containing an optional section exploring mental health issues. Statistical quantitative data analysis included
descriptive statistics, correlation and multiple linear regression analysis for the mental health responses. Thematic analysis of
open free-text responses was performed for qualitative data.
Results: A total of 832 respondents from 94 countries participated in the online survey with 489 responses to the optional
mental health section. Of the respondents, 82% reported depression symptoms and 78% rejection. One-fifth reported mental
health issues before HIV diagnosis. Respondents reported experiencing a 3.5-fold higher number of mental health issues after
diagnosis (8.71 vs 2.48, t[488]23.00, pB0.001). Nearly half (n224; 45.8%) had multiple socially disadvantaged identities
(SDIs). The number of SDIs was positively correlated with experiencing mental health issues (pB0.05). Women described how
mental health issues affected their ability to enjoy their right to sexual and reproductive health and to access services. These
included depression, rejection and social exclusion, sleep problems, intersectional stigma, challenges with sexual and intimate
relationships, substance use and sexual risk, reproductive health barriers and human rights (HR) violations. Respondents
recommended that policymakers and clinicians provide psychological support and counselling, funding for peer support and
interventions to challenge gender-based violence and to promote HR.
Conclusions: Interventions addressing intersecting stigmas and any especial impacts of diagnosis during pregnancy are required
to ensure women’s SRH&HR. Global policy guidelines regarding women living with HIV must incorporate mental health
considerations.
Keywords: HIV; women; human rights; gender-based violence; mental health; values and preferences; survey;
intimate partner violence; evidence base.
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Introduction
Worldwide, about 50 to 55% [1,2] of adults with HIV are
women. Mental health is core to wellbeing [35]. Yet, despite
PubMed citing nearly 800 peer-reviewed articles on mental
health in relation to women with HIV [6], this issue is either
lacking [7] or has been insufficiently addressed [812] in
global policy guidelines.
As for all women, those with HIV experience reciprocal
effects of mental health on gender-based violence (GBV)
[13], their sexual and reproductive health and human rights
(SRH&HR) [8] and their capacity to access and adhere to
healthcare and medication, when required [14,15]. These
intersecting issues are not addressed comprehensively in any
one guideline. Given that psychiatric symptoms, particularly
depression, and mental health vulnerabilities (e.g. maladaptive
coping skills) are widespread among pregnant women living
with HIV [16], it is especially concerning that mental health
does not feature in global perinatal transmission guide-
lines [7]. Even women living with HIV, who have long
recognized that HIV affects them in many different, reciprocal
and gendered ways [17], have rarely addressed mental
health.
The World Health Organization’s (WHO) Department of
Reproductive Health and Research commissioned a user-led
and -designed ‘‘values and preferences’’ global consultation to
enable policymakers to address the SRH&HR of women living
with HIVas part of their guideline update process [18].The aim
of this article is to describe the extent and impact of mental
health issues as experienced by women living with HIV on
their SRH&HR.





A pre-survey exercise led by a global reference group (GRG)
identifiedmental health as a key issue. A surveywas developed
and pilot-tested by the 14 GRG members in English with
iterative feedback.
Survey
The research involved implementation of a WHO global values
and preferences survey that aimed to understand access to
services and priority issues among women living with HIV. The
survey was distributed in seven languages and translated back
into English where necessary. All sections included open-
ended responses [19]. One optional section (of eight; Table 1)
explored mental health issues using simply understood com-
mon terms rather than formal instruments and inquiring
when respondents had experienced these issues in relation to
their HIV diagnosis [19]. Answer options were not exclusive.
Women were also asked to describe in free text how these
mental health disorders affected their SRH&HR and how they
felt that women living with HIV could best be supported to
accommodate or overcome them.
Participants
The survey study population included any woman around
the world living with HIV. The process ran from February
to June 2014, building on a non-random snowball sampling
model developed by the ATHENA Network [20], advertised
and promoted through regional and global listservs of net-
works of women living with HIV and clinical networks.
Consent
The anonymous, confidential online survey began with an
explanation of the questionnaire aims and purposes, includ-
ing an overview of the structure and question areas, and
definitions of SRH&HR [19]. Respondents were shown the
following message: ‘‘I understand that by filling in the survey,
I give my consent for my responses to be used in these publi-
cations. Please click agree to be able to continue.’’ Respon-
dents who did not click ‘‘I agree’’ were unable to proceed, and
their responses were not counted. Participation was taken as
implicit consent. For in-person focus groups, respondents gave
explicit written or verbal consent before the discussion began.
Respondents were informed that they could opt to discon-
tinue at any time or choose not to answer any individual
question.
Ethical considerations
Institutional review board approval for this survey was not
sought, after discussion with the WHO Reproductive Health
and Research Department and members of the Guidelines
Review Committee, as this was a consultative element of the
guidelines development process. Ethical considerations were
undertaken in line with the WHO 2001 Ethical and Safety
Recommendations for Research on Domestic Violence against
Women and the International Community of Women Living
with HIV/AIDS 2004 guidelines on involving women living
with HIV in research [21,22].
Data collection and analyses
The qualitative and quantitative data analyzed were from
the online survey. Descriptive analyses were conducted to
determine frequencies, mean values and standard deviations
for variables. When answers were not exclusive, frequencies
were derived based on the number of respondents who had
never experienced the issues or who answered ‘‘don’t know.’’
Bivariate correlations, t-tests and chi-square analyses were
conducted to assess associations between mental health
issues, socio-demographic variables and social identities.
To examine the relationship between socially disadvantaged
identities (SDIs) and mental health issues of respondents, a
variable named social identity index was created, by summing
identity categories to which the respondents referred them-
selves (Table 2). Two identities (heterosexual; married or in a
stable relationship) were not considered socially disadvan-
taged and thus were excluded from analyses of SDI. Multiple
regression analyses were performed to investigate the asso-
ciations among socio-demographic variables, SDIs and mental
health issues experienced before and after (since or because
of) HIV diagnosis.
A mental health outcome index was created by summing
the mental health issues that respondents reported experi-
encing. The options ‘‘since’’ and ‘‘because of my diagnosis’’
were combined into one variable to indicate the occurrence
of a mental health issue following HIV diagnosis. Respondents
who reported experiences both before and after acquiring HIV
were categorized as experiencing ‘‘persistent’’ mental health
issues.
Thematic analysis of open-ended survey responses was
performed by two social science investigators (LO, CL) [23].
Transcripts were read several times and investigators made
note of initial thoughts and ideas in the data; first-level codes
were then developed by highlighting relevant quotes about
key areas of interest (e.g. depression). Codes were collated
across data sets to produce themes that highlighted similar
experiences among respondents (e.g. stigma and mental
health). Themes were then structured into a thematic map
Table 1. Content and language dissemination of the online
values and preferences survey to update the WHO SRH&HR
guidelines
A. Mandatory section, including experience of accessing services,
priority issues
B. Eight optional section themes
1 Healthy sex life
2 Pregnancy and fertility
3 Violence against women living with HIV
4 Mental health issues
5 Women living with HIV in all of our diversity
6 Puberty, menstrual issues and menopause
7 HIV treatment and side effects
8 Financial issues affecting access to services
The online survey was disseminated in English, French, Spanish,
Russian, Portuguese, Bahasa Indonesian and Chinese. SRH&HR,
sexual and reproductive health and human rights.
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(e.g. the convergence of stigma and mental health issues
to compromise sexual and reproductive health (SRH)) and
refined (e.g. recommendations created for supporting the
mental health of women living with HIV across the micro-,
meso- and macro-levels).
Results
A total of 1173 respondents were recorded on the online
survey system, but 341 did not meet the criteria of giving
consent and confirming HIV status. Thus there were
832 online respondents from 94 countries.
Quantitative findings
As 66 of 832 respondents did not give their age, the final
sample for quantitative analysis was 766. A further 278 (36.3%)
respondents did not answer any questions in the optional
mental health section so were not entered into subsequent
analyses, resulting in a sample of n489 for correlation and















15 to 24 162 (21.4%) 95 (19.4%) 67 (24.1%)
25 to 34 288 (37.6%) 173 (35.4%) 115 (41.4%)
35 to 44 211 (27.5%) 150 (30.7%) 62 (22.3%)
45 to 54 97 (12.7%) 66 (13.5%) 31 (11.2%)
55 to 64 8 (1%) 5 (1%) 3 (1.1%)
Mean age (SD) 32.98 (9.61) 33.64 (0.43) 31.81 (0.58) t2.55*
Language of respondents
English 385 (50.3%) 258 (52.8%) 127 (45.7%) x220.92**
Indonesian 19 (2.5%) 11 (2.2%) 8 (2.9%) NS
Chinese 44 (5.7%) 16 (3.3%) 28 (10.1%) NS
Portuguese 20 (2.6%) 11 (2.2%) 10 (3.6%) NS
French 36 (4.7%) 22 (4.5%) 14 (5.0%) NS
Spanish 86 (11.2%) 63 (12.9%) 23 (8.3%) NS
Russian 176 (23.0%) 108 (22.1%) 68 (24.5) NS
Social identity index
1. I do or have done sex work. 101 (13.2%) 66 (13.5%) 35 (12.6%) NS
2. I inject/use or have injected/used drugs. 136 (17.7%) 102 (20.9%) 34 (12.2) x28.92**
3. My sexual partner(s) injects/uses or has injected/used drugs. 164 (21.4%) 107 (21.9%) 57 (20.5%) NS
4. I am a client of opioid substitution therapy programme. 26 (3.4%) 20 (4.1%) 6 (2.2%) NS
5. I am/have been in prison. 50 (6.5%) 35 (7.2%) 15 (5.4%) NS
6. I am/have been in a detention centre. 52 (6.8%) 32 (6.5%) 20 (7.2%) NS
7. I am living with one or more disabilities. 101 (13.2%) 77 (15.7%) 24 (8.6%) x27.75**
8. I have or have had active TB. 99 (12.9%) 69 (14.1%) 30 (10.8%) NS
9. I have or have had hepatitis C. 157 (20.5%) 107 (21.9%) 50 (18.0%) NS
10. I have or have had malaria. 119 (15.5%) 96 (19.6%) 23 (8.3%) x217.30***
11. I migrated from one country to another for economic reasons. 59 (7.7%) 45 (9.2%) 14 (5.0%) x24.28*
12. I migrated from one country to another for political reasons. 17 (2.2%) 8 (1.6%) 9 (3.2%) NS
13. I am lesbian, bisexual or have sex with women. 37 (4.8%) 20 (4.1%) 17 (6.1%) NS
14. I am a trans woman. 29 (3.8%) 17 (3.5%) 12 (4.3%) NS
15. I am a heterosexual woman. 462 (60.2%) 299 (61.1%) 163 (58.6%) NS
16. I am married or in a stable relationship. 361 (47.1%) 229 (46.8%) 133 (47.8%) NS
17. I am intersex. 4 (0.5%) 1 (0.2%) 3 (1.1%) NS
18. I have experienced any form of female genital cutting or
mutilation, including circumcision.
39 (5.1%) 28 (5.7%) 11 (4.0%) NS
19. I am or have been homeless. 78 (10.2%) 55 (11.2%) 23 (8.3%) NS
20. I am an indigenous woman. 62 (8.1%) 51 (11.4%) 11 (4.0%) x29.92**
NS, not significant; TB, tuberculosis; *pB0.05, **pB0.01, ***pB0.001; x2, chi-squared; t, student t-test.
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regression analyses. The early drop-outs were found to be
younger (t2.55, pB0.05) and less likely to speak English
(x220.92, pB0.01), use drugs (x28.92, pB0.01), have a
disability (x27.75, pB0.01), have had malaria (x217.30,
pB0.001) or be economic immigrants (x24.28, pB0.05).
Respondents’ information on age, language and social iden-
tities are presented in Table 2.
Respondents’ experiences of mental health issues are
shown in Table 3. Approximately one-fifth had experienced
depression (23.9%), low self-esteem (22.5%), body image
issues (18.5%), feelings of rejection (18.1%) and substance use
(22%) before receiving their HIV diagnosis. Paranoia (5.0%)
and anorexia (5.5%) were relatively uncommon. HIV diagnosis
was identified as a critical point for mental health issues,
where around 70% of respondents reported experiences
of depression (74.0%), shame (70.8%), self-blame (70.0%),
feelings of rejection (69.9%) and insomnia (68.4%), among
others. Compared to the rates before HIV diagnosis, problems
occurring ‘‘since/because of’’ HIV diagnosis showed consi-
derable increases across all mental health issues, ranging
from 1.2-fold (substance use) to 6.7-fold (paranoia). Analyses
indicate that the average number of mental health issues
experienced after HIV diagnosis (8.71, SD 4.74) is signifi-
cantly greater than that before HIV diagnosis (2.48, SD 3.89),
t(488)23.00, pB0.001.
As indicated in Table 2, one-third (n158; 32.3%) of the
respondents did not identify themselves with any SDI other
than HIV. One-fifth (n107; 21.9%) acknowledged one SDI (in
addition to HIV). Nearly half of respondents (n224; 45.8%)
had multiple SDIs. Three variables, experiencing mental health
issues before, after and persistently (both before and after HIV
diagnosis), were created to understand the rate, types and
changes in mental health among respondents. Table 4 shows
Pearson’s correlation coefficient results indicating that the
more SDIs a woman living with HIV reported, the more mental
health issues she would experience before diagnosis (r0.19,
pB0.01), after (r0.13, pB0.01) and persistently (r0.14,
pB0.01).
Multiple regression analyses were conducted to examine
whether socio-demographic variables (age) or SDIs were signi-
ficant predictors of experiencing mental health issues before
and after HIV diagnosis. Regression results are presented
in Table 5. The results showed that older women with more
SDIs were more likely to experience mental health issues
prior to their HIV diagnosis (F[2,486]11.96, pB0.001). In
addition, women with more SDIs were more likely to report
mental health issues after their HIV diagnosis (F2.95
[3, 485], pB0.05).
Qualitative findings
Stigma and mental health
While a significant proportion of respondents experienced
mental health issues pre-diagnosis, women indicated that
HIV diagnosis is, in itself, a flashpoint for immediate and on-
going mental health problems, especially depression, feelings
of rejection and insomnia.
Depression
Most mental health survey respondents (82%) reported ex-
periencing depression and depressive symptoms, often fol-
lowing an HIV diagnosis:


















Depression 116 (23.9) 360 (74.0) 3.10 70 (14.4) 68 (14.0) 14 (2.9) 486
Shame 86 (17.7) 325 (70.8) 3.78 46 (10.0) 96 (20.9) 8 (1.7) 459
Self-blame 69 (14.4) 334 (70.0) 4.84 44 (9.2) 104 (21.8) 15 (3.1) 478
Very low self-esteem 107 (22.5) 292 (61.5) 2.73 57 (12) 113 (23.8) 21 (4.4) 475
Feelings of rejection 85 (18.1) 327 (69.9) 3.85 49 (10.5) 87 (18.6) 18 (3.8) 468
Body image issues 86 (18.5) 263 (56.4) 3.06 42 (9.0) 126 (27.0) 36 (7.7) 466
A strong sense of isolation 54 (11.4) 253 (53.4) 4.69 23 (4.9) 170 (35.9) 22 (4.6) 474
Paranoia 23 (5.0) 154 (33.2) 6.70 12 (2.6) 241 (51.9) 62 (13.4) 464
Anxiety 64 (13.5) 314 (66.1) 4.91 38 (8.0) 118 (24.8) 19 (4.0) 475
Insomnia 63 (13.7) 314 (68.4) 4.98 34 (7.4) 96 (20.9) 23 (5.0) 459
Anorexia 25 (5.5) 140 (30.6) 5.6 7 (1.5) 272 (59.5) 28 (6.1) 457
Difficulty going out and socializing 49 (10.4) 223 (47.4) 4.55 28 (6.0) 215 (45.7) 12 (2.6) 470
Spiritual isolation 50 (10.8) 176 (37.9) 3.52 18 (3.9) 228 (49.1) 30 (6.5) 464
Loneliness 87 (18.4) 302 (65.1) 3.47 47 (10.0) 115 (24.3) 17 (3.6) 473
Suicidal feelings 75 (15.9) 177 (37.4) 2.36 37 (7.8) 228 (48.3) 25 (5.3) 472
Post-traumatic stress disorder 69 (14.6) 177 (37.4) 2.57 36 (7.6) 182 (38.4) 33 (7.0) 474
Harmful use of drugs and/or alcohol 104 (22.0) 125 (28.5) 1.20 39 (8.3) 243 (51.5) 32 (6.8) 472
aTotal n represents the respondents who gave an answer to each respective mental health issue question. Due to the multiple-choice design, the
total number of respondents for each item does not amount to the summation of options.
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It took me well over two years to recover mentally
from my diagnosis. I was withdrawn, depressed and
at times suicidal. There was a lack of adequate
psychological and community support services. My
family and friends helped me through the worst, but
I’m lucky that I have good family and friends. Many
others would be totally isolated. (Ireland)
HIV-related stigma contributed to fear about disclosing
to friends, which played a role in enhancing depression: ‘‘The
high stigma attached to HIV infection means that I have felt
very lonely  unable to fully confide in friends . . . This also
contributed to my depression’’ (UK).
Rejection and social exclusion
Over three-quarters (78%) of survey respondents reported
experiencing rejection. Respondents discussed both experi-
ences and fears of being rejected because of HIV-related
stigma. This factor was a barrier to disclosure: ‘‘I live a life of
fear of disclosure and secrecy with few knowing my status
and little good support’’ (Ireland).
This point underscores linkages between lack of disclosure
and lower social support.
Respondents also discussed rejection from friends: ‘‘I have
lost friends, have a hugely restricted social circle and friends
from before I was diagnosed with HIV’’ (UK).
In other situations, family members enacted stigma:
Family member[s are] blaming me for [the] death of
my husband, [I] fear [to] disclose [my status] to even
my mother because she will isolate me from my
siblings and use me as an example in every case.
(Uganda)
Another narrative highlights coping strategies, such as
exercise, employed to manage isolation:
I am again feeling very sad and [have] become a
recluse again. I think HIV is a very sad and isolating
disease. For all of that I will train and complete a half
marathon and just will not give up. (New Zealand)
Sleep problems
Most survey respondents (69 to 75%) reported having experi-
enced sleep problems and discussed many root causes,
including nightmares: ‘‘During [the] night you dream things
which at times if you wake up  you fear even to go out or
you think maybe you can die’’ (Tanzania).
For some women, nightmares were associated with past
trauma:
I have PTSD as a result of multiple traumas. Don’t
get enough sleep because I’m afraid of getting night-
mares. I do fine in a crisis but after everyone is safe
I shut down and don’t function well. (US)
Another respondent, whose concerns for her child were
an extra source of stress, also discussed this narrative of
functioning all day, but having challenges sleeping at night:
I do not sleep, all sorts of thoughts go through my
head, mostly related to my health. I feel sorry for
myself, and for my son. He will be left alone; who
will support him? And if during the day I almost
never think about it, [because] I’m busy all the time,
at night I cannot calm down and often cry. (Ukraine)
Intersectional stigma
Respondents discussed the convergence of HIV-related stigma
with the stigmas surrounding other factors in their life, in-
cluding those related to mental health, drug use and trans-
gender identity. A respondent articulated how fear of disclosure
due to mental health stigma can exacerbate social isolation:
Mental health problems are looked upon in a bad way
by society, [they are] perceived as something that
should be hidden, and most often those that struggle




Mental health issues after HIV
diagnosis (since/because of)
Persistent mental health issues
(before and after) diagnosis
SDI  0.19* 0.13* 0.14*
Mental health issues before HIV  0.05 0.77*
Mental health issues after HIV
(since/because of)
 0.33*
Persistent mental health issues
(before and after diagnosis)

SDIs, socially disadvantaged identities; *pB0.01.
Table 5. Multiple regression analyses of correlates of experi-













SDI, socially disadvantaged identity; *pB0.05; **pB0.01;
***pB0.001.
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with mental health issues are reluctant to share
with anyone resulting in further isolation. (Canada)
This was reinforced by another respondent, who described
stigmas converging with sexism: ‘‘There is also stigma around
mental health and it compounds HIV stigma and other forms
of misogyny’’ (Italy).
Others discussed stigma targeting people who use drugs:
Women who use drugs are subjected to double or
sometimes triple stigma. There are cases of dis-
crimination against these women, even in [the] HIV-
service organizations in which they work. (Ukraine)
Transgender stigma also emerged in service provision
and laws:
Think of any service a youth could benefit from and
just know that trans kids probably aren’t allowed to
access it. (US)
The Anti Homosexuality Act has affected trans
women from getting friendly services. (Uganda)
Stigma, mental health issues and SRH
Respondents discussed the stigma and mental health issues
that present challenges for realizing SRH. Stigma and mental
health issues converged to create challenges with attaining
SRH&HR in three areas: sexual and intimate relationships;
subtance use and its connection with sexual risk and stigma;
and, human rights (HR) violations.
Challenges with sexual and intimate relationships
Respondents discussed HIV-related stigma and mental health
issues presenting challenges both in engaging and asserting
agency and control within sexual/intimate relationships.
Shame and fear were described as barriers:
I have stopped engaging in sexual relationships since
being diagnosed. I feel embarrassed [and] will never
disclose to anyone. (Nigeria)
The issues around dating and having to talk to your
lover or partner about your status at times brings
anxiety, fear and depression of being rejected.
(Kenya)
As a woman explained: ‘‘It makes me less assertive and
I sometimes give permission to my partner to take advantage
of me by having sex when I would rather not’’ (Nigeria).
Another discussed a result as ‘‘little or no condom
negotiation’’ (Jamaica).
Low self-esteem also influenced sexual relationships.
A respondent articulated how low self-esteem and violence
could reduce the desire to be in a relationship:
I had felt very low energy level[s] at times when my
self-esteem was low, whenever I experienced vio-
lence within a marital relationship and didn’t feel
like getting into any relationship[s] with any men for
some period in my life. (India)
By contrast, a respondent discussed how low self-esteem
could result in wanting to be in a sexual relationship:
When your self-esteem is low it is very difficult
to have sex because you really want to have it.
You have sex because you want to be accepted,
you are lonely, you just want somebody to touch you
. . . not because you really want to. (Italy)
Substance use and sexual risk
Substance use was often connected to coping with mental
health challenges and/or socializing.This substance use in turn
was discussed in relation to sexual risk in relationships and in
sex work. A respondent discussed how substance use was a
way of coping with low self-esteem but led to elevated sexual
risks and presented a barrier to developing relationships:
Low mood, anxiety, lack of self-esteem generally
combined with enjoying alcohol with socializing (and
drinking a lot when I do) resulted in putting myself
at risk for HIV and hence acquisition. Ongoing low
mood, anxiety etc., worsened by HIV diagnosis, en-
courages drinking a lot (socially) and preventing
formation of close relationships. (UK)
Reproductive health barriers and HR violations
Respondents discussed many reproductive health barriers
and HR violations, including being dissuaded from having
children, mistreatment while pregnant and forced or coerced
sterilization.Women who wanted to have children were often
constructed as wanting to transmit the virus:
In Gabon, it is a problem to decide to have children.
Women [living with HIV] who choose to do it with-
out their doctor’s advice are perceived as women
who wish to transmit HIV. (Gabon)
This construction of women living with HIV as wanting
to transmit the virus through childbirth resulted in some
respondents unwillingly choosing not to have children:
When I found out I was HIV positive, my doctor at
Planned Parenthood told me I could never have
children. That I might infect them and I would be [a]
‘‘horrible woman’’ to do so. I didn’t have children
but I have regretted that decision every day of
my life since. I did refuse sterilization when it was
‘‘encouraged’’ but still wish I had considered having
children as a possibility. (US)
Some women also reported coerced and forced steriliza-
tion, which can have a profound and devastating impact on a
woman’s mental health:
Find a law that strongly punishes doctors performing
forced sterilization and that does not expire, and
[allows] time to make a lawsuit if necessary be-
cause many times we realize that we were sterilized
many years later andwe can do nothing. (Puerto Rico)
Others discussed childbirth mistreatment, which could
prevent efforts to reduce vertical transmission:
The moment a woman identifies herself as living
positively with HIV, they are neglected, especially
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during delivery, hence [there is an] increased num-
ber of children born with HIV because women prefer
to keep it a secret and be treated like the rest.
(Uganda)
Respondents’ recommendations
Women living with HIV recommended psychological support
and counselling, peer support, challenging stigma (which is
one form of GBV) and promoting HR.
Psychological support and counselling
Respondents recommended psychological support and coun-
selling that was affordable, accessible, holistic and integrated.
Some called for future-oriented services:
Access and encouragement to use professional
mental health services. Psychologists, counsellors
etc. who also have [an] understanding of the need
to build a life based on well being and acceptance
not over focusing on problems of the past; solution
building. (UK)
Many respondents recommended integrating HIV services
into a one-stop shop and that counselling should include
substance use and other issues: ‘‘treat underlying causes.
I was an addict & couldn’t get better till I gave up all
drugs. HIV was a cause/symptom of that rather than the
problem’’ (UK).
Respondents reinforced the importance of trained, skilled
provision of integrated mental health and substance use
services and highlighted the need to address trauma, includ-
ing ‘‘resources that actually name and explain deep rooted
subconscious responses and behaviours (that are normal).
Post-traumatic stress counselling’’ (Australia).
Underscored across many narratives was the need to
increase ‘‘access to mental health services for low income
women’’ (US), preferably without payment.
Peer support
Peer support was discussed as highly important in helping
respondents manage mental health issues: ‘‘Connecting with
other positive women was the best thing I ever did for
myself’’ (US).
Peer support groups and networks provide: ‘‘women
‘spaces’ to be themselves, to talk about what they are going
through without judgment’’ (UK).
This support provided hope:
Peer mentoring can be helpful. Knowing that
there is life after HIV is difficult at the start of a
diagnosis and anyone that can show you that there
is the possibility to survive and thrive is important.
(Ireland)
It was also a source of learning coping and health
strategies:
Joining support groups or forums where one could
meet with other infected women and learn from
each other as well as how others are living with and
managing their conditions/lives and medication.
(Zimbabwe)
Challenging stigma and promoting HR
Regarding mental health experiences, women wanted policy-
makers ‘‘not to stigmatize women living with HIV’’ (Uganda)
and to ‘‘end the stigma by all means possible! Policies,
laws, education, public information etc. What other way is
there?’’ (UK)
Others discussed the need to tackle ‘‘the stigma related to
mental health and as well as some social norms that make
mental health taboo’’ (Uganda).
Challenging stigma and promoting HR required policies:
‘‘real health policies addressing HIV women and girls issues
respecting their dignity and human rights’’ (Brazil).
Discussion
This largest-ever survey of women living with HIV globally
examined their mental health, across the complexity of their
lives and in relation to SRH&HR, GBV and treatment access
combined. Women have substantial mental health issues
before HIV diagnosis but experience a significant manyfold
increase in the incidence of mental health issues after HIV
diagnosis. Seven out of ten women report depression, shame,
self-blame, feelings of rejection and insomnia, and over
50% have multiple issues. These are linked with stigma/social
marginalization based on intersecting identities. SDI was a
significant predictor of mental health issues before and after
HIV diagnosis. This point shows the importance of examin-
ing the intersecting identities of women living with HIV and
strongly corroborates the qualitative findings of intersectional
stigma. Stigma (itself a form of GBV [2427]) that targets
women’s identities is a key reason for the increased mental
health issues post-diagnosis, highlighting the role of social and
structural factors in influencing the mental health of women
living with HIV.
A key strength of this original user-led and -defined study
is that it examines women’s perspectives of mental health
before and after diagnosis with a global population.The instru-
ment and the community-based participation were grounded
in appreciative enquiry approaches [28], building on strategies
and practices that work for women living with HIV. Parti-
cipation was global, including women from a diverse range of
ages, stages, countries and contexts, although this was not
a representative sample by geography. The mixed methodol-
ogy gives a comprehensive view of women’s challenges in
negotiating life beyond an HIV diagnosis. Due to the study
design, respondents may be more connected to activist and
resilient networks. They had to be mentally well enough
to participate: some even reported finding it cathartic and
healing. Others may have found its length and the in-depth
nature of questioning too hard. Only half responded to the
optional section but non-responders did not appear to have
more SDIs, supporting generalizability. Although not intended
as a representative sample, quantitative results thus con-
tain selection biases and imprecision. Participation was also
limited by language, Internet access and connection to net-
works of women living with HIV. Those in greater isolation,
poverty or specific contexts may be experiencing yet greater
mental health challenges, for example in areas recently
affected by conflict.
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In order to increase access to the survey, nine focus group
discussions (FGDs) in seven countries (Ethiopia (two surveys),
Jamaica, Myanmar, Nepal, Senegal (two surveys), Thailand
and the United Kingdom), using five further languages
(Amharic, Burmese, Nepali, Thai, Wolof), ran parallel to the
online survey, using the same questionnaire (data not shown).
These FGDs reached out to other women living with HIV
without computers, or with limited literacy or no knowledge
of the online languages used. They were facilitated by GRG
members or by other women well trusted by the participants.
Data analysis did not produce significant differences in res-
ponses between online survey respondents and FGD partici-
pants. This result supports the content validity of the online
survey findings, since findings were not just from a relatively
elite group of women with online access, but also applicable
to the FGD participants.
The results are comparable with reported mental health
prevalence levels of people with HIV, although only one-third
of studies of interventions have included women [15]. The
results are cause for concern, in terms of the complexity of
these findings: the burden of HIV disease alone, conflated
with the known reciprocal links between mental health,
SRH&HR [8], GBV [13] and treatment access [8,14,15].
The findings indicate that clinicians and global policymakers
must address the complex reciprocal effects of mental health
on the lives of women living with HIV in relation to their
experiences of GBV, their ability to realize their SRH&HR and
their capacity to access and adhere to treatment, as a matter
of urgency. Moreover, root causes of mental health issues
among women living with HIV such as stigma (one pervasive
form of GBV) and social marginalization need urgent attention.
Given widespread HIV testing and diagnosis during pregnancy
[16], itself a time of heightened potential vulnerability, and
recognizing diagnosis as a critical point for mental health
issues, it is especially important that future global policy
guidelines regarding perinatal transmission address mental
health [29].
Women living with HIV recommend that their mental
health issues be addressed urgently and comprehensively in
policy guidelines, in training health workers and in providing
relevant services [30,31].
Implications for research
Further research is required into the following areas: ex-
ploration into and understanding of mental health issues
as a contributing factor to HIV acquisition and as a consequ-
ence of HIV diagnosis (during and outside of pregnancy
and childbirth); implementation of mental health strategies
in sexual health services, GBV reduction services, perinatal
care and in HIV care, support and treatment; mental health
issues as a significant barrier to accessing all these areas.
Peer-led strategies and the effectiveness of practices that
many women living with HIV find of value to manage
mental health, without use of (or in combination with)
relevant medication, should be tested. Links for women be-
tween conflict, mental health and HIV remain inadequately
explored.
Conclusions
Mental health challenges for women living with HIV recipro-
cally affect their experiences of GBV, SRH&HR and treatment
access. Women living with HIV who have other SDIs can be
especially affected by mental health issues. If women’s mental
health issues are resolved it will benefit their SRH and HR.
The limited attention given in global policy guidelines to the
mental health of women living with HIV as a consequence
of their diagnosis is an oversight that must be addressed.
Furthermore, while policymakers and clinicians clearly have a
role to play, the state also needs to act more broadly and
cross-sectorally to address mental health issues and social
disadvantage through supportive laws and policies.
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Abstract
Introduction: Women living with HIV are vulnerable to gender-based violence (GBV) before and after diagnosis, in multiple
settings. This study’s aim was to explore how GBV is experienced by women living with HIV, how this affects women’s sexual and
reproductive health (SRH) and human rights (HR), and the implications for policymakers.
Methods: A community-based, participatory, user-led, mixed-methods study was conducted, with women living with HIV from
key affected populations. Simple descriptive frequencies were used for quantitative data. Thematic coding of open qualitative
responses was performed and validated with key respondents.
Results: In total, 945 women living with HIV from 94 countries participated in the study. Eighty-nine percent of 480 respondents
to an optional section on GBV reported having experienced or feared violence, either before, since and/or because of their HIV
diagnosis. GBV reporting was higher after HIV diagnosis (intimate partner, family/neighbours, community and health settings).
Women described a complex and iterative relationship between GBV and HIV occurring throughout their lives, including
breaches of confidentiality and lack of SRH choice in healthcare settings, forced/coerced treatments, HR abuses, moralistic and
judgemental attitudes (including towards women from key populations), and fear of losing child custody. Respondents
recommended healthcare practitioners and policymakers address stigma and discrimination, training, awareness-raising, and HR
abuses in healthcare settings.
Conclusions: Respondents reported increased GBV with partners and in families, communities and healthcare settings after their
HIV diagnosis and across the life-cycle. Measures of GBV must be sought and monitored, particularly within healthcare settings
that should be safe. Respondents offered policymakers a comprehensive range of recommendations to achieve their SRH and HR
goals. Global guidance documents and policies are more likely to succeed for the end-users if lived experiences are used.
Keywords: HIV; women; human rights; gender-based violence; values and preferences; survey; intimate partner violence;
evidence base.
Received 8 May 2015; Revised 19 October 2015; Accepted 23 October 2015; Published 1 December 2015
Copyright: – 2015 Orza L et al; licensee International AIDS Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution
3.0 Unported (CC BY 3.0) License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly cited.
Introduction
Evidence over the past 15 years, documented in peer-
reviewed and informal literature, shows that women living
with HIV globally experience high levels of gender-based
violence (GBV) and human rights (HR) abuses, including
structural violence [120]. Intimate partner violence (IPV),
and violence against women, as well as stigma and discrimina-
tion, can be viewed as overlapping sub-sets of GBV [7,15].
There are varied definitions of GBV [7,15,21,22], with different
combinations of physical, sexual, psychological, financial, legal
or structural abuses. Only one, from a key 2011 document
aiming to start documenting the forms and extent of violence
they experience, relates specifically to women living with HIV:
‘‘violence against positive women is any act, structure or
process in which power is exerted in such a way as to cause
physical, sexual, psychological, financial or legal harm to
women living with HIV’’ [15].
GBV before HIV diagnosis
IPV is already recognized to increase during pregnancy for
some women regardless of HIV status: this also increases risk
of poor pregnancy outcomes [23]. The World Health Organiza-
tion (WHO) and others [8,10] document how IPV can increase
women’s vulnerability to acquiring HIV. For example, forced
sex, limited or compromised negotiation about safer sex and
consequent increased sexual risk-taking can all result in
women acquiring HIV [4]. Violence-related mental health
problems can also result in HIVacquisition and progression [4].
GBV after HIV diagnosis
Global HIV policies regarding women with HIV have remained
largely silent on GBV experienced after HIV diagnosis [2428].
Yet IPV can affect women’s ability to initiate or adhere to
treatment [20].Thismay have policy implications onwhen best
to start [27,29]. Moreover, other GBV consequences, including
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poor mental health, poverty and lack of widow’s property and
inheritance rights can particularly affect capacity for women to
cope with HIV, with subsequent health consequences for their
children also [7].
Healthcare is recognized as a setting where professionals
can support women experiencing GBV [30]. However, HR
abuses against women living with HIV in healthcare settings,
such as forced and coerced sterilization [31] and related
psychological violence, have been documented and represent
manifestations of structural and GBV [17,18,21,22].
Balancing the impact of ‘‘formal’’ (scholarly/peer-reviewed/
replicable) and ‘‘informal’’ (policy/activist/community-based)
evidence is challenging, but there is ongoing value in ensuring
the voices and experiences of women living with HIVare heard
when developing policies which affect them. In 2014, the
World Health Organization (WHO) commissioned a user-led
and -designed global values and preferences survey of women
living with HIV, to enable policymakers to update its 2006
Guidelines on the sexual and reproductive health (SRH) of
women living with HIV [32]. These guidelines required up-
dating through changing biomedical and political aspects of
the HIV response, and internal WHO technical guidelines
production processes [33]. WHO aimed to enhance the
relevance and effectiveness of global guidelines, policies and
programmes by exploring the lived experiences ofwomenwith
HIV through involving and listening to women from the outset.
The aim of this article is to explore the ways women living
with HIV experienced GBV. It describes how this impacted on
their SRH and HR, as elicited from this community-based
participatory research process, and implications of these
finding for policymakers.
Methods
Overall survey development and dissemination
As community-based participatory research, this comprised an
anonymous, confidential, mixed-methods, global, web-based
values and preferences survey [3436]. A Global Reference
Group (GRG) of 14 women with diverse experiences of
acquiring and living with HIV shaped the instrument using
Survey Monkey, as described elsewhere [33,37].The GRG used
a written pre-survey exercise, developed by the core team,
which reviewed women’s lives over the lifecourse and to
reflect on all facets (physical, psychological, material, sexual,
spiritual) of women’s lives in relation to their SRH. The results
from the pre-survey exercise informed all the survey sections
and questions. The survey used an appreciative inquiry
approach (which focuses on the respondent as expert in
creating positive, future-oriented outcomes) [38], grounded in
HR [33] and sought to identify strategies which already work
and can be expanded.
The resulting survey had one mandatory and eight optional
sections, included quantitative and qualitative elements, was
pilot-tested with iterative feedback by the GRG and dissemi-
nated in English, French, Spanish, Russian, Portuguese, Bahasa
Indonesian and Chinese.
The process ran from February to June 2014, building on a
non-random snowball sampling model developed by ATHENA
Network [39], advertized and promoted through regional and
global listservs of networks of women with HIV and clinical
networks also [33]. The survey study population included any
woman around the world living with HIV [37].
Gender-based violence questions
The GRG identified GBV as a key issue. Questions on
experiences of GBV (including within SRH services), gender
inequality, harmful traditional/cultural practices, and violence
from intimate partners/family members/community were
thus included in the initial, mandatory section.
One optional section focused further on GBV [37]. This
explored experiences and fear of GBV (from intimate partner,
family and neighbours, wider community, health services, and
prison/detention). Another question asked women to rank as
‘‘critical,’’ ‘‘important’’ or ‘‘less important’’ a series of policy
and programme recommendations to address or prevent
GBV that had been informed by the GRG regarding specific
identities of women with HIV.Women were asked about their
experiences of various types of GBV and when these were
experienced in relation to HIV diagnosis (‘‘before’’, ‘‘since’’ and
‘‘because of’’ answer options were not mutually exclusive).
Women were also offered freetext space to detail experiences
of violence and how they had accessed support.
Analysis
Simple descriptive frequencies and proportions were used for
quantitative survey data. When answers were not mutually
exclusive, ‘‘ever experienced’’ was calculated by subtraction
of ‘‘never’’ and ‘‘don’t know’’ from the total.
Freetext answers in all survey sections were translated back
into English where necessary and reviewed for themes about
experiences of GBVand for policy and programme recommen-
dations [15]. Thematic coding of all open qualitative responses
(survey freetext answers) was performed by one social
scientist (LO), through manual textual analysis to identify
emergent common themes, and validated with GRGmembers.
Ethical considerations
Institutional review board approval for the survey was not
sought, after discussion with the WHO Reproductive Health
and Research Department and members of Guidelines Review
Committee, as this study was a consultative element of the
guidelines development process. Ethical considerations were
undertaken, however, in line with the WHO 2001 Ethical and
Safety Recommendations for Research on Domestic Violence
against Women and the International Community of Women
Living with HIV/AIDS 2004 guidelines on involving women with
HIV in research [40,41].
Full explanations of the survey aims and purposes, including
overviews of the structure and question areas, and definitions
of SRH and HR, opened the survey. Respondents were required
to confirm they had HIV and that they gave their consent for
their responses to be used in these publications. Online
respondents who did not click ‘‘I agree’’ could not proceed.




In total, 832 women living with HIV from 94 countries
participated in an online survey [33]. Their ages ranged from
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15 to 72 years, with most in their 30s (32%) and 40s (32%).
Their diversity is shown in Table 1.
Quantitative responses
GBV was reported in every section of the survey [33]. In the
one mandatory section, participants overwhelmingly agreed
that addressing GBV in all three contexts (within SRH services;
in the home and community; and harmful traditional practices)
was an ‘‘absolute must’’ or ‘‘high priority’’ (555559/589:
9497%). Few (1834/589: 36%) considered addressing GBV
to be ‘‘lower priority.’’
The optional GBV section was completed by over half the
online survey respondents (480/832, 58%). Table 2 shows the
types, frequencies and timings of violence reported. For all six
categories, some respondents gave multiple answers accord-
ing to when the violence had occurred. Of respondents to the
optional section, 89% (422/480) had experienced at least one
form of violence in any of the six categories. Only 58
respondents (11%) said they had ‘‘never’’ experienced any
form of violence (six of these ticked ‘‘never’’ in all six areas and
at least one other response, but were counted as not having
experienced violence). 100% (57) of respondents answering
this section from Eastern Europe and Central Asia experienced
at least one form of violence.
Fear of violence was the most commonly reported form of
GBV (322/473, 68.1%), but only 15 (3%) reported ‘‘fear of
violence’’ alone. The least reported form of GBV was from
police/military/prison or detention (16.6%) (Table 2). The
commonest form of violence before diagnosis was IPV (43%),
which was exacerbated afterwards for some. Reports of four
types of GBV (from family/neighbours, community, health
settings, and fear of violence), were higher ‘‘since’’ or
‘‘because of’’ HIV diagnosis than ‘‘before.’’
Qualitative responses
In the one mandatory survey section, violence emerged as a
key theme in freetext responses to the question ‘‘What’s the
most important issue that you would like to see the WHO
Guidelines address in order to make it the most useful tool for
you?’’ Answers varied from one word, ‘‘violence’’ (multiple
responses), to longer statements concerning ways GBV inter-
sects with HIV:
The impact of violence and the trauma associated
with being a girl/woman in many parts of the world
affect every aspect of our fight against HIV – from risk
to diagnosis to accessing care to managing treatment
to survival. (US)
Lifelong violence
The optional GBVsurvey section also revealed that violence is not
a one-off occurrence, and that it cannot be easily packaged as
either a cause or consequence of HIV.The freetext results indicate
the wide breadth of forms of GBV and its complex and itera-
tive relationship with HIV, occurring throughout women’s lives:
Before HIV, I was victim of different types of violence
(physical, psychological, financial) besides the impact
my partner’s alcoholism and machismo; this lead me
to get several STIs, including HIV. (El Salvador)
Violence occurred both before and after my diagnosis
and post diagnosis the violence was related to stigma,
which in turn resulted in being discriminated against,
gossiped about, treated badly by family, asked to not
use utensils, etc . . .. (Canada)
When I was newly diagnosed and had lost about 40Kg
my neighbours and members of my church choir
started avoiding me and in fact disallowed their
children to come to my home and my son to enter
theirs. Itwassuchapainfulexperienceforme.(Nigeria)
Violence within healthcare settings
HIV diagnosis and disclosure can act as specific triggers for
violence. They also expose women to new settings of HIV-
related violence, including within healthcare institutions,
especially concerning SRH. In other survey sections, women
Table 1. Participant characteristics  online survey (n832, 100%)
Survey participants’ self-identification of diversitya
Heterosexual 524 (63%)
Inject/use or have injected/used drugs 116 (14%)
Do, or have done, sex work 116 (14%)
Lesbian or bisexual 46 (5.5%)
Transgender women 37 (4.5%)
Intersex 6 (0.7%)
Indigenous 67 (8%)
In stable relationships 374 (45%)
Have experienced any form of genital cutting or mutilation 42 (5%)
Have or have had active tuberculosis, malaria or hepatitis C (respectively) 108 (13%), 150 (18%), 137 (16.5%)
Have been incarcerated or detained 42 (5%)
Have migrated for economic or political reasons (respectively) 158 (19%), 21 (2.5%)
Have other disabilities 100 (12%)
Are or have been homeless 116 (14%)
aNumbers do not add up to 100% as these were optional questions.
Orza L et al. Journal of the International AIDS Society 2015, 18(Suppl 5):20285
http://www.jiasociety.org/index.php/jias/article/view/20285 | http://dx.doi.org/10.7448/IAS.18.6.20285
67
also reported confidentiality breaches leading to involuntary
disclosure (exposing women to further forms of violence from
partners, family and community members): ‘‘No Confidenti-
ality. Nurse at hospital told my whole family. Lost my family
business’’ (Belize/US).
Also from freetext responses, women indicated that their
choice whether to test for HIV, and whether, when and how to
disclose their status to their partner(s) was often compromised
in maternity contexts:
Service providers should stop forcing women with
HIV to disclose to their husbands, they should teach
on how to help them to disclose, cause if a woman
doesn’t disclose she is not attended to. (Uganda)
Lack of SRH choice
Whilst many respondents reported improved SRH services
over the last 20 years,many still experienced negative provider
attitudes regarding fertility desires, and no access to a full
choice of services relating to contraception,maternity care and
obstetrics, fertility treatment and adoption. Freetext survey
responses included: ‘‘Aftermy delivery, the midwives, knowing
that I was HIV positive, didn’t direct me towards family
planning services . . . according to them I no longer had the
right to have children’’ (Cote D’Ivoire).
The moment a woman identifies herself as living
positively with HIV, they are neglected especially
during delivery hence increased number of children
born with HIV because women prefer to keep it a
secret and be treated like the rest. Others have
avoided giving birth from health centers . . . because
of negligence in those hospitals. They prefer tradi-
tional birth attendants. (Uganda)
Respondents also reported mixed experiences regarding
contraceptive choice. Service providers reportedly told many
only to use condoms. Others have been coerced or forced into
using long-acting or permanent birth-control methods, includ-
ing intra-uterine devices (IUD, coils), injectable hormonal
contraceptives, or tubal ligation (sterilization). Once diag-
nosed, women also reported treatment refusal (especially
fertility treatment) or being forced or coerced into services
they did not freely choose, including abortion: ‘‘When I got
pregnant with my daughter, doctors tried to convince me
to abort’’ (Portugal).
I went to the health facility for an IUD which they
did willingly but after 6 months I wanted it removed
because I wanted to have a baby. They told me the
family planning method I used was for 12 yrs so they
gave me a hard time that I wasted their IUD which
another person would have used, ‘someone who is
not like me’. It hurt me so much and I left. So I gave
up removing it. (Uganda)
Make sure that there is a law that can heavily penalize
doctors who perform forced sterilization andmore; in
many cases like mine we only realize many years later
and [then] you cannot do anything. (Mexico)
Human rights abuses and diversity
HR abuses were documented throughout the survey. In the
human rights section, 180/589 (30%) respondents disagreed
or strongly disagreed with the statement: ‘‘I experience the
same service as any other women when I go for sexual and re-
productive health services.’’ Their freetext responses included:
‘‘When it comes to referral to reproductive sexual health, STIs
etc., the staff is completely uninformed and discrimination still
persists, leaving care of women living with HIV til last’’ (Peru).
Women often faced considerable ignorance from health
providers regarding SRH rights, and judgemental attitudes.This
was exacerbated for sex workers, lesbians and transgender
women especially around fertility and family planning access:
Because I am a sex worker I am ignored most of the
times. (Malawi)
Health providers have no experience in dealing with
lesbian women especially those living with HIV. . . .
When asked to come with my ‘‘male partner’’ I
responded that I am lesbian. The [healthcare profes-
sional] was very much disgusted when I revealed my
sexual preference. I have never attended that hospital
again. (Kenya)

















From a sexual partner or
spouse
208 (43) 80 (17) 70 (15) 282 (59) 181 (38) 17 (4) 480 (100)
From a family
member/neighbours
75 (16) 80 (17) 112 (24) 215 (45) 244 (51) 16 (3) 475 (100)
In the community 76 (16) 109 (23) 146 (32) 250 (53) 196 (42) 25 (5) 471 (100)
In health settings 28 (6) 133 (28) 164 (35) 253 (53) 209 (44) 13 (3) 475 (100)
From police/military/prison or
detention services
44 (9) 34 (7) 26 (6) 78 (17) 360 (77) 31 (7) 469 (100)
Fear of violence 118 (25) 136 (29) 184 (39) 322 (68) 140 (30) 11 (2) 473 (100)
aCategories in columns 2 to 4 are not mutually exclusive. Only columns 5 to 7 add up to 100% across each row.
Orza L et al. Journal of the International AIDS Society 2015, 18(Suppl 5):20285
http://www.jiasociety.org/index.php/jias/article/view/20285 | http://dx.doi.org/10.7448/IAS.18.6.20285
68
As a trans woman, healthcare providers do not have
the correct information about my body. They are very
uncomfortable dealing with a woman who has a
penis. . . . Now I avoid such centres. (South Africa)
Being Trans and HIV makes getting compassionate
and comprehensive care very difficult. I have been
hospitalized at the University of X Hospital, Y
University Hospital, and University of Z Hospital – all
places made me feel extremely unsafe. (US)
Women who used drugs also reported considerable stigma,
discrimination and violence, especially regarding their repro-
ductive rights. These respondents reported high anxiety,
particularly over child custody by free text: ‘‘When my
mother-in-law found out about my HIV-positive status from
the hospital nurses, she made every effort to take away my
daughter’’ (Russia/Ukraine).
When I was diagnosed doctors actively discouraged me
from having a baby  even if we already knew good
interventions to stop vertical transmission. Maybe it
was because I was an ex-drug user and also had
Hepatitis C Virus . . . But it took me many years to even
ask again if I could have children & it was too late. (Italy)
Support for policies to address or prevent GBV
Survey respondents were asked what messages to offer
policymakers, or to give recommendations on how to address
and prevent violence against women with HIV:
I would like them to address gender violence
because women are suffering in the hands of their
husbands. Most women like me stay in the marriage
not because I want but because I have nowhere else
to go and also the business I do is family business so
if I leave I won’t have any financial support, so I
endure the beatings, insults etc. because I don’t
have an alternative. (Kenya)
Policy recommendations
Women’s responses to the policy recommendations pre-
sented in the optional GBV section covered a wide range of
issues (Table 3). Over 80% of respondents agreed that these
are critical or important ways healthcare services can address
violence against women with HIV [33].
In looking beyond ‘‘just’’ an end to GBV, further policy and
practice suggestions were ranked as shown in Table 4. A range
of 5493% of respondents agreed proposed measures were
‘‘critical’’ or ‘‘important.’’ For lower percentage responses, a













Through safe health services that protect, respect and uphold women’s rights
Sensitize healthcare workers to the rights of women living with HIV 363 (77) 86 (18) 11 (2) 11 (2) 471 (100)
Increase access to quality support services for women who experience
gender-based violence (including sexual violence)
356 (76) 94 (20) 11 (2) 8 (2) 469 (100)
Ensure effective complaints/redress mechanisms in case of rights
violations within health services
332 (71) 114 (24) 10 (2) 10 (2) 466 (100)
Provide a minimum post-rape care and support package, including
post-exposure prophylaxis, emergency contraception, screening for other
sexually transmitted infections, and psychosocial care/counselling
330 (71) 114 (24) 9 (2) 13 (3) 466 (100)
Increase access to harm reduction-based treatment for women who
use drugs
238 (51) 178 (38) 26 (6) 23 (5) 465 (100)
Address alcohol abuse 206 (44) 182 (39) 54 (12) 22 (5) 464 (100)
Through a protective legal and policy environment and decriminalization
Strengthen laws and policies to protect the rights of people living
with HIV
376 (80) 79 (17) 9 (2) 8 (2) 472 (100)
Strengthen legal protections around all forms of violence against
women/gender-based violence
358 (76) 90 (19) 9 (2) 14 (3) 471 (100)
Recognize and address marital rape and ‘‘date rape’’ 280 (60) 143 (31) 17 (4) 25 (5) 465 (100)
Remove laws which criminalize HIV exposure/transmission 235 (51) 112 (24) 63 (14) 48 (10) 458 (100)
Remove laws which criminalize same sex practices 181 (40) 131 (29) 97 (21) 48 (11) 457 (100)
Remove laws which criminalize sex work 166 (35) 153 (33) 89 (19) 61 (13) 469 (100)
Remove laws which criminalize drug use 157 (34) 148 (32) 106 (23) 54 (12) 465 (100)
Through financial security
Increase social protection for women and children 333 (71) 116 (25) 12 (3) 8 (2) 469 (100)
Increase access to employment for women, including transgender women 269 (58) 153 (33) 26 (6) 17 (4) 465 (100)
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consistently greater proportion also answered ‘‘don’t know’’
(up to 30%).
One survey respondent highlighted the importance of
using the guidelines in conflict-afflicted countries:
Issues around GBV and HIV/AIDS for women and
girls in South Sudan. The . . . country continues to be
troubled in political issues and insecurity, women
and girls continue to suffer the brunt of it all. WHO
should be specific . . . on how to address GBV and
HIV/AIDS for women and girls in an insecure
country. (South Sudan)
Discussion
This mixed-methods study, developed and led by women
living with HIV, describes the experiences of 945 participants
from 94 countries globally. Eight-hundred and thirty-two
women took part in an online survey, the data from which
are described above. A further 113 women living with HIV
from key affected populations took part in 11 focus group
discussions (FGDs) in seven countries. This enabled more
respondents with no limited literacy or no computer access
or limited literacy to answer the same survey questions and,
through discussion, to deepen understanding and triangulate
findings. Data analysis did not produce significant differences
in responses between online survey respondents and FGD
participants, therefore supporting the content validity of the
online survey findings (data not shown). It is the largest study
of its kind to explore SRH and HRs of women with HIV.
Of concern is that 89% of respondents to the GBV section of
the online survey reported violence. Women reported HIV-
related violence before, since and because of HIV diagnosis 
or a combination of all three. Fear of violence was more
common than other forms of GBV, but there were high
background IPV levels before and after diagnosis. Notably,
higher levels of violence were experienced post-diagnosis in
health settings and the community. Peer-review literature to
date has not highlighted the increased levels of GBV in such
settings, nor the very high proportion of respondents
reporting violence at different stages of their lives. GBV was
a high priority for many women with HIV, including sex
workers, transgender women and women who used drugs.
The range and complexity of the violence experienced by
women living with HIV combined to constrain their capacity to
enjoy SHR and HRs.
Table 4. Policy recommendations that would improve the SRH of women living with HIV in all their diversity (from optional section
relating to diversity)
Policy recommendations that would improve the SRH of women living with HIV in all their diversity
Proportion endorsing
recommendations
as critical or important n (%)
Women who use drugs
Access to methadone or buprenorphine for women living with HIV who inject drugs and are pregnant 250/430 (56)
Treatment and support for hepatitis C co-morbidities 398/428 (93)
Education on prevention and first-aid for overdoses, including access to naloxone *
Sex workers
Interventions to halt and address violence and discrimination against sex workers 375/425 (88)
Lesbian, bisexual, transgender women, and other women who have sex with women
SRH services tailored for lesbian, bisexual, transgender women or other women living with HIV who
have sex with women
288/428 (67)
Introduction of SRH guidelines/policy for transgender women 279/419 (67)
Access to sexual reassignment surgery for transgender women 234/424 (55)
Access to other gender-affirming surgeries for transgender women 226/422 (54)
Women in prison or detention
Continuity of treatment access and adherence support for women in prison or detention and women
re-entering into society
393/426 (92)
Addressing HIV-related stigma and discrimination among prison staff and inmates 399/428 (93)




Tailored access to information and services for women with disabilities 402/431 (93)
For all women with HIV, throughout the life-cycle
Comprehensive sexuality education 403/433 (93)
Removal of age-restrictive polices 254/403 (63)
Treatment and support for TB co-morbidities 398/428 (93)
*Inadvertently not included in the survey, but later highlighted by GRG members.
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The strengths of this largest-ever survey of women with
HIV include being user-led, with efforts made to ensure
inclusion of women living with HIV in multiple contexts and
diversities. It was based on a snowballing technique via
informed networks, used both qualitative and quantitative
methods, and achieved a large global response.
With constrained timeframe and budget, the study’s key
limitation is that participants do not represent all women with
HIV and was biased towards women with Internet access who
had an activist interest through their listserv membership.
Experience of GBV might influence the wish to participate in
either direction. Numbers from each of many key populations
are relatively small due to the breadth of participation. It was
particularly difficult to reach younger women and women
living with HIV in conflict-affected situations, who may have
other specific experiences of violence not captured by the
survey. Nevertheless, the response exceeded expectations and
achieved sufficient breadth and depth of information required
to support generalizability.
The implications for clinicians and policymakers are: that
stigma and discrimination against women living with HIV are
forms of GBV and need to be recognized as such; and that
GBV is commonly experienced by women living with HIV
globally. Safety is the foundation of an effective response to
violence against women in the context of HIV. WHO/UNAIDS
have documented the existing evidence base for effective
interventions in four strategic areas: effective laws and
policies, transformative gender norms, integrated violence
against women and HIV services, and empowering women
and girls though integrated multi-sectoral approaches [7].
Survey respondents highlighted all these strategic areas, and
also others including alcohol policies and peer-support.
Healthcare settings need to be safe places for all women
including key populations [42], and there is a need for greater
awareness-raising and evidence-informed debate in these
areas.
Healthcare practitioners and policymakers should be
trained to explore the effects of their words and actions,
both on the women themselves and on their ability to care
for their children. Moreover, policies related to antiretroviral
initiation must consider, measure and mitigate the GBV that
may follow an HIV diagnosis.
Since so many women are diagnosed with HIV during
pregnancy, healthcare practitioners and policymakers need
to be particularly mindful of the incremental effects of a
diagnosis on GBV. Considering the reports of lack of safety and
HR protection within healthcare services, HR violations
including mandatory testing, disclosure, and coerced or forced
sterilization and abortion should be particularly urgently
addressed. Such information might be sought directly (e.g.
via community surveys, non-governmental organizations, legal
redress, complaints), or found indirectly (e.g. from measuring
access to care and treatment, non-attendance or subsequent
retention in care) [43].
Implications also include that women living with HIV need
to be aware of their rights and the different forms of GBV,
and that they may identify and name violence, recognize
rights violations, find support and develop greater agency to
seek redress and safety. In addition to the priorities identified
in the survey, this study supports suggestions that all
healthcare staff should also be equipped to enquire about
GBV, as a part of routine, everyday, safe interactions within
healthcare settings [44,45], as benefit for all women and
girls, especially those with HIV. Healthcare services must also
have formal pathways to advocacy and safety planning for
women who disclose GBV [44,45].
Regarding future research, there is urgent need for
replication, quantification, refinement and testing of inter-
ventions informed by the experiences of violence and the
intersections of health and HR across the life-cycle. Research
should address health, dignity, and welfare; the interface
between violence and HIV exposure, acquisition and impact;
the interface between violence and other factors, such as
gender identity and gender expression; their impact on the
SRH and HR of women living with HIV; women’s capacity to
take antiretrovirals  as well as their ability to act as primary
carers of the next generation.
Conclusions
Women living with HIV experience unacceptable levels of
violence, including in healthcare settings, across their life-
cycle. This study contributes to the growing literature on GBV
in women living with HIV, both before and after diagnosis.
Global policymakers should heed this literature in policy
formulation and implementation. Since guidelines examine
the formal evidence base which takes time to be published,
any time-lag in information or implementation risks failing
the very end-users that global polices seek to support in
the absence of such key information. Community-based
information can act as a valuable early-warning monitoring
system to assess unintended consequences of global policies.
No woman, with or without HIV, should have to experience
GBV, especially not in healthcare settings, over which policy-
makers and service providers have most control. GBV should
be recognized as a barrier to effectiveness of many policies
regarding testing, care, treatment initiation and adherence.
Addressing GBV as a critical policy issue has instrumental as
well as inherent value. Forthcoming guidelines should en-
compass recommendations for policy, formal healthcare, and a
more holistic view of the current SRH and HR of women living
with HIV in all their diversities, which include community
engagement, a firm foundation of safety, and are based on a
HR framework.
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Abstract
Introduction: Supporting individuals as they disclose their HIV serostatus may lead to a variety of individual and public health
benefits. However, many women living with HIV are hesitant to disclose their HIV status due to fear of negative outcomes such
as violence, abandonment, relationship dissolution and stigma.
Methods: We conducted a systematic review of studies evaluating interventions to facilitate safer disclosure of HIV status for
women living with HIV who experience or fear violence. Articles, conference abstracts and programme reports were included if
they reported post-intervention evaluation results and were published before 1 April 2015. Searching was conducted through
electronic databases for peer-reviewed articles and conference abstracts, reviewing websites of relevant organizations for grey
literature, hand searching reference lists of included studies and contacting experts. Systematic methods were used for screening
and data abstraction, which was conducted in duplicate. Study quality (rigor) was assessed with the Cochrane risk of bias tool.
Results: Two interventions met the inclusion criteria: the Safe Homes and Respect for Everyone cluster-randomized trial
of combination HIV and intimate partner violence (IPV) services in Rakai, Uganda, and the South Africa HIV/AIDS Antenatal
Post-Test Support study individual randomized trial of an enhanced counselling intervention for pregnant women undergoing
HIV testing and counselling. Both programmes integrated screening for IPV into HIV testing services and trained counsellors
to facilitate discussions about disclosure based on a woman’s risk of violence. However, both were implemented as part of
multiple-component interventions, making it impossible to isolate the impact of the safer disclosure components.
Conclusions: The existing evidence base for interventions to facilitate safe HIV serostatus disclosure for women who experience
or fear violence is limited. Development and implementation of new approaches and rigorous evaluation of safe disclosure
outcomes is needed to guide programme planners and policy makers.
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Introduction
HIV serostatus disclosure has been associated with many
potential benefits. People who disclose their HIV status may
receive social support and experience reduced stigma [1],
which may in turn lead to other positive outcomes for them,
their partners and their families, such as engagement in HIV
prevention services (including prevention of mother-to-child
transmission [PMTCT]) and uptake of and adherence to HIV
care and treatment services [2]. Disclosure to sexual partners
could also increase rates of HIV testing and reduce transmis-
sion risk behaviours [3], including increasing the use of anti-
retroviral treatment [4] or pre-exposure prophylaxis (PrEP)
[5] to prevent HIV transmission in sero-discordant couples.
Despite these potential benefits, evidence from a number
of studies and several reviews shows that a substantial
number of women are hesitant to disclose their HIV status
due to fear of negative outcomes such as violence, abandon-
ment, relationship dissolution, stigma, loss of children or
loss of their home [6,7]. Violence is common in the lives of
women. Globally, 35% of women age 15 and older are
estimated to have experienced physical or sexual violence by
an intimate partner or non-partner sexual violence in their
lifetime [8]. A recent survey of 832 women living with HIV
from 94 countries found that participants identified violence
as a significant concern related to their sexual and repro-
ductive health [9]. Violence can be both a risk factor for and
an outcome of HIV infection [8]. Women who are currently in
violent relationships may be at risk of further violence that is
triggered by HIV serostatus disclosure, while other women
who have not previously experienced violence may newly
experience it as an outcome of disclosure. A 2003 systematic
review found that following HIV serostatus disclosure to a
partner between 3.5 and 14.6% of women across studies
reported experiencing negative reactions, including violence
[6]; another non-systematic review also found that violence
may occur around disclosure [10]. More recent studies
from Ethiopia, Nigeria and Zimbabwe have found that large
proportions of women report negative reactions, including
Kennedy CE et al. Journal of the International AIDS Society 2015, 18(Suppl 5):20292
http://www.jiasociety.org/index.php/jias/article/view/20292 | http://dx.doi.org/10.7448/IAS.18.6.20292
74
violence, as outcomes of disclosure and that women who
disclosed were at increased risk of physical and emotional
violence compared to those who had not [1113]. Further, a
systematic review of studies from sub-Saharan Africa found
that a history of domestic violence is associated with non-
disclosure of HIV serostatus among pregnant and postpartum
women [14]. Uptake of HIV testing services among women
has increased, especially among pregnant women in the
context of PMTCT programmes. However, fear of disclosure
and experience of violence and other traumatic or stressful
life events after disclosure of HIV status have been associated
with lower adherence to antiretroviral treatment for women’s
own health and for PMTCT [1519]. Fear and experience of
violence related to HIV serostatus disclosure may also prevent
women from receiving social support, accessing other repro-
ductive health services such as postpartum care and being
able to negotiate safer sex [20,21].
In 2006, the WHO issued a meeting report on addressing
violence against women in HIV testing and counselling ser-
vices [22]. This report called for operational research to assess
counselling, communication and referral tools to support
women through the disclosure and risk-reduction planning
processes. The report identified multiple models for integra-
tion in this area, including in HIV testing and counselling
protocols that considered risk of violence as part of efforts
to evaluate the safety of HIV status disclosure. However,
the report did not assess evidence of success of these
programmes. To examine the evidence for such programmes
nearly a decade after the release of this report, we conduc-
ted a systematic review of rigorous evaluations of interven-
tions to facilitate safe disclosure of HIV status for women
living with HIV who fear violence or are currently experien-
cing violence.
Methods
We conducted a systematic review of the literature following
PRISMA guidelines [23].
Inclusion criteria
Inclusion criteria for the review were as follows:
1) Published in a peer-reviewed journal, presented as an
abstract at a scientific conference or presented as a
grey literature report prior to the search date of 1 April
2015
2) Comparative study (including either pre-/post- or multi-
arm comparison groups) assessing one or more inter-
ventions to facilitate safe disclosure of HIV status for
women living with HIV who fear violence or who
disclose that they are currently experiencing violence
compared with no intervention or standard of care
3) Measures one or more of the following outcomes:
(1) disclosure, (2) violence (physical, sexual, emotional),
(3) fear of violence, (4) other adverse events (e.g.
relationship dissolution, abandonment, job loss, loss of
children, loss of access to services, etc.) or (5) positive
outcomes (e.g. feelings of individual empowerment,
safety, partner involvement, better physical health for
self and children, HIV care and treatment engagement,
adherence to antiretroviral treatment, etc.)
Following Obermeyer et al. [7], we defined HIV serostatus
disclosure as ‘‘the process of revealing a person’s HIV status.’’
However, while Obermeyer et al.’s definition encompasses
both HIV-positive and HIV-negative serostatus disclosure, we
focused on disclosure outcomes among HIV-positive women
where such data were available. We included studies among
all populations of women living with HIV, including adoles-
cents (10 to 19 years) and young people (20 to 24 years) [24]
and women who are members of key populations (e.g. sex
workers, women who use drugs, and women in prisons or
other closed settings). We also included all women living with
HIV, not just those who are newly diagnosed through HIV
testing services.
Interventions to facilitate safer disclosure of HIV status were
defined as any effort to reduce the risk of violence or other
negative outcomes associated with HIV serostatus disclosure.
Such efforts could include identifying people at risk of violence
following disclosure, helping them find strategies to disclose
in a way that reduced their risk of violence (such as through
facilitated disclosure, role plays or safe disclosure plans)
or helping them decide when non-disclosure was the safest
option. Studies examining all types of violence were included,
including physical, sexual and emotional violence, and all
types of violence perpetrators, including intimate partners,
family members and others. Studies could assess violence
using any measure (e.g. the conflict tactic scale, WHO metho-
dology, DHS methodology or an alternate measure). We defi-
ned current experience of violence as recent violence (in the
past 12 months); however, we included articles that used any
definition of current or recent experience of violence as long
as it was intended to identify violence experienced after
the intervention. We were particularly interested in outcome
measures that captured violence related to HIV serostatus
disclosure as opposed to background levels of violence, such
as lifetime prevalence of violence.
No restrictions were placed based on location of the inter-
vention. No language restrictions were used on the search;
if we had identified articles published in languages other
than English that met the inclusion criteria, we intended to
translate them into English.
Search strategy
We searched the following electronic databases through
the cutoff date of 1 April 2015: PubMed, CINAHL (Cumulative
Index to Nursing and Allied Health Literature) and EMBASE.
The following terms were entered into all computer data-
bases: (disclos*) AND (violence OR abuse OR rape OR
‘‘forced sex’’ OR ‘‘coerced sex’’) AND (HIV OR AIDS). We
also conducted secondary reference searching on all studies
included in the review as well as other review articles on
interventions to facilitate HIV serostatus disclosure [25] and
key meeting reports [22]. We used Google Scholar to identify
articles that cited the 2006 WHO meeting report ‘‘Addressing
violence against women in HIV testing and counselling’’ [22].
Further, we contacted a small number of selected experts in
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the field, including the lead authors of included studies, to
identify any additional studies we may have missed.
We searched for conference abstracts by searching web-
sites for the following conferences through 1 April 2015:
International AIDS Conference; IAS Conference on HIV Patho-
genesis, Treatment, and Prevention; the Conference on
Retroviruses and Opportunistic Infections; the International
Conference on AIDS and STIs in Africa; and the Sexual
Violence Research Initiative (SVRI) conference. We attempted
to include abstracts from the End Violence Against Women
International Annual Conference and the World Association
for Sexual Health Congress, but they were not available
online.
To search for other grey literature, we searched the
USAID Development Experience Clearinghouse (DEC) under
the terms HIV and violence and reviewed websites of the
following organizations known to be involved in initiatives
related to violence and HIV: SVRI, the STRIVE research con-
sortium, London School of Hygiene and Tropical Medicine 
Gender Violence and Health Centre, Futures without Violence,
the Futures Group, Columbia University ICAP programme, Inter-
national Planned Parenthood Federation, FHI360, MenEngage,
EngenderHealth and Population Council.
Screening abstracts
Citations identified through the search strategy underwent
an initial screening by a single reviewer based on title
and abstract. All citations that were considered possibly
relevant were then screened by two reviewers separately to
assess whether they met the inclusion criteria, with differ-
ences resolved through consensus. Full text articles were
obtained of all selected abstracts and two independent
reviewers made a final determination of study inclusion after
full text review.
Data extraction and analysis
Data were extracted independently by two reviewers using
standardized forms. Differences in data extraction were re-
solved through consensus and discussion with all authors
when necessary. The following information was gathered
from each included study: citation information, study objec-
tives, location, population characteristics, description of the
intervention, study design, sample size, follow-up periods and
loss to follow-up, analytic approach, violence measures, out-
come measures, comparison groups, effect sizes, confidence
intervals (CIs), significance levels, conclusions and limitations.
For randomized controlled trials, risk of bias was assessed
using the Cochrane Collaboration’s tool for assessing risk of
bias [26].
Meta-analysis was not conducted due to the small number
of included studies. Instead, we present a descriptive sum-
mary of the findings across studies based on our coding
categories and outcomes.
Results
Our initial database search yielded 1080 published citations
(Figure 1). In addition, over 2200 conference abstracts,
unpublished reports and other grey literature publications
were reviewed. The vast majority of these were excluded in
the initial screening; 52 were retained for closer considera-
tion by two independent reviewers. At this level, 45 citations
were excluded for not meeting the inclusion criteria 
generally because they did not report specific intervention
evaluation data related to safer HIV disclosure  and five
were literature reviews included as background material.
Records identified
through database
searching (n=1080)   
Conference abstracts
and grey literature
screened (n>2200)  
Abstracts screened at first level
(n~2948)  
Records after duplicates removed (n~2948)
Abstracts screened at second
level (n=52)
Records excluded (n~2896)
Studies included in review 
(n=2)
Full-text articles excluded 
(n=50) because:
• Did not meet inclusion
  criteria (n=45) 
• Review articles coded as
  background (n=5) 
Figure 1. PRISMA flowchart showing disposition of citations through the search and screening process.
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We identified two studies that ultimately met the inclusion
criteria. One of the studies published evaluation results in
2015 [27], and the other is completed [28] but evaluation
results for the safer disclosure component have not yet been
published. The lead authors of both studies were contacted
to obtain additional information.
Study descriptions
Table 1 presents descriptions of the included studies. Both
were conducted in sub-Saharan Africa, one in rural Uganda
[27] and one in urban South Africa [28]. Both integrated
screening for intimate partner violence (IPV) into HIV testing
and counselling and trained counsellors to facilitate discus-
sions about disclosure based on a woman’s risk of violence. In
addition, both studies included multiple other intervention
components designed to address community norms around
IPV and HIV [27] or to enhance services for women under-
going HIV testing [28].
In the rural Rakai district, Uganda, the Safe Homes and
Respect for Everyone (SHARE) project provided a combina-
tion of IPV prevention and HIV services from 2005 to 2009
[27]. SHARE employed two main approaches to achieve these
goals: a screening and brief intervention in HIV testing and
counselling to reduce HIV disclosure-related violence and
sexual risk and community-based mobilization to change
attitudes and social norms that contribute to IPV and HIV risk
[29]. For the safer disclosure component, counsellors were
trained to screen women for IPV and handle or refer IPV
cases, help HIV-positive women develop safe HIV disclosure
plans and help abused women develop safe sex negotiation
skills. Additional community mobilization activities included
advocacy with local leaders, officials and policy makers;
capacity building and activism with community members and
volunteers; dissemination of booklets, brochures, posters,
story cards and other learning materials; special events such
as fairs, marches, campaigns and poster shows; work with
youth and men; and support groups for HIV-positive women.
The intervention was evaluated through a cluster-randomized
trial nested within the Rakai Community Cohort Study  an
open, community-based cohort [27].
In Umlazi Township, Durban, South Africa, the South Africa
HIV/AIDS Antenatal Post-Test Support (SAHAPS) study eval-
uated an enhanced counselling intervention for pregnant
women undergoing HIV testing and counselling [28]. The
intervention group received enhanced pre- and post-test
counselling during antenatal care as well as two additional
counselling sessions at 6 and 10 weeks postpartum. Women
also had the option to use support groups and onsite legal
services. For the safer disclosure component, counselling
included a five-question structured discussion tool to help
women assess their risk for physical harm following dis-
closure. Counsellors were then trained to explore women’s
risk of disclosure-related violence and to explore alternative
options where indicated. The intervention was evaluated
through an individual randomized controlled trial [28].
Study results
Table 2 presents a summary of key characteristics and out-
comes for the included studies. Both studies received gen-
erally high marks on the Cochrane risk of bias tool, although
due to the nature of the interventions, neither study was
able to blind participants or study staff to intervention
allocation. Both studies examined the impact of the inter-
vention on disclosure and violence; both measured violence
using an adapted version of the conflict tactics scale. The
SAHAPS study measured disclosure and violence 14 weeks
after the receipt of HIV test results and excluded women who
already knew they were HIV-positive, enabling measurement
of violence that was proximal to disclosure. In contrast, the
SHARE study measured disclosure and violence in the past
year among community members residing in the intervention
and control communities, including people who did not
receive new HIV results during the time of the intervention.
Neither study measured the effect of the intervention on
fear of violence, other adverse events or positive outcomes.
Neither study reported outcomes specifically among women
living with HIV who were identified as experiencing or fearing
violence who received the safer disclosure intervention;
however, the SHARE study was able to provide unpublished
data for the sub-sample of women living with HIV. Below, we
present outcomes of both studies on disclosure and violence
among women.
In the SHARE study, women in the intervention group
reported higher rates of HIV serostatus disclosure than
women in the control group at the second follow-up; the
adjusted prevalence rate ratio (aPRR) was 1.15 (95% CI: 1.06
to 1.24). Women’s reports of past-year physical IPV, sexual
IPV and forced sex were lower in the intervention group
compared to the control group at the second follow-up
(35 months after baseline) (physical IPV: aPRR: 0.79, 95% CI:
0.67 to 0.92; sexual IPV: aPRR: 0.80, 95% CI: 0.67 to 0.97;
forced sex: aPRR: 0.80, 95% CI: 0.65 to 0.96). Reports of
emotional IPV were not statistically significantly different at
second follow-up, nor were any outcomes significant at the
first follow-up (16 months after baseline).
The SHARE study authors provided additional data for
women living with HIV in the sample. These data reflect
women with prevalent infection, rather than just those who
were newly learning their HIV-positive status (the main target
of the safer disclosure intervention), and they reflect all
women from the sample in the intervention communities
rather than just women who received the safer disclosure
intervention. At baseline, there was no difference in dis-
closure among women living with HIV across study arms. At
both follow-ups, a higher proportion of women living with
HIV in the intervention group reported disclosing compared
to the control group, but this difference was not significant
(prevalence rate ratio for entire follow-up period: 1.08; 95%
CI: 0.82 to 1.43).
While the SAHAPS study has not yet published disclosure
and violence outcomes, the study authors provided addi-
tional data showing that there were no significant differences
across study arms in either disclosure or IPV at the 14
week postpartum assessment. While the effect of the safer
disclosure component cannot be isolated from the effect of
the rest of the intervention, the fact that the study saw no
measurable effect on disclosure or violence overall may also
suggest that the individual components had no measurable
effect. The authors also looked at interactions between HIV
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Table 1. Descriptions of evaluated interventions
Study Setting Population characteristics Intervention description




59% female, 41% male
Age range: 16 to 42 years
Safe disclosure component: The Safe Homes and Respect for Everyone (SHARE) project included a screening and brief
intervention to reduce HIV-disclosure-related violence and sexual risk in women seeking HTC. HIV counselling protocols were
modified to address IPV, and HTC counsellors were trained to screen women for IPV and handle or refer IPV cases; help
HIV-positive women develop safe HIV disclosure plans; and help abused women develop safe sex negotiation skills.
The intervention was designed for women newly diagnosed with HIV, but was offered to women who were diagnosed
previously but had not disclosed their status and expressed fear of violence.
Other components: SHARE also included extensive community-based mobilization to change attitudes and social norms that
contribute to IPV and HIV risk.








Mean age: 25.5 years
Safe disclosure component: The South Africa HIV/AIDS Antenatal Post-test Support (SAHAPS) study included an additional
structured discussion tool to help women assess their risk for physical harm following disclosure in women seeking HTC. The
counselling tool consisted of five questions that were meant to prompt discussion about the possibility of disclosure-related
violence between the counsellors and their clients. Based on answers to these questions, counsellors were trained to explore
women’s risk of disclosure-related violence and potentially explore alternative options including opting not to disclose,
deferring disclosure to a time when women’s safety can be insured or developing a plan for mediated disclosure in which the
women either brings the partner to the clinic to disclose in the presence of a counsellor or identifies a trusted family member
or friend who can be present with the woman when she shares her HIV test results with her partner, or alternative options.
Other components: SAHAPS also included enhanced HIV pre- and post-test counselling at the first antenatal visit, as well as
two additional counselling sessions at 6 and 10 weeks postpartum. The postpartum counselling sessions were conducted by
the same counsellors the women saw during their antenatal visit. Women also had the option to use support groups, which
were ongoing through the antenatal and postpartum period, and the option to use onsite legal services.










































































































Table 2. Study characteristics and outcomes among women
















Assessments took place at
baseline, 16 months and
35 months follow-up.
Among all women:
Reported disclosure was significantly higher among
women in intervention compared to control
communities at 35 months (42%,
37%; aPRR1.15 [95% CI 1.06, 1.24]), but was not
significantly different at 16 months.
Among HIVwomen:
Reported disclosure was higher, but not statistically
significantly different, among HIV women in
intervention compared to control communities at
16 months (27%, 25%, p0.34) or 35 months
(33%, 29%; p0.24); PRR1.08 (95% CI 0.82,
1.43).
Among all womena:
Reported physical violence was significantly lower
among women in intervention compared to
control communities at 35 months (12%, 16%;
aPRR0.79 [95% CI 0.67, 0.92]), but was not
significantly different at 16 months.
Reported sexual violence and forced sex were
significantly lower among women in intervention
compared to control communities at 35 months
(10%, 13%; aPRR0.80 [CI: 0.67, 0.97]; 8%,
11%; aPRR0.79 [CI: 0.65, 0.96]), but were not
significantly different at 16 months.
No significant difference in reported emotional








Total study population N1480






Assessments took place at
baseline (first antenatal care
visit), 14 weeks postpartum and
9 months postpartum.
Among all womena:
No significant differences in reported disclosure
rates among women between intervention and
control groups at 14 weeks postpartum.
Among all womena:
No significant differences in reported physical,
emotional or sexual violence among women
between intervention and control groups at
14 weeks postpartum.










































































































status, disclosure and IPV among participants in both study
arms at follow-up. Among women who disclosed, IPV at
14 weeks postpartum was not significantly different for HIV-
positive and HIV-negative women. However, among women
who had not disclosed, the odds of reporting IPV at 14 weeks
was almost five times higher for HIV-positive women as
compared to HIV-negative women.
Discussion
Despite significant attention to the intersections between
HIV and violence as well as international policy consensus
on the need to facilitate safer disclosure of HIV serostatus for
women who experience or fear violence, we identified only
two studies evaluating such interventions globally. Both
studies were from sub-Saharan Africa and employed strong
randomized designs. However, neither provided clear evi-
dence for the effectiveness of a safer disclosure intervention
as they were not designed to isolate the contribution of the
safer disclosure components from the broader multiple-
component interventions. The evidence base for interven-
tions to facilitate safer disclosure is thus quite limited, and
further studies are needed.
For all women, the SHARE study in Uganda reported
positive outcomes for disclosure and violence at the second
follow-up. Unpublished data among HIV-positive women
showed non-significant but positive trends in disclosure.
However, these analyses could not distinguish women who
had received the enhanced counselling intervention from
those who had not or newly diagnosed women from those
who had known their HIV-positive status for a long time, both
of which would likely attenuate an effect toward the null. In
the SAHAPS study in South Africa, unpublished data showed
that women who were exposed to the enhanced counselling
intervention were no more likely to disclose to their partner
or report violence after HIV diagnosis than women who
received standard of care HIV testing services. Additional
analyses suggested that women who were already at higher
risk of IPV  particularly HIV-positive women  chose not to
disclose despite, or perhaps because of, the safer disclosure
intervention, while women who disclosed were those who
already knew it was safe to do so. This interpretation is
supported by previous descriptive studies showing that
women who have disclosed their status are less likely to
have ever experienced violence [30] and a systematic review
of male involvement in PMTCT programmes, which found
that women who want to test together as couples may be a
self-selected group of those already in non-violent relation-
ships [31]. Together, these findings suggest that while IPV
continues to be a significant barrier to disclosure for women
who fear violence, it has not been adequately addressed
in current approaches related to provision of HIV testing,
treatment and care services in healthcare settings. There
are several options to be considered in such a scenario.
One option is that in the absence of specific interventions
to respond to violence or promote safety, women who are at
risk of violence may be better off being supported in a
decision not to disclose their status. Another consideration is
to promote safety for women who do want to disclose or
who may experience inadvertent disclosure of their status
and to do so in line with WHO guidelines. These guidelines
recommend training of healthcare providers, especially in
HIV testing settings, to identify women who are at risk of IPV
and offer a response that includes first-line psychological
support including safety planning, addressing immediate
needs for physical and mental health and providing referrals
to appropriate services that address violence [32].
Both studies included in this review evaluated interventions
that integrated screening for IPV into HIV testing services and
trained counsellors to facilitate discussions about disclosure
based on a woman’s risk of violence. HIV testing services
provide an opportunity for safer disclosure interventions,
but this is not the only potential approach to facilitating
safer disclosure for womenwho experience violence.The 2006
WHO consultation found that programmes jointly addressing
the problems of HIV and violence used two broad types of
strategies: those addressing violence against women in HIV
testing programmes and those addressing HIV-related needs
among women who experience violence [22]. While both of
the interventions identified in this review integrated violence
assessments with HIV services, there may be other interven-
tions addressing violence risk in the context of HIV serostatus
disclosure outside of testing that have not been evaluated.
Creative ideas include integrating safer disclosure messages
into support groups for people living with HIV and training
peer counsellors to address disclosure-related violence as part
of their work. We encourage programmes currently attempt-
ing to intervene to facilitate safer disclosure of HIV status for
women who experience or fear violence to share their results
in implementation science journals, short report formats
or by other means of dissemination to add to the existing
evidence base.
In this review, we included all studies that attempted
to directly address safer HIV serostatus disclosure for women
who experience or fear violence. We did not include studies
that may indirectly encourage safer disclosure. For example,
many violence prevention programmes that seek to change
community norms around violence give women legal rights
and protections and give women greater control over
financial resources may also have the effect of creating
safer environments for women to disclose their serostatus.
Similarly, interventions that attempt to reduce HIV-related
stigma and discrimination may also reduce the risk of
violence for women living with HIV who choose to disclose.
Efforts to change community norms that justify or tolerate
violence against women and that perpetrate HIV-related
stigma are critical to creating enabling environments that
reduce violence, which in turn can contribute to facilitating
safer disclosure [33]. However, our review focused on direct
interventions to facilitate safe HIV disclosure that can be
implemented within the context of existing HIV services.
Our findings must be seen in the context of the limitations
of our review. While we did not include any language res-
trictions in our inclusion criteria and searched several
online databases that include articles in languages other
than English, our search for grey literature only included
English-language websites as we were not familiar with any
relevant websites in other languages. We may therefore have
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missed some unpublished evaluations of interventions in
other languages.
While HIV serostatus disclosure may lead to many positive
outcomes, for many women living with HIV, fear of violence
in response to HIV serostatus disclosure is a serious concern.
In many settings, health workers are not trained to identify
women at risk of violence, provide them with appropriate
care and support them in enhancing their safety in relation
to health behaviours (e.g. disclosure, safer sex). Moreover,
in many settings there are few support services or referral
options for women who experience violence generally,
regardless of their HIV status. This situation poses a challenge
for all health services, including HIV and reproductive health
programmes, which are often resource-constrained at the
human and financial levels and may not be able to provide
comprehensive violence services. Further, as new approaches
to HIV testing are expanded as part of efforts to reach the
UNAIDS 90-90-90 targets, including community-based and
provider-initiated testing, self-testing and testing conducted
by lay healthcare providers [34], programmes will need to
consider how to achieve safer disclosure of HIV status within
the complexities inherent in each of these models [35].
Further research is needed to identify which interventions
can best achieve the objective of supporting women living
with HIV who experience or fear violence to safely disclose
their HIV serostatus  or not to disclose at all, as appropriate 
in order to inform programme and policy decisions.
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Abstract
Introduction: This commentary provides the rationale and makes a call for greater investment and effort to meet the sexual and
reproductive health (SRH) problems of adolescent girls living with HIV in low- and middle-income countries (LMIC).
Discussion: Adolescent girls in LMIC are at a greater risk of acquiring HIV infection than their male peers. They also face a
number of other serious SRH problems  early pregnancy, pregnancy- and childbirth-related complications, unsafe abortions,
sexual abuse and intimate partner violence and sexually transmitted infections. While many LMIC have made notable progress in
preventing HIV in children and adults and in improving the access of these population groups to HIV treatment and care,
adolescents in general and adolescent girls in particular have not received the same effort and investment.
Conclusions: Much more needs to be done to implement proven approaches to prevent new HIV infections in adolescent girls in
LMIC and to meet the needs of those living with HIV.
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Introduction
In the 15 years since the United Nations Millennium Declara-
tion, the world has made tremendous progress in reducing the
number of new HIV infections and in reducing deaths in those
living with HIV [1,2].
Relative to this improvement, there has been limited
progress in preventing new HIV infections in adolescents, es-
pecially in low- and middle-income countries (LMIC) [1,2]. This
is both because the interventions that have been used have
been shown to be of limited effectiveness [3] and because HIV
prevention efforts in adolescents have not received the
investment and effort needed [4]. Many LMIC have made
substantial progress in diagnosing and treating children and
adults with HIV infection. Lack of concerted efforts directed at
adolescents has meant that LMIC have made relatively less
progress in reaching this population groupwith HIV testing and
counselling, as well as treatment and care services [1,5,6].
While HIV infections and HIV-related mortality and morbid-
ity occur in both adolescent boys and girls, the number of new
infections and the number of individuals living with HIV are far
higher in the latter [1,2,5,6]. This is primarily because
biological as well as social, cultural and economic factors
increase girls’ vulnerability to HIV infection and to its health
and social consequences. While acknowledging that boys and
young men need concerted attention too, the focus of this
paper is on adolescent girls and young women, with a special
focus on those living with HIV. It provides the rationale and
makes a call for greater investment and effort to meet the
sexual and reproductive health (SRH) problems of adolescent
girls living with HIV in LMIC.
Discussion
This paper begins by describing the SRH problems that
adolescent girls face. It then discusses the limited progress
that has been made in preventing these problems, respond-
ing to them when they occur and especially in addressing the
social, cultural and economic drivers of these problems. It
then discusses the need to increase access to HIV testing and
counselling for adolescent girls and to treatment and care for
those living with HIV.
SRH problems in adolescent girls
While most adolescents make the transition to adulthood in
good health, not all are so fortunate. They face SRH problems;
in endemic countries, HIV is an important one of them.
Globally, new HIV infections in all age groups declined by
38% since 2001 [6]. New HIV infections among adolescents
declined even more sharply, by 43%. However, a substantial
number of HIV infections  an estimated 250,000 new
infections  occurred in adolescents globally in 2012 (range
210,000 to 290,000). Progress was uneven across different
regions. For example, while new infections have decreased
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substantially in Eastern and Southern Africa, they have
remained stable in Asia and the Pacific [1,5,6]. Adolescent
girls are affected more than their male peers; 64% of the new
infections were in girls aged 15 to 19 [1,5,6]. Finally, data from
the few available studies on adolescent girls in key populations
(Note: Key populations (also referred to as most-at-risk popu-
lations) are people who inject drugs, gay men and other men
who have sex with men, transgender persons and sex workers.
They are disproportionately infected with HIV compared to
the general population.) suggest that they have significantly
higher HIV prevalence and other sexually transmitted infec-
tions (STIs) than their peers in the general population [7,8].
Adolescent girls are affected by a number of other SRH
problems. An estimated 16 million girls aged 15 to 19 and
some onemillion girls less than 15 years give birth every year 
most in LMIC [9,10]. Complications during pregnancy and
childbirth are the second leading cause of death for 15 to 19
year-old girls globally (after road traffic injuries) [9]. Adoles-
cent pregnancy, especially when it occurs in early adolescence,
is associated with higher rates of maternal mortality and
morbidity [11]. It is also associated with increased risks of
mortality and morbidity in newborns and children [12]. Of the
estimated 22 million unsafe abortions that occur every year,
15% occur among girls aged 15 to 19 [13]. Adolescent girls are
at risk of childhood sexual abuse in homes and community
settings such as schools, from influential adults around them.
Globally, 1 in 10 girls under the age of 20 have been sexually
abused [14]. Additionally, an estimated 30% of girls aged 15
to 19 experience intimate partner violence [15]. The WHO
estimates that every year 500 million people become ill with
one of four curable STIs  chlamydia, gonorrhoea, syphilis and
trichomoniasis. In addition there is a huge burden of viral STIs.
TheWHO also estimates thatmore than 530million people are
infected with the herpes simplex virus, which causes genital
herpes, and more than 290 million women with the human
papilloma virus, which causes genital warts and cervical
cancer. The available data is not disaggregated by age and so
we do not have global estimates for STIs in adolescents.
However, in most populations higher levels of infection are
noted in young populations [16].
Globally, there are an estimated 35 million people living
with HIV. In 2013, an estimated 1.5million died of AIDS-related
illnesses. This figure represents a 35% decline since the peak of
2.4 million deaths, recorded in 2005. AIDS-related deaths,
however, have not decreased among adolescents aged 10 to
19 [2]. At the end of 2013, an estimated 2.1million adolescents
(aged 10 to 19 years) were living with HIV; with the majority in
sub-Saharan Africa [6]. This estimate includes both perinatally
infected children surviving into adolescence as well as
individuals infected in the second decade of their lives. In
2013, an estimated 120,000 adolescents aged 10 to 19 years
(range 100,000 to 130,000) died of AIDS-related illnesses [1,5].
AIDS remains the number one killer of adolescents in sub-
Saharan Africa [2].
Meeting the SRH information and service needs
of all adolescent girls and of those living with HIV
In many contexts, adolescent girls are ill-informed about their
bodies and their health and are unprepared for the changes
they are experiencing and the challenges they could face. For
example, only 30% of young women aged 15 to 24 in sub-
Saharan Africa countries (with available data) had compre-
hensive, correct knowledge of HIV transmission in 2014. This
represents an increase of less than 10% in four years [2].
Improving adolescent girls’ knowledge and understanding of
SRH and building their life skills to take charge of their health
is a crucial step in meeting their health needs and fulfilling
their rights [17]. As girls move from older childhood into and
through adolescence and then into early adulthood, they
need sexuality education that responds to their develop-
mental stages and circumstances and evolves with their
changing needs. The sexuality education they receive should
be comprehensive; it should both include and go beyond
information on sexuality, reproduction and SRH problems
and how to avoid them [18,19].
Adolescent girls living with HIV must learn what all girls
need to. In addition they must learn to live with a chronic
illness and to deal with the emotional and psychological
issues associated with the knowledge that HIV is a highly
stigmatized transmissible infection. This aspect often has an
enormous impact on their sexual health and relationships.
Adolescent girls living with HIV do not lose their desire for
sex or to have families. Some have not yet had sex but hope/
intend to do so in the future and have questions and
concerns. Many others have had sex and have unanswered
questions and concerns about infecting others, disclosing
their status to their partners and having sex and children
safely. They need information and counselling that responds
to these needs [20,21].
Almost universally, adolescent girls lack access to the SRH
commodities (such as condoms and other contraceptives)
that they need to protect themselves or to the health
services they need (e.g. diagnosis and treatment of STIs, HIV
testing and counselling, treatment and care). Restrictive laws
and policies in many countries forbid the provision of these
services to unmarried adolescents, those below the age of
majority. Often adolescent girls do not know where and how
to obtain the health services they need. Even when they are
able to obtain health services, they are often reluctant to do
so because of fears about privacy, confidentiality, of being
judged and of being treated with disrespect [17]. And as a
study by Nalwadda et al. in Uganda highlighted, when they
do seek care, adolescent girls say that they are treated with
disrespect or are even turned away by providers who refuse
to offer them services [22].
Adolescents living with HIV face an additional burden.
Stigma and discrimination against people living with HIV and
key populations in healthcare settings continue to undermine
HIV responses [23]. Adolescent girls can be labelled as
promiscuous or discriminated against by not being provided
the health services they need [23]. Further, in some settings,
they can be coerced into procedures such as sterilization or
pregnancy termination [24].
Whether or not they are living with HIV, adolescent girls
have a right to a healthy, enjoyable and safe sex life. SRH
services should enable them to reduce or avoid health prob-
lems and should enable those who experience health pro-
blems to recover [25,26]. Countries should eliminate medical
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and social restrictions to the provision of SRH services
including contraceptives to adolescent girls and should sup-
port and enable them to obtain commodities and services that
are appropriate to their needs and preferences through
delivery mechanisms that are acceptable to them [27]. Health
services should also be ready to provide those girls who are
pregnant with quality antenatal care including linkages to
prevention of mother-to-child transmission of HIV care or to
help in obtaining a safe abortion where this is permitted by
law. Effective care during childbearing is important to ensuring
the survival of mothers and their babies and the prevention of
mother-to-child transmission and other problems such as
fistulas resulting fromobstructed labour. Adolescent girls living
with HIV need access to contraceptive services including
emergency contraception, safe abortion services and services
to prevent mother-to-child transmission of HIV, if they get
pregnant and want to continue with their pregnancies. They
also need information and services to avoid STIs and diagnosis
and treatment for STIs when they occur.
Addressing the social, cultural and economic
drivers of SRH problems in all adolescent girls
and in those living with HIV
In several settings, adolescent girls engage in sexual relation-
ships with men who are several years older than them. These
relationships entail the exchange of sex for essentials (such as
food and school fees) as well as non-essential ones (such as
mobile phones). Cross-generational sexual relationships are a
key driver of HIV risk among adolescent girls. To respond to
this, a number of research studies and projects have been
undertaken to test approaches to reduce the vulnerabilities of
adolescent girls through economic empowerment interven-
tions such as waivers of school fees, cash transfers and
microfinance schemes. There is a growing knowledge base in
this area [28].
There is also growing research evidence and project
experience in preventing sexual coercion of girls [29,30]. This
endeavour requires amultifaceted andmultilevel approach. At
the wider societal level, laws that forbid violence against
women and girls should be passed and enforced effectively.
Together with this action, efforts are needed to develop social
norms that are intolerant of such violence. At the community
level, steps should be taken to protect girls and women from
physical and emotional violence at home, as well as sexual
harassment and coercion in educational institutions and other
community settings. These efforts should include activities
directed at boys and men to address masculine norms that
encourage boys and young men to take sexual risks to prove
their manhood and to assert their masculinity by coercing girls
and women to have sex. Adolescent girls and boys should
be taught that violence is an unacceptable way to resolve
conflicts. Moreover, boys and young men should be taught
that sexual relationships should be based on equity and
respect [29,30].
Studies from many countries point to the common
occurrence of forced sex involving adolescent girls and the
HIV risk associated with it [31].There is a dearth of information
on whether adolescent girls with HIV experience coerced
sex or pressure to have transactional sex. However, such a
situation is not unlikely. Given this information, adolescent
girls living with HIV should be included in empowering
interventions directed at girls uninfected with HIV.
Increasing access to HIV testing and counselling
for adolescent girls and to treatment and care
for those living with HIV
As indicated earlier, there are an estimated 1.2 million ado-
lescents living with HIV, with 70 to 80% living in sub-Saharan
African. Many of the latter are unaware of their HIV status
[2,5]. While there are currently no estimates of antiretroviral
coverage for adolescents, the available evidence suggests
higher rates of loss to follow-up, poor adherence and increa-
sed requirement for psychosocial support in this age group
[3236]. Studies have also pointed to gaps and weaknesses in
health services to address the SRH needs of adolescents living
with HIV [3739]. For example, a Kenyan study of adolescents
living with HIV reported low rates of contraceptive use (66%).
Of those sexually active female respondents, 68% had already
been pregnant and three-quarters of those were unintended
pregnancies [38]. Additionally, higher mother-to-child trans-
mission risk was seen among infants of HIV-positive adolescent
mothers compared to adult mothers, with a 1.7-fold increased
risk compared to adult mothers in one study in KwaZulu Natal,
South Africa [39]. Adolescent girls from key population groups
are also often subject to significant levels of stigma, discrimi-
nation, violence, increased risk for criminalization and incar-
ceration and social isolation. These further exclude them from
essential platforms for support and access to SRH and other
prevention or treatment services [23].
Looking back at the global response to meeting
the needs and fulfilling the rights of adolescent
girls, 21 years since the International Conference
on Population and Development, and 15 years
since the United Nations Millennium Declaration
In 2014, the world commemorated the twentieth anniversary
of the International Conference on Population and Develop-
ment (ICPD). Reviews of progress in the implementation of
adolescent sexual and reproductive health policies and
programmes over the two decades since the landmark
conference noted that progress was limited and patchy [40].
The Millennium Development Goals report for 2015 also
points to limited progress made in adolescents in relation to
Goals 5 and 6 [2].
A review of the ICPD’s achievements that focused on
adolescent girls echoed these findings: ‘‘. . . many countries
have yet to make significant progress in delaying marriage and
childbearing, reducing unintended childbearing, narrowing
gender disparities that put girls at risk of poor sexual and
reproductive health outcomes, expanding health awareness or
enabling access to sexual and reproductive health services’’ [41].
Given this backdrop, UNAIDS has called for a much stronger
collective response to preventing HIV and HIV-related mortal-
ity in adolescents [42].
Two recent reviews stress the need to strengthen HIV
prevention efforts directed at adolescent girls in LMIC, by
using tailor-made combinations of biomedical, behavioural
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and structural interventions to address the web of individual
and environmental factors that increase their vulnerability to
HIV. Both stress the importance of developing more effective
prevention options [28,43].
HIV prevention efforts must be implemented with efforts
to improve the provision of, access to and uptake of quality
health services (including SRH services, HIV testing counsel-
ling and HIV treatment and care services) to adolescent girls
living with HIV. Two complementary approaches are needed.
Firstly, lack of the required competencies and moralistic
attitudes or values stand in the way of health workers
providing adolescents living with HIV with the health services
they need. Training, value clarification and ongoing support
can enable them to make the contributions they need to.
Two important starting points are making an assessment of
sexual activity and providing full and accurate information
[44]. Secondly, in most LMIC, health services are either not
available or are not geared towards adolescents. Existing
services should be made more welcoming (accessible and
acceptable) to adolescents living with HIV  including those
in key populations. Integrating SRH services with other health
services, decentralizing their provision away from hospitals to
clinics in the adolescent’s neighbourhood and reaching out
with services in the community can extend their range [45].
Conclusions
Limited progress has been made in preventing SRH problems,
notably HIV infections, in adolescent girls and in preventing
HIV-related mortality in this group. This inadequate improve-
ment, especially in relation to the progress made in other
groups, is unacceptable. Much more needs to be done to
prevent HIV in girls and to enable those living with HIV to
survive and live to their full potential.
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